AGE|AGE_SPECIFIC_CI_LOWER|AGE_SPECIFIC_CI_UPPER|AGE_SPECIFIC_RATE|COUNT|ICCC_GROUP|POPULATION|YEAR
10-14|0.1|0.2|0.1|20|IV Neuroblastoma and other peripheral nervous cell tumors|19773006|2006
15-19|~|~|~|~|IV Neuroblastoma and other peripheral nervous cell tumors|20449826|2006
5-9|0.3|0.4|0.3|66|IV Neuroblastoma and other peripheral nervous cell tumors|18880537|2006
<1|4.4|5.9|5.1|205|IV Neuroblastoma and other peripheral nervous cell tumors|4007564|2006
1-4|1.7|2.1|1.9|299|IV(a) Neuroblastoma and ganglioneuroblastoma|15607694|2006
10-14|0.0|0.1|0.1|16|IV(a) Neuroblastoma and ganglioneuroblastoma|19773006|2006
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|20449826|2006
5-9|0.3|0.4|0.3|65|IV(a) Neuroblastoma and ganglioneuroblastoma|18880537|2006
<1|4.4|5.9|5.1|205|IV(a) Neuroblastoma and ganglioneuroblastoma|4007564|2006
1-4|~|~|~|~|II(e) Unspecified lymphomas|15917630|2005
10-14|~|~|~|~|II(e) Unspecified lymphomas|20461017|2005
15-19|~|~|~|~|II(e) Unspecified lymphomas|20618219|2005
1-4|~|~|~|~|II(a) Hodgkin lymphomas|15607694|2006
10-14|1.1|1.4|1.2|245|II(a) Hodgkin lymphomas|19773006|2006
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15688413|2004
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20724858|2004
15-19|~|~|~|~|XII(a) Other specified malignant tumors|20301027|2004
5-9|~|~|~|~|XII(a) Other specified malignant tumors|19244948|2004
<1|~|~|~|~|XII(a) Other specified malignant tumors|4020211|2004
15-19|2.9|3.4|3.1|641|II(a) Hodgkin lymphomas|20449826|2006
5-9|0.4|0.6|0.5|90|II(a) Hodgkin lymphomas|18880537|2006
<1|~|~|~|~|II(a) Hodgkin lymphomas|4007564|2006
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15688413|2004
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20724858|2004
15-19|~|~|~|~|XII(b) Other unspecified malignant tumors|20301027|2004
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|19244948|2004
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|4020211|2004
1-4|0.3|0.5|0.4|57|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15607694|2006
10-14|0.8|1.0|0.9|179|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19773006|2006
15-19|1.3|1.7|1.5|304|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20449826|2006
5-9|0.5|0.7|0.6|108|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|18880537|2006
<1|0.3|0.8|0.5|20|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|4007564|2006
1-4|19.9|21.3|20.6|3281|All ICCC Groups Combined|15917630|2005
10-14|12.4|13.4|12.9|2632|All ICCC Groups Combined|20461017|2005
15-19|21.3|22.6|22.0|4529|All ICCC Groups Combined|20618219|2005
5-9|11.0|11.9|11.4|2191|All ICCC Groups Combined|19173994|2005
<1|22.5|25.5|23.9|965|All ICCC Groups Combined|4030153|2005
1-4|0.1|0.3|0.2|29|II(c) Burkitt lymphoma|15607694|2006
10-14|0.2|0.4|0.3|57|II(c) Burkitt lymphoma|19773006|2006
15-19|0.2|0.3|0.2|47|II(c) Burkitt lymphoma|20449826|2006
5-9|0.2|0.4|0.3|55|II(c) Burkitt lymphoma|18880537|2006
<1|~|~|~|~|II(c) Burkitt lymphoma|4007564|2006
1-4|8.1|9.0|8.5|1360|I Leukemias, myeloproliferative & myelodysplastic diseases|15917630|2005
10-14|2.7|3.2|3.0|606|I Leukemias, myeloproliferative & myelodysplastic diseases|20461017|2005
15-19|2.8|3.2|3.0|618|I Leukemias, myeloproliferative & myelodysplastic diseases|20618219|2005
5-9|3.5|4.0|3.7|716|I Leukemias, myeloproliferative & myelodysplastic diseases|19173994|2005
<1|4.0|5.4|4.7|188|I Leukemias, myeloproliferative & myelodysplastic diseases|4030153|2005
1-4|6.8|7.6|7.2|1140|I(a) Lymphoid leukemias|15917630|2005
10-14|1.7|2.1|1.9|388|I(a) Lymphoid leukemias|20461017|2005
15-19|1.4|1.8|1.6|329|I(a) Lymphoid leukemias|20618219|2005
5-9|2.8|3.3|3.1|590|I(a) Lymphoid leukemias|19173994|2005
<1|1.5|2.4|1.9|77|I(a) Lymphoid leukemias|4030153|2005
1-4|0.1|0.3|0.2|30|II(d) Miscellaneous lymphoreticular neoplasms|15607694|2006
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19773006|2006
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20449826|2006
5-9|0.0|0.1|0.1|16|II(d) Miscellaneous lymphoreticular neoplasms|18880537|2006
<1|0.3|0.8|0.5|20|II(d) Miscellaneous lymphoreticular neoplasms|4007564|2006
1-4|~|~|~|~|II(e) Unspecified lymphomas|15607694|2006
10-14|~|~|~|~|II(e) Unspecified lymphomas|19773006|2006
15-19|~|~|~|~|II(e) Unspecified lymphomas|20449826|2006
5-9|~|~|~|~|II(e) Unspecified lymphomas|18880537|2006
<1|~|~|~|~|II(e) Unspecified lymphomas|4007564|2006
1-4|7.1|8.0|7.6|1185|I(a) Lymphoid leukemias|15688413|2004
10-14|1.7|2.0|1.8|382|I(a) Lymphoid leukemias|20724858|2004
1-4|~|~|~|~|X(d) Gonadal carcinomas|15151945|2003
10-14|~|~|~|~|X(d) Gonadal carcinomas|20383692|2003
15-19|0.1|0.2|0.1|19|X(d) Gonadal carcinomas|19681033|2003
5-9|~|~|~|~|X(d) Gonadal carcinomas|19012396|2003
<1|~|~|~|~|X(d) Gonadal carcinomas|3882968|2003
1-4|0.8|1.1|0.9|149|I(b) Acute myeloid leukemias|15917630|2005
10-14|0.6|0.8|0.7|136|I(b) Acute myeloid leukemias|20461017|2005
15-19|0.7|1.0|0.8|174|I(b) Acute myeloid leukemias|20618219|2005
5-9|0.3|0.5|0.4|75|I(b) Acute myeloid leukemias|19173994|2005
<1|1.2|2.0|1.6|64|I(b) Acute myeloid leukemias|4030153|2005
1-4|3.7|4.3|4.0|622|III CNS and misc intracranial and intraspinal neoplasms|15607694|2006
10-14|2.2|2.7|2.4|480|III CNS and misc intracranial and intraspinal neoplasms|19773006|2006
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15151945|2003
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20383692|2003
15-19|0.1|0.2|0.1|20|X(e) Other and unspecified malignant gonadal tumors|19681033|2003
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19012396|2003
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3882968|2003
1-4|0.1|0.2|0.1|17|I(c) Chronic myeloproliferative diseases|15917630|2005
10-14|0.1|0.3|0.2|41|I(c) Chronic myeloproliferative diseases|20461017|2005
15-19|0.3|0.4|0.3|67|I(c) Chronic myeloproliferative diseases|20618219|2005
5-9|~|~|~|~|I(c) Chronic myeloproliferative diseases|19173994|2005
<1|~|~|~|~|I(c) Chronic myeloproliferative diseases|4030153|2005
1-4|0.1|0.3|0.2|28|XI Other malignant epithelial neoplasms and malignant melanomas|15151945|2003
10-14|1.2|1.5|1.4|280|XI Other malignant epithelial neoplasms and malignant melanomas|20383692|2003
15-19|4.7|5.3|5.0|982|XI Other malignant epithelial neoplasms and malignant melanomas|19681033|2003
5-9|0.2|0.4|0.3|53|XI Other malignant epithelial neoplasms and malignant melanomas|19012396|2003
15-19|2.0|2.4|2.2|454|III CNS and misc intracranial and intraspinal neoplasms|20449826|2006
5-9|2.9|3.4|3.1|590|III CNS and misc intracranial and intraspinal neoplasms|18880537|2006
<1|2.7|3.8|3.2|129|III CNS and misc intracranial and intraspinal neoplasms|4007564|2006
<1|0.3|0.8|0.5|21|XI Other malignant epithelial neoplasms and malignant melanomas|3882968|2003
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15688413|2004
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20724858|2004
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|20301027|2004
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|19244948|2004
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|4020211|2004
1-4|0.3|0.5|0.4|66|III(a) Ependymomas and choroid plexus tumor|15607694|2006
10-14|0.1|0.2|0.2|34|III(a) Ependymomas and choroid plexus tumor|19773006|2006
15-19|0.2|0.3|0.2|46|III(a) Ependymomas and choroid plexus tumor|20449826|2006
5-9|0.2|0.3|0.2|47|III(a) Ependymomas and choroid plexus tumor|18880537|2006
<1|0.3|0.8|0.5|21|III(a) Ependymomas and choroid plexus tumor|4007564|2006
1-4|~|~|~|~|VIII(b) Chondrosarcomas|72032406|2002-2006
10-14|0.0|0.1|0.0|41|VIII(b) Chondrosarcomas|94924078|2002-2006
15-19|0.1|0.1|0.1|75|VIII(b) Chondrosarcomas|93992876|2002-2006
5-9|~|~|~|~|VIII(b) Chondrosarcomas|89136197|2002-2006
<1|~|~|~|~|VIII(b) Chondrosarcomas|18407240|2002-2006
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15151945|2003
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20383692|2003
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|19681033|2003
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|19012396|2003
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3882968|2003
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15688413|2004
10-14|0.4|0.6|0.5|111|XI(b) Thyroid carcinomas|20724858|2004
15-19|1.7|2.1|1.9|388|XI(b) Thyroid carcinomas|20301027|2004
5-9|0.1|0.2|0.2|34|XI(b) Thyroid carcinomas|19244948|2004
<1|~|~|~|~|XI(b) Thyroid carcinomas|4020211|2004
1-4|7.9|8.8|8.4|1307|I Leukemias, myeloproliferative & myelodysplastic diseases|15607694|2006
10-14|3.0|3.5|3.2|640|I Leukemias, myeloproliferative & myelodysplastic diseases|19773006|2006
15-19|3.0|3.4|3.2|653|I Leukemias, myeloproliferative & myelodysplastic diseases|20449826|2006
5-9|3.5|4.1|3.8|715|I Leukemias, myeloproliferative & myelodysplastic diseases|18880537|2006
<1|4.7|6.2|5.4|218|I Leukemias, myeloproliferative & myelodysplastic diseases|4007564|2006
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15151945|2003
10-14|0.4|0.6|0.5|106|XI(b) Thyroid carcinomas|20383692|2003
15-19|1.6|2.0|1.8|350|XI(b) Thyroid carcinomas|19681033|2003
5-9|~|~|~|~|XI(b) Thyroid carcinomas|19012396|2003
<1|~|~|~|~|XI(b) Thyroid carcinomas|3882968|2003
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15688413|2004
10-14|0.1|0.2|0.1|22|XI(c) Nasopharyngeal carcinomas|20724858|2004
15-19|0.1|0.2|0.1|21|XI(c) Nasopharyngeal carcinomas|20301027|2004
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|19244948|2004
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|4020211|2004
1-4|6.6|7.4|7.0|1091|I(a) Lymphoid leukemias|15607694|2006
10-14|2.0|2.4|2.2|427|I(a) Lymphoid leukemias|19773006|2006
15-19|1.4|1.8|1.6|330|I(a) Lymphoid leukemias|20449826|2006
5-9|2.9|3.4|3.1|586|I(a) Lymphoid leukemias|18880537|2006
<1|1.7|2.6|2.1|85|I(a) Lymphoid leukemias|4007564|2006
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15151945|2003
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20383692|2003
15-19|0.1|0.3|0.2|40|XI(c) Nasopharyngeal carcinomas|19681033|2003
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|19012396|2003
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3882968|2003
1-4|0.1|0.2|0.1|21|XI(d) Malignant melanomas|15688413|2004
10-14|0.3|0.5|0.4|88|XI(d) Malignant melanomas|20724858|2004
15-19|1.7|2.0|1.9|376|XI(d) Malignant melanomas|20301027|2004
5-9|0.1|0.2|0.2|34|XI(d) Malignant melanomas|19244948|2004
<1|~|~|~|~|XI(d) Malignant melanomas|4020211|2004
1-4|0.1|0.1|0.1|72|VIII(c) Ewing tumor and related sarcomas of bone|72032406|2002-2006
10-14|0.3|0.4|0.4|367|VIII(c) Ewing tumor and related sarcomas of bone|94924078|2002-2006
15-19|0.4|0.5|0.4|406|VIII(c) Ewing tumor and related sarcomas of bone|93992876|2002-2006
5-9|0.2|0.2|0.2|190|VIII(c) Ewing tumor and related sarcomas of bone|89136197|2002-2006
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|18407240|2002-2006
1-4|0.8|1.2|1.0|154|I(b) Acute myeloid leukemias|15607694|2006
10-14|0.6|0.9|0.7|148|I(b) Acute myeloid leukemias|19773006|2006
15-19|0.8|1.1|0.9|190|I(b) Acute myeloid leukemias|20449826|2006
5-9|0.3|0.5|0.4|76|I(b) Acute myeloid leukemias|18880537|2006
<1|1.2|2.0|1.5|62|I(b) Acute myeloid leukemias|4007564|2006
1-4|~|~|~|~|XI(d) Malignant melanomas|15151945|2003
10-14|0.3|0.5|0.4|81|XI(d) Malignant melanomas|20383692|2003
15-19|1.6|2.0|1.8|353|XI(d) Malignant melanomas|19681033|2003
5-9|0.0|0.1|0.1|16|XI(d) Malignant melanomas|19012396|2003
<1|~|~|~|~|XI(d) Malignant melanomas|3882968|2003
1-4|~|~|~|~|XI(e) Skin carcinomas|15688413|2004
10-14|~|~|~|~|XI(e) Skin carcinomas|20724858|2004
15-19|~|~|~|~|XI(e) Skin carcinomas|20301027|2004
5-9|~|~|~|~|XI(e) Skin carcinomas|19244948|2004
<1|~|~|~|~|XI(e) Skin carcinomas|4020211|2004
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|72032406|2002-2006
10-14|0.0|0.1|0.1|49|VIII(d) Other specified malignant bone tumors|94924078|2002-2006
15-19|0.1|0.1|0.1|85|VIII(d) Other specified malignant bone tumors|93992876|2002-2006
5-9|0.0|0.0|0.0|23|VIII(d) Other specified malignant bone tumors|89136197|2002-2006
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|18407240|2002-2006
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|15607694|2006
1-4|0.1|0.2|0.1|16|VIII(c) Ewing tumor and related sarcomas of bone|15151945|2003
10-14|0.3|0.5|0.4|78|VIII(c) Ewing tumor and related sarcomas of bone|20383692|2003
15-19|0.3|0.5|0.4|71|VIII(c) Ewing tumor and related sarcomas of bone|19681033|2003
5-9|0.1|0.2|0.2|34|VIII(c) Ewing tumor and related sarcomas of bone|19012396|2003
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3882968|2003
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15688413|2004
10-14|0.2|0.4|0.3|60|XI(f) Other and unspecified carcinomas|20724858|2004
15-19|0.9|1.2|1.1|218|XI(f) Other and unspecified carcinomas|20301027|2004
5-9|0.1|0.2|0.1|21|XI(f) Other and unspecified carcinomas|19244948|2004
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|4020211|2004
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|72032406|2002-2006
10-14|0.0|0.0|0.0|26|VIII(e) Unspecified malignant bone tumors|94924078|2002-2006
15-19|0.0|0.0|0.0|22|VIII(e) Unspecified malignant bone tumors|93992876|2002-2006
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|89136197|2002-2006
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|18407240|2002-2006
10-14|0.1|0.2|0.1|26|I(c) Chronic myeloproliferative diseases|19773006|2006
15-19|0.3|0.5|0.4|77|I(c) Chronic myeloproliferative diseases|20449826|2006
5-9|~|~|~|~|I(c) Chronic myeloproliferative diseases|18880537|2006
<1|0.4|0.9|0.6|23|I(c) Chronic myeloproliferative diseases|4007564|2006
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15151945|2003
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|20383692|2003
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|15688413|2004
10-14|0.0|0.1|0.1|17|XII Other and unspecified malignant neoplasms|20724858|2004
15-19|0.1|0.2|0.1|24|XII Other and unspecified malignant neoplasms|20301027|2004
1-4|0.3|0.4|0.3|237|X Germ cell, trophoblastic tumors & neoplasms of gonads|72032406|2002-2006
10-14|0.7|0.8|0.7|687|X Germ cell, trophoblastic tumors & neoplasms of gonads|94924078|2002-2006
15-19|2.6|2.9|2.7|2580|X Germ cell, trophoblastic tumors & neoplasms of gonads|93992876|2002-2006
1-4|0.1|0.3|0.2|27|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15607694|2006
10-14|0.1|0.2|0.1|19|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19773006|2006
15-19|0.1|0.2|0.1|25|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20449826|2006
5-9|0.1|0.2|0.1|18|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|18880537|2006
<1|0.5|1.1|0.8|31|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|4007564|2006
15-19|~|~|~|~|VIII(d) Other specified malignant bone tumors|19681033|2003
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|19012396|2003
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3882968|2003
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|19244948|2004
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|4020211|2004
1-4|0.1|0.2|0.1|20|I(e) Unspecified and other specified leukemias|15607694|2006
10-14|0.1|0.2|0.1|20|I(e) Unspecified and other specified leukemias|19773006|2006
15-19|0.1|0.2|0.2|31|I(e) Unspecified and other specified leukemias|20449826|2006
5-9|0.1|0.2|0.1|21|I(e) Unspecified and other specified leukemias|18880537|2006
<1|0.2|0.7|0.4|17|I(e) Unspecified and other specified leukemias|4007564|2006
5-9|0.2|0.3|0.2|194|X Germ cell, trophoblastic tumors & neoplasms of gonads|89136197|2002-2006
<1|1.8|2.3|2.0|376|X Germ cell, trophoblastic tumors & neoplasms of gonads|18407240|2002-2006
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15151945|2003
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20383692|2003
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19681033|2003
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19012396|2003
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3882968|2003
1-4|0.2|0.4|0.3|49|X Germ cell, trophoblastic tumors & neoplasms of gonads|15688413|2004
10-14|0.7|1.0|0.8|176|X Germ cell, trophoblastic tumors & neoplasms of gonads|20724858|2004
15-19|2.5|3.0|2.8|560|X Germ cell, trophoblastic tumors & neoplasms of gonads|20301027|2004
5-9|0.2|0.3|0.2|43|X Germ cell, trophoblastic tumors & neoplasms of gonads|19244948|2004
<1|1.4|2.3|1.8|74|X Germ cell, trophoblastic tumors & neoplasms of gonads|4020211|2004
1-4|~|~|~|~|VI(b) Renal carcinomas|14396227|2002
10-14|~|~|~|~|VI(b) Renal carcinomas|19533296|2002
15-19|0.1|0.2|0.1|20|VI(b) Renal carcinomas|18815493|2002
5-9|~|~|~|~|VI(b) Renal carcinomas|18503153|2002
<1|~|~|~|~|VI(b) Renal carcinomas|3691140|2002
1-4|0.7|1.0|0.9|136|II Lymphomas and reticuloendothelial neoplasms|15607694|2006
10-14|2.3|2.7|2.5|494|II Lymphomas and reticuloendothelial neoplasms|19773006|2006
15-19|4.6|5.2|4.9|1009|II Lymphomas and reticuloendothelial neoplasms|20449826|2006
5-9|1.3|1.6|1.4|271|II Lymphomas and reticuloendothelial neoplasms|18880537|2006
<1|0.7|1.4|1.0|40|II Lymphomas and reticuloendothelial neoplasms|4007564|2006
1-4|0.0|0.0|0.0|18|X(a) Intracranial & intraspinal germ cell tumors|72032406|2002-2006
10-14|0.2|0.3|0.2|237|X(a) Intracranial & intraspinal germ cell tumors|94924078|2002-2006
15-19|0.2|0.3|0.2|214|X(a) Intracranial & intraspinal germ cell tumors|93992876|2002-2006
5-9|0.1|0.1|0.1|79|X(a) Intracranial & intraspinal germ cell tumors|89136197|2002-2006
<1|0.1|0.3|0.2|37|X(a) Intracranial & intraspinal germ cell tumors|18407240|2002-2006
<1|1.4|1.8|1.6|289|VI(a) Nephroblastoma and other nonepithelial renal tumors|18407240|2002-2006
1-4|0.3|0.5|0.4|59|X Germ cell, trophoblastic tumors & neoplasms of gonads|15151945|2003
10-14|0.6|0.8|0.7|147|X Germ cell, trophoblastic tumors & neoplasms of gonads|20383692|2003
15-19|2.3|2.8|2.5|501|X Germ cell, trophoblastic tumors & neoplasms of gonads|19681033|2003
5-9|0.1|0.2|0.2|32|X Germ cell, trophoblastic tumors & neoplasms of gonads|19012396|2003
<1|1.3|2.2|1.7|66|X Germ cell, trophoblastic tumors & neoplasms of gonads|3882968|2003
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15688413|2004
10-14|0.2|0.4|0.3|60|X(a) Intracranial & intraspinal germ cell tumors|20724858|2004
15-19|0.2|0.3|0.3|51|X(a) Intracranial & intraspinal germ cell tumors|20301027|2004
5-9|0.1|0.2|0.1|19|X(a) Intracranial & intraspinal germ cell tumors|19244948|2004
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|4020211|2004
1-4|~|~|~|~|VI(b) Renal carcinomas|72032406|2002-2006
10-14|0.0|0.1|0.1|54|VI(b) Renal carcinomas|94924078|2002-2006
15-19|0.1|0.2|0.1|120|VI(b) Renal carcinomas|93992876|2002-2006
5-9|0.0|0.0|0.0|22|VI(b) Renal carcinomas|89136197|2002-2006
<1|~|~|~|~|VI(b) Renal carcinomas|18407240|2002-2006
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15151945|2003
10-14|0.2|0.3|0.2|49|X(a) Intracranial & intraspinal germ cell tumors|20383692|2003
15-19|0.1|0.3|0.2|39|X(a) Intracranial & intraspinal germ cell tumors|19681033|2003
5-9|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|19012396|2003
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3882968|2003
1-4|0.1|0.2|0.2|26|X(b) Malignant extracranial & extragonadal germ cell tumors|15688413|2004
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20724858|2004
15-19|0.1|0.2|0.1|25|X(b) Malignant extracranial & extragonadal germ cell tumors|20301027|2004
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|14396227|2002
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|19533296|2002
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|18815493|2002
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|18503153|2002
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3691140|2002
1-4|0.1|0.2|0.1|18|XI(d) Malignant melanomas|15917630|2005
10-14|0.3|0.4|0.4|72|XI(d) Malignant melanomas|20461017|2005
15-19|1.7|2.0|1.9|382|XI(d) Malignant melanomas|20618219|2005
5-9|0.1|0.3|0.2|40|XI(d) Malignant melanomas|19173994|2005
<1|0.2|0.6|0.4|16|XI(d) Malignant melanomas|4030153|2005
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|72032406|2002-2006
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|94924078|2002-2006
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|93992876|2002-2006
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|89136197|2002-2006
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|18407240|2002-2006
1-4|1.0|1.3|1.1|163|IX Soft tissue and other extraosseous sarcomas|14214314|2001
10-14|1.0|1.3|1.2|223|IX Soft tissue and other extraosseous sarcomas|19360577|2001
15-19|1.4|1.8|1.6|297|IX Soft tissue and other extraosseous sarcomas|18791536|2001
5-9|0.6|0.8|0.7|133|IX Soft tissue and other extraosseous sarcomas|18776213|2001
<1|1.2|2.0|1.6|58|IX Soft tissue and other extraosseous sarcomas|3735453|2001
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19244948|2004
<1|0.9|1.6|1.2|47|X(b) Malignant extracranial & extragonadal germ cell tumors|4020211|2004
1-4|~|~|~|~|XI(e) Skin carcinomas|15917630|2005
10-14|~|~|~|~|XI(e) Skin carcinomas|20461017|2005
15-19|~|~|~|~|XI(e) Skin carcinomas|20618219|2005
5-9|~|~|~|~|XI(e) Skin carcinomas|19173994|2005
<1|~|~|~|~|XI(e) Skin carcinomas|4030153|2005
1-4|0.4|0.5|0.5|337|VII Hepatic tumors|72032406|2002-2006
10-14|0.1|0.1|0.1|76|VII Hepatic tumors|94924078|2002-2006
15-19|0.1|0.1|0.1|113|VII Hepatic tumors|93992876|2002-2006
5-9|0.0|0.1|0.1|53|VII Hepatic tumors|89136197|2002-2006
<1|1.0|1.3|1.1|207|VII Hepatic tumors|18407240|2002-2006
1-4|0.7|1.0|0.9|125|IX(a) Rhabdomyosarcomas|14214314|2001
10-14|0.3|0.4|0.4|68|IX(a) Rhabdomyosarcomas|19360577|2001
15-19|0.4|0.5|0.4|83|IX(a) Rhabdomyosarcomas|18791536|2001
5-9|0.3|0.5|0.4|75|IX(a) Rhabdomyosarcomas|18776213|2001
<1|~|~|~|~|IX(a) Rhabdomyosarcomas|3735453|2001
1-4|0.1|0.3|0.2|28|X(b) Malignant extracranial & extragonadal germ cell tumors|15151945|2003
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20383692|2003
15-19|0.1|0.2|0.1|28|X(b) Malignant extracranial & extragonadal germ cell tumors|19681033|2003
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19012396|2003
<1|0.9|1.6|1.2|47|X(b) Malignant extracranial & extragonadal germ cell tumors|3882968|2003
1-4|0.1|0.2|0.1|18|X(c) Malignant gonadal germ cell tumors|15688413|2004
10-14|0.4|0.6|0.5|95|X(c) Malignant gonadal germ cell tumors|20724858|2004
15-19|2.0|2.4|2.2|446|X(c) Malignant gonadal germ cell tumors|20301027|2004
5-9|0.1|0.2|0.1|20|X(c) Malignant gonadal germ cell tumors|19244948|2004
<1|0.2|0.6|0.4|16|X(c) Malignant gonadal germ cell tumors|4020211|2004
1-4|0.3|0.5|0.4|59|VII Hepatic tumors|14396227|2002
10-14|~|~|~|~|VII Hepatic tumors|19533296|2002
15-19|0.1|0.2|0.1|19|VII Hepatic tumors|18815493|2002
5-9|~|~|~|~|VII Hepatic tumors|18503153|2002
<1|0.4|1.0|0.7|24|VII Hepatic tumors|3691140|2002
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15917630|2005
10-14|0.3|0.5|0.4|82|XI(f) Other and unspecified carcinomas|20461017|2005
15-19|1.0|1.3|1.1|228|XI(f) Other and unspecified carcinomas|20618219|2005
5-9|0.1|0.2|0.1|24|XI(f) Other and unspecified carcinomas|19173994|2005
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|4030153|2005
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|14214314|2001
10-14|0.1|0.2|0.1|22|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19360577|2001
15-19|0.1|0.3|0.2|39|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|18791536|2001
5-9|0.1|0.2|0.1|19|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|18776213|2001
<1|0.5|1.0|0.7|26|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3735453|2001
1-4|0.1|0.3|0.2|27|X(c) Malignant gonadal germ cell tumors|15151945|2003
10-14|0.3|0.5|0.4|77|X(c) Malignant gonadal germ cell tumors|20383692|2003
15-19|1.8|2.2|2.0|395|X(c) Malignant gonadal germ cell tumors|19681033|2003
5-9|~|~|~|~|X(c) Malignant gonadal germ cell tumors|19012396|2003
<1|~|~|~|~|X(c) Malignant gonadal germ cell tumors|3882968|2003
1-4|~|~|~|~|X(d) Gonadal carcinomas|15688413|2004
10-14|~|~|~|~|X(d) Gonadal carcinomas|20724858|2004
15-19|0.1|0.2|0.1|22|X(d) Gonadal carcinomas|20301027|2004
5-9|~|~|~|~|X(d) Gonadal carcinomas|19244948|2004
<1|~|~|~|~|X(d) Gonadal carcinomas|4020211|2004
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|15917630|2005
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20461017|2005
15-19|0.1|0.2|0.2|37|XII Other and unspecified malignant neoplasms|20618219|2005
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|19173994|2005
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|4030153|2005
1-4|0.4|0.5|0.4|320|VII(a) Hepatoblastoma|72032406|2002-2006
10-14|~|~|~|~|VII(a) Hepatoblastoma|94924078|2002-2006
15-19|~|~|~|~|VII(a) Hepatoblastoma|93992876|2002-2006
5-9|0.0|0.0|0.0|26|VII(a) Hepatoblastoma|89136197|2002-2006
<1|0.9|1.2|1.1|197|VII(a) Hepatoblastoma|18407240|2002-2006
1-4|~|~|~|~|IX(c) Kaposi sarcoma|14214314|2001
10-14|~|~|~|~|IX(c) Kaposi sarcoma|19360577|2001
15-19|~|~|~|~|IX(c) Kaposi sarcoma|18791536|2001
5-9|~|~|~|~|IX(c) Kaposi sarcoma|18776213|2001
<1|~|~|~|~|IX(c) Kaposi sarcoma|3735453|2001
1-4|0.3|0.5|0.4|56|VII(a) Hepatoblastoma|14396227|2002
10-14|~|~|~|~|VII(a) Hepatoblastoma|19533296|2002
15-19|~|~|~|~|VII(a) Hepatoblastoma|18815493|2002
5-9|~|~|~|~|VII(a) Hepatoblastoma|18503153|2002
<1|0.4|1.0|0.7|24|VII(a) Hepatoblastoma|3691140|2002
1-4|0.4|0.6|0.5|69|III(a) Ependymomas and choroid plexus tumor|14042091|2000
10-14|0.1|0.2|0.2|30|III(a) Ependymomas and choroid plexus tumor|18847598|2000
15-19|0.1|0.2|0.1|22|III(a) Ependymomas and choroid plexus tumor|18475345|2000
1-4|0.3|0.6|0.4|66|VII Hepatic tumors|15151945|2003
10-14|0.1|0.2|0.1|21|VII Hepatic tumors|20383692|2003
15-19|0.1|0.2|0.1|21|VII Hepatic tumors|19681033|2003
5-9|~|~|~|~|VII Hepatic tumors|19012396|2003
<1|1.0|1.7|1.3|51|VII Hepatic tumors|3882968|2003
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15688413|2004
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20724858|2004
15-19|0.0|0.1|0.1|16|X(e) Other and unspecified malignant gonadal tumors|20301027|2004
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19244948|2004
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|4020211|2004
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15917630|2005
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20461017|2005
15-19|~|~|~|~|XII(a) Other specified malignant tumors|20618219|2005
5-9|~|~|~|~|XII(a) Other specified malignant tumors|19173994|2005
<1|~|~|~|~|XII(a) Other specified malignant tumors|4030153|2005
1-4|~|~|~|~|VII(b) Hepatic carcinomas|72032406|2002-2006
10-14|0.1|0.1|0.1|62|VII(b) Hepatic carcinomas|94924078|2002-2006
15-19|0.1|0.1|0.1|111|VII(b) Hepatic carcinomas|93992876|2002-2006
5-9|0.0|0.0|0.0|26|VII(b) Hepatic carcinomas|89136197|2002-2006
<1|~|~|~|~|VII(b) Hepatic carcinomas|18407240|2002-2006
1-4|3.5|4.2|3.8|545|III CNS and misc intracranial and intraspinal neoplasms|14214314|2001
10-14|2.4|2.8|2.6|502|III CNS and misc intracranial and intraspinal neoplasms|19360577|2001
15-19|1.9|2.4|2.1|402|III CNS and misc intracranial and intraspinal neoplasms|18791536|2001
5-9|3.1|3.6|3.3|625|III CNS and misc intracranial and intraspinal neoplasms|18776213|2001
<1|2.7|3.9|3.3|122|III CNS and misc intracranial and intraspinal neoplasms|3735453|2001
1-4|~|~|~|~|VII(b) Hepatic carcinomas|14396227|2002
10-14|~|~|~|~|VII(b) Hepatic carcinomas|19533296|2002
15-19|0.1|0.2|0.1|18|VII(b) Hepatic carcinomas|18815493|2002
5-9|~|~|~|~|VII(b) Hepatic carcinomas|18503153|2002
<1|~|~|~|~|VII(b) Hepatic carcinomas|3691140|2002
1-4|0.3|0.5|0.4|62|VII(a) Hepatoblastoma|15151945|2003
10-14|~|~|~|~|VII(a) Hepatoblastoma|20383692|2003
15-19|~|~|~|~|VII(a) Hepatoblastoma|19681033|2003
5-9|~|~|~|~|VII(a) Hepatoblastoma|19012396|2003
<1|1.0|1.7|1.3|50|VII(a) Hepatoblastoma|3882968|2003
5-9|0.2|0.3|0.2|41|III(a) Ependymomas and choroid plexus tumor|18755372|2000
<1|~|~|~|~|III(a) Ependymomas and choroid plexus tumor|3528687|2000
1-4|0.2|0.3|0.2|37|XI Other malignant epithelial neoplasms and malignant melanomas|15688413|2004
10-14|1.2|1.6|1.4|289|XI Other malignant epithelial neoplasms and malignant melanomas|20724858|2004
15-19|4.7|5.3|5.0|1007|XI Other malignant epithelial neoplasms and malignant melanomas|20301027|2004
5-9|0.4|0.6|0.5|93|XI Other malignant epithelial neoplasms and malignant melanomas|19244948|2004
<1|0.5|1.0|0.7|28|XI Other malignant epithelial neoplasms and malignant melanomas|4020211|2004
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|72032406|2002-2006
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|94924078|2002-2006
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|93992876|2002-2006
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|89136197|2002-2006
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|18407240|2002-2006
1-4|1.0|1.3|1.1|162|IX Soft tissue and other extraosseous sarcomas|14396227|2002
10-14|1.0|1.3|1.1|220|IX Soft tissue and other extraosseous sarcomas|19533296|2002
15-19|1.3|1.6|1.4|270|IX Soft tissue and other extraosseous sarcomas|18815493|2002
5-9|0.8|1.1|0.9|173|IX Soft tissue and other extraosseous sarcomas|18503153|2002
<1|1.2|2.1|1.6|60|IX Soft tissue and other extraosseous sarcomas|3691140|2002
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15151945|2003
10-14|0.0|0.1|0.1|16|VII(b) Hepatic carcinomas|20383692|2003
15-19|0.1|0.2|0.1|21|VII(b) Hepatic carcinomas|19681033|2003
5-9|~|~|~|~|VII(b) Hepatic carcinomas|19012396|2003
1-4|1.7|2.1|1.9|267|III(b) Astrocytomas|14042091|2000
10-14|1.4|1.8|1.6|296|III(b) Astrocytomas|18847598|2000
15-19|1.0|1.4|1.2|220|III(b) Astrocytomas|18475345|2000
5-9|1.5|1.8|1.6|307|III(b) Astrocytomas|18755372|2000
<1|1.1|1.9|1.4|50|III(b) Astrocytomas|3528687|2000
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15688413|2004
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15917630|2005
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20461017|2005
15-19|0.1|0.2|0.1|24|XII(b) Other unspecified malignant tumors|20618219|2005
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|19173994|2005
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|4030153|2005
1-4|0.1|0.2|0.2|114|VIII Malignant bone tumors|72032406|2002-2006
10-14|1.3|1.4|1.3|1261|VIII Malignant bone tumors|94924078|2002-2006
15-19|1.4|1.6|1.5|1428|VIII Malignant bone tumors|93992876|2002-2006
5-9|0.5|0.6|0.6|496|VIII Malignant bone tumors|89136197|2002-2006
<1|0.0|0.1|0.1|16|VIII Malignant bone tumors|18407240|2002-2006
1-4|0.3|0.5|0.4|57|III(a) Ependymomas and choroid plexus tumor|14214314|2001
10-14|0.1|0.2|0.2|34|III(a) Ependymomas and choroid plexus tumor|19360577|2001
15-19|0.1|0.2|0.1|25|III(a) Ependymomas and choroid plexus tumor|18791536|2001
5-9|0.2|0.3|0.2|44|III(a) Ependymomas and choroid plexus tumor|18776213|2001
<1|0.3|0.8|0.5|19|III(a) Ependymomas and choroid plexus tumor|3735453|2001
<1|~|~|~|~|VII(b) Hepatic carcinomas|3882968|2003
1-4|0.8|1.2|1.0|137|III(c) Intracranial and intraspinal embryonal tumors|14042091|2000
10-14|0.4|0.6|0.5|94|III(c) Intracranial and intraspinal embryonal tumors|18847598|2000
15-19|0.3|0.4|0.3|63|III(c) Intracranial and intraspinal embryonal tumors|18475345|2000
5-9|0.7|1.0|0.8|153|III(c) Intracranial and intraspinal embryonal tumors|18755372|2000
<1|0.6|1.3|0.9|33|III(c) Intracranial and intraspinal embryonal tumors|3528687|2000
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20724858|2004
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20301027|2004
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19244948|2004
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|4020211|2004
1-4|19.2|20.6|19.9|3100|All ICCC Groups Combined|15607694|2006
10-14|12.5|13.6|13.0|2580|All ICCC Groups Combined|19773006|2006
15-19|20.5|21.8|21.1|4322|All ICCC Groups Combined|20449826|2006
5-9|11.1|12.0|11.5|2177|All ICCC Groups Combined|18880537|2006
<1|23.6|26.7|25.1|1007|All ICCC Groups Combined|4007564|2006
1-4|0.7|1.0|0.8|121|IX(a) Rhabdomyosarcomas|14396227|2002
10-14|0.2|0.4|0.3|62|IX(a) Rhabdomyosarcomas|19533296|2002
15-19|0.3|0.4|0.3|65|IX(a) Rhabdomyosarcomas|18815493|2002
5-9|0.4|0.6|0.5|94|IX(a) Rhabdomyosarcomas|18503153|2002
<1|0.4|1.0|0.7|25|IX(a) Rhabdomyosarcomas|3691140|2002
1-4|1.7|2.1|1.9|267|III(b) Astrocytomas|14214314|2001
10-14|1.2|1.5|1.3|260|III(b) Astrocytomas|19360577|2001
15-19|1.0|1.3|1.1|208|III(b) Astrocytomas|18791536|2001
5-9|1.5|1.9|1.7|311|III(b) Astrocytomas|18776213|2001
<1|0.9|1.7|1.3|47|III(b) Astrocytomas|3735453|2001
1-4|0.0|0.1|0.0|32|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|72032406|2002-2006
10-14|0.1|0.2|0.1|133|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|94924078|2002-2006
15-19|0.2|0.2|0.2|176|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|93992876|2002-2006
5-9|0.1|0.1|0.1|59|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|89136197|2002-2006
<1|0.4|0.6|0.5|85|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|18407240|2002-2006
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15151945|2003
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20383692|2003
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19681033|2003
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19012396|2003
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3882968|2003
1-4|0.1|0.2|0.1|23|VIII Malignant bone tumors|15688413|2004
10-14|1.3|1.6|1.5|301|VIII Malignant bone tumors|20724858|2004
15-19|1.3|1.6|1.5|297|VIII Malignant bone tumors|20301027|2004
5-9|0.4|0.6|0.5|99|VIII Malignant bone tumors|19244948|2004
<1|~|~|~|~|VIII Malignant bone tumors|4020211|2004
1-4|0.8|1.1|0.9|129|I(b) Acute myeloid leukemias|14042091|2000
10-14|0.4|0.6|0.5|94|I(b) Acute myeloid leukemias|18847598|2000
15-19|0.7|1.0|0.9|158|I(b) Acute myeloid leukemias|18475345|2000
5-9|0.3|0.5|0.4|81|I(b) Acute myeloid leukemias|18755372|2000
<1|1.2|2.1|1.6|58|I(b) Acute myeloid leukemias|3528687|2000
1-4|0.1|0.2|0.1|23|X(c) Malignant gonadal germ cell tumors|15917630|2005
10-14|0.3|0.5|0.4|77|X(c) Malignant gonadal germ cell tumors|20461017|2005
15-19|2.1|2.5|2.3|472|X(c) Malignant gonadal germ cell tumors|20618219|2005
5-9|0.0|0.1|0.1|16|X(c) Malignant gonadal germ cell tumors|19173994|2005
<1|0.3|0.8|0.5|20|X(c) Malignant gonadal germ cell tumors|4030153|2005
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|14396227|2002
10-14|0.1|0.2|0.1|26|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19533296|2002
15-19|0.1|0.2|0.1|21|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|18815493|2002
5-9|0.1|0.1|0.1|17|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|18503153|2002
<1|0.3|0.8|0.5|20|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3691140|2002
1-4|0.9|1.2|1.0|145|III(c) Intracranial and intraspinal embryonal tumors|14214314|2001
10-14|0.3|0.5|0.4|78|III(c) Intracranial and intraspinal embryonal tumors|19360577|2001
15-19|0.3|0.5|0.4|82|III(c) Intracranial and intraspinal embryonal tumors|18791536|2001
5-9|0.6|0.9|0.7|139|III(c) Intracranial and intraspinal embryonal tumors|18776213|2001
<1|0.8|1.5|1.1|41|III(c) Intracranial and intraspinal embryonal tumors|3735453|2001
1-4|0.1|0.3|0.2|26|VIII Malignant bone tumors|15151945|2003
10-14|1.2|1.5|1.4|276|VIII Malignant bone tumors|20383692|2003
15-19|1.3|1.6|1.5|288|VIII Malignant bone tumors|19681033|2003
5-9|0.4|0.6|0.5|89|VIII Malignant bone tumors|19012396|2003
<1|~|~|~|~|VIII Malignant bone tumors|3882968|2003
1-4|~|~|~|~|IX(c) Kaposi sarcoma|72032406|2002-2006
10-14|~|~|~|~|IX(c) Kaposi sarcoma|94924078|2002-2006
15-19|~|~|~|~|IX(c) Kaposi sarcoma|93992876|2002-2006
5-9|~|~|~|~|IX(c) Kaposi sarcoma|89136197|2002-2006
<1|~|~|~|~|IX(c) Kaposi sarcoma|18407240|2002-2006
1-4|~|~|~|~|VIII(a) Osteosarcomas|15688413|2004
10-14|0.8|1.0|0.9|185|VIII(a) Osteosarcomas|20724858|2004
15-19|0.7|1.0|0.8|168|VIII(a) Osteosarcomas|20301027|2004
5-9|0.2|0.4|0.3|59|VIII(a) Osteosarcomas|19244948|2004
<1|~|~|~|~|VIII(a) Osteosarcomas|4020211|2004
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|14042091|2000
10-14|0.1|0.2|0.1|22|I(c) Chronic myeloproliferative diseases|18847598|2000
15-19|0.1|0.2|0.1|23|I(c) Chronic myeloproliferative diseases|18475345|2000
5-9|~|~|~|~|I(c) Chronic myeloproliferative diseases|18755372|2000
<1|~|~|~|~|I(c) Chronic myeloproliferative diseases|3528687|2000
1-4|~|~|~|~|X(d) Gonadal carcinomas|15917630|2005
10-14|~|~|~|~|X(d) Gonadal carcinomas|20461017|2005
15-19|0.1|0.2|0.1|26|X(d) Gonadal carcinomas|20618219|2005
5-9|~|~|~|~|X(d) Gonadal carcinomas|19173994|2005
<1|~|~|~|~|X(d) Gonadal carcinomas|4030153|2005
1-4|0.3|0.5|0.4|59|III(d) Other gliomas|14214314|2001
10-14|0.5|0.7|0.6|110|III(d) Other gliomas|19360577|2001
15-19|0.3|0.5|0.4|72|III(d) Other gliomas|18791536|2001
5-9|0.5|0.8|0.6|119|III(d) Other gliomas|18776213|2001
<1|~|~|~|~|III(d) Other gliomas|3735453|2001
1-4|~|~|~|~|VIII(a) Osteosarcomas|15151945|2003
10-14|0.7|1.0|0.8|169|VIII(a) Osteosarcomas|20383692|2003
15-19|0.9|1.2|1.0|197|VIII(a) Osteosarcomas|19681033|2003
5-9|0.2|0.3|0.2|45|VIII(a) Osteosarcomas|19012396|2003
<1|~|~|~|~|VIII(a) Osteosarcomas|3882968|2003
1-4|0.1|0.2|0.2|123|IX(d) Other specified soft tissue sarcomas|72032406|2002-2006
10-14|0.5|0.6|0.5|521|IX(d) Other specified soft tissue sarcomas|94924078|2002-2006
15-19|0.8|0.9|0.9|834|IX(d) Other specified soft tissue sarcomas|93992876|2002-2006
5-9|0.2|0.3|0.2|206|IX(d) Other specified soft tissue sarcomas|89136197|2002-2006
<1|0.4|0.6|0.5|94|IX(d) Other specified soft tissue sarcomas|18407240|2002-2006
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15688413|2004
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20724858|2004
15-19|0.1|0.2|0.1|23|VIII(b) Chondrosarcomas|20301027|2004
5-9|~|~|~|~|VIII(b) Chondrosarcomas|19244948|2004
<1|~|~|~|~|VIII(b) Chondrosarcomas|4020211|2004
1-4|~|~|~|~|IX(c) Kaposi sarcoma|14396227|2002
10-14|~|~|~|~|IX(c) Kaposi sarcoma|19533296|2002
15-19|~|~|~|~|IX(c) Kaposi sarcoma|18815493|2002
5-9|~|~|~|~|IX(c) Kaposi sarcoma|18503153|2002
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|14214314|2001
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|19360577|2001
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|18791536|2001
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|18776213|2001
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3735453|2001
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15151945|2003
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20383692|2003
15-19|~|~|~|~|VIII(b) Chondrosarcomas|19681033|2003
5-9|~|~|~|~|VIII(b) Chondrosarcomas|19012396|2003
<1|~|~|~|~|VIII(b) Chondrosarcomas|3882968|2003
1-4|0.1|0.2|0.1|16|VIII(c) Ewing tumor and related sarcomas of bone|15688413|2004
10-14|0.3|0.5|0.4|89|VIII(c) Ewing tumor and related sarcomas of bone|20724858|2004
15-19|0.3|0.5|0.4|78|VIII(c) Ewing tumor and related sarcomas of bone|20301027|2004
5-9|0.1|0.2|0.2|31|VIII(c) Ewing tumor and related sarcomas of bone|19244948|2004
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|4020211|2004
1-4|0.0|0.1|0.1|46|IX(e) Unspecified soft tissue sarcomas|72032406|2002-2006
10-14|0.1|0.2|0.1|126|IX(e) Unspecified soft tissue sarcomas|94924078|2002-2006
15-19|0.1|0.2|0.2|162|IX(e) Unspecified soft tissue sarcomas|93992876|2002-2006
5-9|0.1|0.1|0.1|61|IX(e) Unspecified soft tissue sarcomas|89136197|2002-2006
<1|0.1|0.2|0.1|27|IX(e) Unspecified soft tissue sarcomas|18407240|2002-2006
1-4|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|14042091|2000
10-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|18847598|2000
15-19|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|18475345|2000
5-9|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|18755372|2000
<1|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3528687|2000
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15917630|2005
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20461017|2005
15-19|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20618219|2005
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19173994|2005
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|4030153|2005
1-4|0.1|0.2|0.1|18|XII Other and unspecified malignant neoplasms|15607694|2006
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|19773006|2006
15-19|0.1|0.2|0.1|28|XII Other and unspecified malignant neoplasms|20449826|2006
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|18880537|2006
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|4007564|2006
10-14|0.4|0.6|0.5|109|IX(d) Other specified soft tissue sarcomas|20383692|2003
15-19|0.7|0.9|0.8|157|IX(d) Other specified soft tissue sarcomas|19681033|2003
5-9|0.1|0.3|0.2|38|IX(d) Other specified soft tissue sarcomas|19012396|2003
<1|0.3|0.8|0.5|20|IX(d) Other specified soft tissue sarcomas|3882968|2003
1-4|0.0|0.1|0.0|30|Not classified by ICCC|72032406|2002-2006
10-14|0.0|0.0|0.0|18|Not classified by ICCC|94924078|2002-2006
15-19|0.0|0.1|0.0|45|Not classified by ICCC|93992876|2002-2006
5-9|0.0|0.0|0.0|22|Not classified by ICCC|89136197|2002-2006
<1|~|~|~|~|Not classified by ICCC|18407240|2002-2006
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15688413|2004
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|20724858|2004
15-19|0.1|0.2|0.1|20|VIII(d) Other specified malignant bone tumors|20301027|2004
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|19244948|2004
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|4020211|2004
1-4|0.1|0.2|0.2|22|I(e) Unspecified and other specified leukemias|14042091|2000
10-14|~|~|~|~|I(e) Unspecified and other specified leukemias|18847598|2000
15-19|0.1|0.2|0.1|23|I(e) Unspecified and other specified leukemias|18475345|2000
5-9|0.1|0.2|0.1|20|I(e) Unspecified and other specified leukemias|18755372|2000
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|3528687|2000
1-4|0.1|0.3|0.2|29|XI Other malignant epithelial neoplasms and malignant melanomas|15917630|2005
10-14|1.2|1.5|1.4|277|XI Other malignant epithelial neoplasms and malignant melanomas|20461017|2005
15-19|4.6|5.2|4.9|1007|XI Other malignant epithelial neoplasms and malignant melanomas|20618219|2005
5-9|0.3|0.5|0.4|83|XI Other malignant epithelial neoplasms and malignant melanomas|19173994|2005
<1|0.4|0.9|0.6|24|XI Other malignant epithelial neoplasms and malignant melanomas|4030153|2005
1-4|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|13822338|1999
10-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|18146881|1999
15-19|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|17976823|1999
5-9|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|18557028|1999
<1|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3417510|1999
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|14214314|2001
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19360577|2001
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|18791536|2001
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|18776213|2001
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3735453|2001
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15607694|2006
10-14|~|~|~|~|XII(a) Other specified malignant tumors|19773006|2006
15-19|~|~|~|~|XII(a) Other specified malignant tumors|20449826|2006
5-9|~|~|~|~|XII(a) Other specified malignant tumors|18880537|2006
<1|~|~|~|~|XII(a) Other specified malignant tumors|4007564|2006
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15151945|2003
10-14|0.1|0.2|0.2|34|IX(e) Unspecified soft tissue sarcomas|20383692|2003
15-19|0.1|0.3|0.2|40|IX(e) Unspecified soft tissue sarcomas|19681033|2003
5-9|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|19012396|2003
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3882968|2003
1-4|0.7|0.9|0.8|572|V Retinoblastoma|72032406|2002-2006
1-4|0.8|1.1|0.9|131|II Lymphomas and reticuloendothelial neoplasms|14042091|2000
10-14|2.2|2.7|2.4|461|II Lymphomas and reticuloendothelial neoplasms|18847598|2000
15-19|4.6|5.3|4.9|911|II Lymphomas and reticuloendothelial neoplasms|18475345|2000
5-9|1.3|1.7|1.5|283|II Lymphomas and reticuloendothelial neoplasms|18755372|2000
<1|0.6|1.3|0.9|33|II Lymphomas and reticuloendothelial neoplasms|3528687|2000
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15917630|2005
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20461017|2005
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|20618219|2005
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|19173994|2005
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|4030153|2005
1-4|0.1|0.3|0.2|25|I(e) Unspecified and other specified leukemias|14214314|2001
10-14|~|~|~|~|I(e) Unspecified and other specified leukemias|19360577|2001
15-19|0.1|0.2|0.1|27|I(e) Unspecified and other specified leukemias|18791536|2001
5-9|~|~|~|~|I(e) Unspecified and other specified leukemias|18776213|2001
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|3735453|2001
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15607694|2006
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|19773006|2006
15-19|~|~|~|~|XII(b) Other unspecified malignant tumors|20449826|2006
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|18880537|2006
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|4007564|2006
1-4|0.1|0.2|0.2|23|I(e) Unspecified and other specified leukemias|13822338|1999
10-14|0.1|0.2|0.1|18|I(e) Unspecified and other specified leukemias|18146881|1999
15-19|0.1|0.2|0.1|20|I(e) Unspecified and other specified leukemias|17976823|1999
5-9|~|~|~|~|I(e) Unspecified and other specified leukemias|18557028|1999
<1|0.3|0.8|0.5|18|I(e) Unspecified and other specified leukemias|3417510|1999
1-4|~|~|~|~|Not classified by ICCC|15151945|2003
10-14|~|~|~|~|Not classified by ICCC|20383692|2003
15-19|~|~|~|~|Not classified by ICCC|19681033|2003
5-9|~|~|~|~|Not classified by ICCC|19012396|2003
<1|~|~|~|~|Not classified by ICCC|3882968|2003
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15688413|2004
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20724858|2004
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20301027|2004
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19244948|2004
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|4020211|2004
10-14|~|~|~|~|V Retinoblastoma|94924078|2002-2006
15-19|~|~|~|~|V Retinoblastoma|93992876|2002-2006
5-9|0.0|0.1|0.0|37|V Retinoblastoma|89136197|2002-2006
<1|2.4|2.8|2.6|479|V Retinoblastoma|18407240|2002-2006
1-4|~|~|~|~|II(a) Hodgkin lymphomas|14042091|2000
10-14|1.1|1.4|1.3|238|II(a) Hodgkin lymphomas|18847598|2000
15-19|2.9|3.4|3.1|575|II(a) Hodgkin lymphomas|18475345|2000
5-9|0.3|0.4|0.4|66|II(a) Hodgkin lymphomas|18755372|2000
<1|~|~|~|~|II(a) Hodgkin lymphomas|3528687|2000
<1|~|~|~|~|IX(c) Kaposi sarcoma|3691140|2002
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15917630|2005
10-14|0.4|0.6|0.5|107|XI(b) Thyroid carcinomas|20461017|2005
15-19|1.6|2.0|1.8|369|XI(b) Thyroid carcinomas|20618219|2005
5-9|0.1|0.1|0.1|17|XI(b) Thyroid carcinomas|19173994|2005
<1|~|~|~|~|XI(b) Thyroid carcinomas|4030153|2005
1-4|0.7|1.1|0.9|127|II Lymphomas and reticuloendothelial neoplasms|14214314|2001
10-14|2.3|2.7|2.5|484|II Lymphomas and reticuloendothelial neoplasms|19360577|2001
15-19|4.6|5.3|4.9|929|II Lymphomas and reticuloendothelial neoplasms|18791536|2001
5-9|1.2|1.6|1.4|263|II Lymphomas and reticuloendothelial neoplasms|18776213|2001
<1|0.5|1.1|0.8|29|II Lymphomas and reticuloendothelial neoplasms|3735453|2001
1-4|0.6|0.9|0.8|114|V Retinoblastoma|15151945|2003
10-14|~|~|~|~|V Retinoblastoma|20383692|2003
15-19|~|~|~|~|V Retinoblastoma|19681033|2003
5-9|~|~|~|~|V Retinoblastoma|19012396|2003
1-4|1.8|2.2|2.0|312|VI Renal tumors|15688413|2004
10-14|0.1|0.2|0.1|31|VI Renal tumors|20724858|2004
15-19|0.1|0.2|0.2|33|VI Renal tumors|20301027|2004
5-9|0.4|0.6|0.5|91|VI Renal tumors|19244948|2004
<1|1.0|1.8|1.3|54|VI Renal tumors|4020211|2004
1-4|1.9|2.1|2.0|1418|VI Renal tumors|72032406|2002-2006
10-14|0.1|0.2|0.1|121|VI Renal tumors|94924078|2002-2006
15-19|0.1|0.2|0.2|153|VI Renal tumors|93992876|2002-2006
5-9|0.5|0.6|0.5|450|VI Renal tumors|89136197|2002-2006
<1|1.4|1.8|1.6|290|VI Renal tumors|18407240|2002-2006
1-4|0.3|0.5|0.4|52|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|14042091|2000
10-14|0.7|0.9|0.8|148|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|18847598|2000
15-19|1.3|1.7|1.5|275|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|18475345|2000
5-9|0.5|0.7|0.6|116|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|18755372|2000
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15917630|2005
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20461017|2005
15-19|0.1|0.1|0.1|20|XI(c) Nasopharyngeal carcinomas|20618219|2005
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|19173994|2005
1-4|0.1|0.3|0.2|25|IX(d) Other specified soft tissue sarcomas|14396227|2002
10-14|0.4|0.7|0.5|106|IX(d) Other specified soft tissue sarcomas|19533296|2002
15-19|0.7|1.0|0.9|163|IX(d) Other specified soft tissue sarcomas|18815493|2002
5-9|0.2|0.4|0.3|49|IX(d) Other specified soft tissue sarcomas|18503153|2002
<1|~|~|~|~|IX(d) Other specified soft tissue sarcomas|3691140|2002
1-4|0.1|0.2|0.1|19|II(a) Hodgkin lymphomas|14214314|2001
10-14|1.0|1.4|1.2|232|II(a) Hodgkin lymphomas|19360577|2001
15-19|2.9|3.4|3.2|596|II(a) Hodgkin lymphomas|18791536|2001
5-9|0.3|0.5|0.4|82|II(a) Hodgkin lymphomas|18776213|2001
<1|~|~|~|~|II(a) Hodgkin lymphomas|3735453|2001
<1|2.1|3.2|2.6|101|V Retinoblastoma|3882968|2003
1-4|1.7|2.2|1.9|292|VI Renal tumors|15151945|2003
1-4|1.9|2.1|2.0|1407|VI(a) Nephroblastoma and other nonepithelial renal tumors|72032406|2002-2006
10-14|0.1|0.1|0.1|63|VI(a) Nephroblastoma and other nonepithelial renal tumors|94924078|2002-2006
15-19|0.0|0.0|0.0|30|VI(a) Nephroblastoma and other nonepithelial renal tumors|93992876|2002-2006
5-9|0.4|0.5|0.5|422|VI(a) Nephroblastoma and other nonepithelial renal tumors|89136197|2002-2006
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3528687|2000
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|4030153|2005
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|14396227|2002
10-14|0.1|0.2|0.1|26|IX(e) Unspecified soft tissue sarcomas|19533296|2002
15-19|0.1|0.2|0.1|21|IX(e) Unspecified soft tissue sarcomas|18815493|2002
5-9|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|18503153|2002
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3691140|2002
1-4|0.3|0.5|0.4|51|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|14214314|2001
10-14|0.1|0.2|0.1|30|VI Renal tumors|20383692|2003
15-19|0.1|0.2|0.1|24|VI Renal tumors|19681033|2003
5-9|0.4|0.6|0.5|97|VI Renal tumors|19012396|2003
<1|1.3|2.2|1.7|66|VI Renal tumors|3882968|2003
1-4|1.8|2.2|2.0|310|VI(a) Nephroblastoma and other nonepithelial renal tumors|15688413|2004
10-14|0.0|0.1|0.1|16|VI(a) Nephroblastoma and other nonepithelial renal tumors|20724858|2004
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|20301027|2004
5-9|0.4|0.6|0.5|87|VI(a) Nephroblastoma and other nonepithelial renal tumors|19244948|2004
<1|1.0|1.7|1.3|53|VI(a) Nephroblastoma and other nonepithelial renal tumors|4020211|2004
1-4|0.0|0.1|0.1|40|III(f) Unspecified intracranial and intraspinal neoplasms|72032406|2002-2006
10-14|0.0|0.0|0.0|32|III(f) Unspecified intracranial and intraspinal neoplasms|94924078|2002-2006
15-19|0.0|0.1|0.0|40|III(f) Unspecified intracranial and intraspinal neoplasms|93992876|2002-2006
5-9|0.0|0.1|0.0|44|III(f) Unspecified intracranial and intraspinal neoplasms|89136197|2002-2006
<1|0.1|0.2|0.1|22|III(f) Unspecified intracranial and intraspinal neoplasms|18407240|2002-2006
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|13822338|1999
10-14|0.3|0.4|0.3|62|XI(f) Other and unspecified carcinomas|18146881|1999
15-19|0.9|1.2|1.1|191|XI(f) Other and unspecified carcinomas|17976823|1999
5-9|~|~|~|~|XI(f) Other and unspecified carcinomas|18557028|1999
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3417510|1999
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15917630|2005
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20461017|2005
15-19|~|~|~|~|VIII(b) Chondrosarcomas|20618219|2005
5-9|~|~|~|~|VIII(b) Chondrosarcomas|19173994|2005
<1|~|~|~|~|VIII(b) Chondrosarcomas|4030153|2005
10-14|0.9|1.2|1.0|194|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19360577|2001
15-19|1.3|1.7|1.5|282|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|18791536|2001
5-9|0.5|0.8|0.7|123|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|18776213|2001
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3735453|2001
1-4|1.7|2.1|1.9|287|VI(a) Nephroblastoma and other nonepithelial renal tumors|15151945|2003
10-14|0.1|0.2|0.1|20|VI(a) Nephroblastoma and other nonepithelial renal tumors|20383692|2003
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|19681033|2003
5-9|0.4|0.6|0.5|89|VI(a) Nephroblastoma and other nonepithelial renal tumors|19012396|2003
<1|1.3|2.2|1.7|66|VI(a) Nephroblastoma and other nonepithelial renal tumors|3882968|2003
1-4|~|~|~|~|VI(b) Renal carcinomas|15688413|2004
10-14|~|~|~|~|VI(b) Renal carcinomas|20724858|2004
15-19|0.1|0.2|0.1|24|VI(b) Renal carcinomas|20301027|2004
5-9|~|~|~|~|VI(b) Renal carcinomas|19244948|2004
<1|~|~|~|~|VI(b) Renal carcinomas|4020211|2004
1-4|~|~|~|~|Not classified by ICCC|14396227|2002
10-14|~|~|~|~|Not classified by ICCC|19533296|2002
15-19|~|~|~|~|Not classified by ICCC|18815493|2002
5-9|~|~|~|~|Not classified by ICCC|18503153|2002
<1|~|~|~|~|Not classified by ICCC|3691140|2002
1-4|2.0|2.2|2.1|1489|IV Neuroblastoma and other peripheral nervous cell tumors|72032406|2002-2006
10-14|0.1|0.2|0.1|123|IV Neuroblastoma and other peripheral nervous cell tumors|94924078|2002-2006
15-19|0.1|0.1|0.1|70|IV Neuroblastoma and other peripheral nervous cell tumors|93992876|2002-2006
5-9|0.3|0.4|0.3|310|IV Neuroblastoma and other peripheral nervous cell tumors|89136197|2002-2006
<1|5.4|6.1|5.8|1065|IV Neuroblastoma and other peripheral nervous cell tumors|18407240|2002-2006
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|13822338|1999
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|18146881|1999
15-19|0.1|0.2|0.1|26|XII Other and unspecified malignant neoplasms|17976823|1999
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|18557028|1999
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3417510|1999
1-4|0.1|0.3|0.2|29|II(c) Burkitt lymphoma|14214314|2001
10-14|0.2|0.3|0.2|45|II(c) Burkitt lymphoma|19360577|2001
15-19|0.1|0.3|0.2|35|II(c) Burkitt lymphoma|18791536|2001
5-9|0.2|0.4|0.3|51|II(c) Burkitt lymphoma|18776213|2001
<1|~|~|~|~|II(c) Burkitt lymphoma|3735453|2001
1-4|~|~|~|~|XII(a) Other specified malignant tumors|13822338|1999
10-14|~|~|~|~|XII(a) Other specified malignant tumors|18146881|1999
15-19|~|~|~|~|XII(a) Other specified malignant tumors|17976823|1999
5-9|~|~|~|~|XII(a) Other specified malignant tumors|18557028|1999
<1|~|~|~|~|XII(a) Other specified malignant tumors|3417510|1999
1-4|0.1|0.3|0.2|25|II(d) Miscellaneous lymphoreticular neoplasms|14214314|2001
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19360577|2001
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|18791536|2001
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|18776213|2001
<1|0.4|0.9|0.6|23|II(d) Miscellaneous lymphoreticular neoplasms|3735453|2001
1-4|0.1|0.2|0.1|17|VIII(c) Ewing tumor and related sarcomas of bone|15917630|2005
10-14|0.3|0.5|0.4|81|VIII(c) Ewing tumor and related sarcomas of bone|20461017|2005
15-19|0.4|0.6|0.5|94|VIII(c) Ewing tumor and related sarcomas of bone|20618219|2005
5-9|0.2|0.3|0.2|45|VIII(c) Ewing tumor and related sarcomas of bone|19173994|2005
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|4030153|2005
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15917630|2005
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|20461017|2005
15-19|0.0|0.1|0.1|16|VIII(d) Other specified malignant bone tumors|20618219|2005
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|19173994|2005
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|4030153|2005
1-4|~|~|~|~|II(e) Unspecified lymphomas|14214314|2001
10-14|~|~|~|~|II(e) Unspecified lymphomas|19360577|2001
15-19|~|~|~|~|II(e) Unspecified lymphomas|18791536|2001
5-9|~|~|~|~|II(e) Unspecified lymphomas|18776213|2001
<1|~|~|~|~|II(e) Unspecified lymphomas|3735453|2001
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15917630|2005
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20461017|2005
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20618219|2005
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19173994|2005
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|4030153|2005
1-4|0.3|0.4|0.3|54|X Germ cell, trophoblastic tumors & neoplasms of gonads|15917630|2005
10-14|0.6|0.8|0.7|137|X Germ cell, trophoblastic tumors & neoplasms of gonads|20461017|2005
15-19|2.6|3.1|2.9|591|X Germ cell, trophoblastic tumors & neoplasms of gonads|20618219|2005
5-9|0.2|0.3|0.2|41|X Germ cell, trophoblastic tumors & neoplasms of gonads|19173994|2005
<1|1.9|2.9|2.4|96|X Germ cell, trophoblastic tumors & neoplasms of gonads|4030153|2005
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15917630|2005
10-14|0.1|0.3|0.2|41|X(a) Intracranial & intraspinal germ cell tumors|20461017|2005
15-19|0.2|0.3|0.2|45|X(a) Intracranial & intraspinal germ cell tumors|20618219|2005
5-9|0.1|0.2|0.1|22|X(a) Intracranial & intraspinal germ cell tumors|19173994|2005
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|4030153|2005
1-4|0.1|0.2|0.2|26|X(b) Malignant extracranial & extragonadal germ cell tumors|15917630|2005
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20461017|2005
15-19|0.1|0.2|0.2|33|X(b) Malignant extracranial & extragonadal germ cell tumors|20618219|2005
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19173994|2005
<1|1.2|2.0|1.5|62|X(b) Malignant extracranial & extragonadal germ cell tumors|4030153|2005
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|13822338|1999
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|18146881|1999
15-19|0.1|0.2|0.1|21|XII(b) Other unspecified malignant tumors|17976823|1999
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|18557028|1999
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3417510|1999
1-4|~|~|~|~|VI(b) Renal carcinomas|15151945|2003
10-14|~|~|~|~|VI(b) Renal carcinomas|20383692|2003
15-19|0.1|0.2|0.1|22|VI(b) Renal carcinomas|19681033|2003
5-9|~|~|~|~|VI(b) Renal carcinomas|19012396|2003
<1|~|~|~|~|VI(b) Renal carcinomas|3882968|2003
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|14042091|2000
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|18847598|2000
15-19|~|~|~|~|XII(b) Other unspecified malignant tumors|18475345|2000
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|18755372|2000
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3528687|2000
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15688413|2004
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20724858|2004
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|20301027|2004
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|19244948|2004
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|4020211|2004
1-4|2.0|2.2|2.1|1482|IV(a) Neuroblastoma and ganglioneuroblastoma|72032406|2002-2006
10-14|0.1|0.1|0.1|102|IV(a) Neuroblastoma and ganglioneuroblastoma|94924078|2002-2006
15-19|0.0|0.1|0.0|38|IV(a) Neuroblastoma and ganglioneuroblastoma|93992876|2002-2006
5-9|0.3|0.4|0.3|303|IV(a) Neuroblastoma and ganglioneuroblastoma|89136197|2002-2006
<1|5.4|6.1|5.8|1061|IV(a) Neuroblastoma and ganglioneuroblastoma|18407240|2002-2006
1-4|0.1|0.2|0.2|26|XI Other malignant epithelial neoplasms and malignant melanomas|15607694|2006
10-14|1.3|1.7|1.5|297|XI Other malignant epithelial neoplasms and malignant melanomas|19773006|2006
15-19|4.3|4.9|4.6|943|XI Other malignant epithelial neoplasms and malignant melanomas|20449826|2006
5-9|0.4|0.6|0.5|85|XI Other malignant epithelial neoplasms and malignant melanomas|18880537|2006
<1|0.3|0.8|0.5|21|XI Other malignant epithelial neoplasms and malignant melanomas|4007564|2006
1-4|19.6|21.0|20.3|2849|All ICCC Groups Combined|14042091|2000
10-14|11.8|12.8|12.3|2313|All ICCC Groups Combined|18847598|2000
15-19|19.7|21.0|20.4|3763|All ICCC Groups Combined|18475345|2000
5-9|11.0|12.0|11.5|2153|All ICCC Groups Combined|18755372|2000
<1|21.9|25.1|23.4|827|All ICCC Groups Combined|3528687|2000
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15917630|2005
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20461017|2005
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|20618219|2005
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|19173994|2005
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|4030153|2005
1-4|0.4|0.6|0.5|74|VII Hepatic tumors|15917630|2005
10-14|0.1|0.1|0.1|19|VII Hepatic tumors|20461017|2005
15-19|0.1|0.2|0.1|21|VII Hepatic tumors|20618219|2005
5-9|~|~|~|~|VII Hepatic tumors|19173994|2005
<1|0.6|1.2|0.9|36|VII Hepatic tumors|4030153|2005
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|72032406|2002-2006
10-14|0.0|0.0|0.0|21|IV(b) Other peripheral nervous cell tumors|94924078|2002-2006
15-19|0.0|0.0|0.0|32|IV(b) Other peripheral nervous cell tumors|93992876|2002-2006
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|89136197|2002-2006
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|18407240|2002-2006
1-4|0.3|0.5|0.4|69|VII(a) Hepatoblastoma|15917630|2005
10-14|~|~|~|~|VII(a) Hepatoblastoma|20461017|2005
15-19|~|~|~|~|VII(a) Hepatoblastoma|20618219|2005
5-9|~|~|~|~|VII(a) Hepatoblastoma|19173994|2005
<1|0.6|1.2|0.9|35|VII(a) Hepatoblastoma|4030153|2005
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15607694|2006
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|19773006|2006
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|20449826|2006
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|18880537|2006
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|4007564|2006
1-4|1.0|1.1|1.0|740|IX Soft tissue and other extraosseous sarcomas|72032406|2002-2006
10-14|1.1|1.3|1.2|1124|IX Soft tissue and other extraosseous sarcomas|94924078|2002-2006
15-19|1.5|1.7|1.6|1525|IX Soft tissue and other extraosseous sarcomas|93992876|2002-2006
5-9|0.8|0.9|0.8|735|IX Soft tissue and other extraosseous sarcomas|89136197|2002-2006
<1|1.5|1.8|1.6|300|IX Soft tissue and other extraosseous sarcomas|18407240|2002-2006
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15917630|2005
10-14|0.0|0.1|0.1|16|VII(b) Hepatic carcinomas|20461017|2005
15-19|0.1|0.1|0.1|20|VII(b) Hepatic carcinomas|20618219|2005
5-9|~|~|~|~|VII(b) Hepatic carcinomas|19173994|2005
<1|~|~|~|~|VII(b) Hepatic carcinomas|4030153|2005
1-4|20.8|22.3|21.6|3064|All ICCC Groups Combined|14214314|2001
10-14|12.8|13.8|13.3|2567|All ICCC Groups Combined|19360577|2001
15-19|20.4|21.7|21.0|3955|All ICCC Groups Combined|18791536|2001
5-9|10.9|11.9|11.4|2144|All ICCC Groups Combined|18776213|2001
<1|23.3|26.5|24.8|928|All ICCC Groups Combined|3735453|2001
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15607694|2006
10-14|0.5|0.7|0.6|115|XI(b) Thyroid carcinomas|19773006|2006
15-19|1.7|2.1|1.9|386|XI(b) Thyroid carcinomas|20449826|2006
5-9|0.1|0.2|0.1|28|XI(b) Thyroid carcinomas|18880537|2006
<1|~|~|~|~|XI(b) Thyroid carcinomas|4007564|2006
1-4|0.7|0.8|0.7|537|IX(a) Rhabdomyosarcomas|72032406|2002-2006
10-14|0.3|0.4|0.4|341|IX(a) Rhabdomyosarcomas|94924078|2002-2006
15-19|0.3|0.4|0.4|348|IX(a) Rhabdomyosarcomas|93992876|2002-2006
5-9|0.4|0.5|0.5|407|IX(a) Rhabdomyosarcomas|89136197|2002-2006
<1|0.4|0.6|0.5|93|IX(a) Rhabdomyosarcomas|18407240|2002-2006
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15917630|2005
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20461017|2005
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20618219|2005
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19173994|2005
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|4030153|2005
1-4|8.7|9.7|9.2|1308|I Leukemias, myeloproliferative & myelodysplastic diseases|14214314|2001
10-14|2.9|3.4|3.1|601|I Leukemias, myeloproliferative & myelodysplastic diseases|19360577|2001
15-19|2.8|3.3|3.1|580|I Leukemias, myeloproliferative & myelodysplastic diseases|18791536|2001
5-9|3.6|4.2|3.9|732|I Leukemias, myeloproliferative & myelodysplastic diseases|18776213|2001
<1|4.2|5.7|4.9|183|I Leukemias, myeloproliferative & myelodysplastic diseases|3735453|2001
1-4|0.4|0.7|0.5|85|VII Hepatic tumors|15688413|2004
10-14|~|~|~|~|VII Hepatic tumors|20724858|2004
15-19|0.1|0.2|0.2|32|VII Hepatic tumors|20301027|2004
5-9|~|~|~|~|VII Hepatic tumors|19244948|2004
<1|1.0|1.8|1.3|54|VII Hepatic tumors|4020211|2004
1-4|0.1|0.2|0.2|27|VIII Malignant bone tumors|15917630|2005
10-14|1.1|1.4|1.3|257|VIII Malignant bone tumors|20461017|2005
15-19|1.3|1.6|1.5|304|VIII Malignant bone tumors|20618219|2005
5-9|0.5|0.7|0.6|112|VIII Malignant bone tumors|19173994|2005
<1|~|~|~|~|VIII Malignant bone tumors|4030153|2005
1-4|7.3|8.2|7.7|1100|I(a) Lymphoid leukemias|14214314|2001
10-14|1.9|2.3|2.1|398|I(a) Lymphoid leukemias|19360577|2001
15-19|1.4|1.8|1.6|303|I(a) Lymphoid leukemias|18791536|2001
5-9|2.9|3.5|3.2|598|I(a) Lymphoid leukemias|18776213|2001
<1|1.5|2.4|1.9|72|I(a) Lymphoid leukemias|3735453|2001
1-4|8.0|8.9|8.4|1184|I Leukemias, myeloproliferative & myelodysplastic diseases|14042091|2000
10-14|2.2|2.7|2.4|461|I Leukemias, myeloproliferative & myelodysplastic diseases|18847598|2000
15-19|2.5|3.0|2.8|510|I Leukemias, myeloproliferative & myelodysplastic diseases|18475345|2000
5-9|3.5|4.1|3.8|711|I Leukemias, myeloproliferative & myelodysplastic diseases|18755372|2000
<1|4.0|5.4|4.6|164|I Leukemias, myeloproliferative & myelodysplastic diseases|3528687|2000
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15151945|2003
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20383692|2003
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|19681033|2003
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|19012396|2003
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3882968|2003
1-4|~|~|~|~|II(e) Unspecified lymphomas|72032406|2002-2006
10-14|0.0|0.0|0.0|21|II(e) Unspecified lymphomas|94924078|2002-2006
15-19|0.0|0.1|0.1|59|II(e) Unspecified lymphomas|93992876|2002-2006
5-9|0.0|0.0|0.0|19|II(e) Unspecified lymphomas|89136197|2002-2006
<1|~|~|~|~|II(e) Unspecified lymphomas|18407240|2002-2006
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15607694|2006
10-14|0.1|0.1|0.1|17|XI(c) Nasopharyngeal carcinomas|19773006|2006
15-19|0.1|0.2|0.2|33|XI(c) Nasopharyngeal carcinomas|20449826|2006
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|18880537|2006
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|4007564|2006
1-4|~|~|~|~|VIII(a) Osteosarcomas|15917630|2005
10-14|0.7|0.9|0.8|157|VIII(a) Osteosarcomas|20461017|2005
15-19|0.7|1.0|0.9|178|VIII(a) Osteosarcomas|20618219|2005
5-9|0.2|0.4|0.3|58|VIII(a) Osteosarcomas|19173994|2005
<1|~|~|~|~|VIII(a) Osteosarcomas|4030153|2005
1-4|0.8|1.1|0.9|129|I(b) Acute myeloid leukemias|14214314|2001
10-14|0.6|0.8|0.7|137|I(b) Acute myeloid leukemias|19360577|2001
15-19|0.7|1.0|0.9|162|I(b) Acute myeloid leukemias|18791536|2001
5-9|0.4|0.6|0.5|87|I(b) Acute myeloid leukemias|18776213|2001
<1|1.2|2.0|1.6|58|I(b) Acute myeloid leukemias|3735453|2001
1-4|6.8|7.7|7.3|1022|I(a) Lymphoid leukemias|14042091|2000
10-14|1.6|2.0|1.8|330|I(a) Lymphoid leukemias|18847598|2000
15-19|1.5|1.8|1.7|305|I(a) Lymphoid leukemias|18475345|2000
5-9|2.9|3.5|3.2|599|I(a) Lymphoid leukemias|18755372|2000
<1|1.9|3.0|2.4|86|I(a) Lymphoid leukemias|3528687|2000
1-4|0.4|0.6|0.5|82|VII(a) Hepatoblastoma|15688413|2004
10-14|~|~|~|~|VII(a) Hepatoblastoma|20724858|2004
15-19|~|~|~|~|VII(a) Hepatoblastoma|20301027|2004
5-9|~|~|~|~|VII(a) Hepatoblastoma|19244948|2004
<1|0.9|1.6|1.2|50|VII(a) Hepatoblastoma|4020211|2004
5-9|0.2|0.4|0.3|55|IV Neuroblastoma and other peripheral nervous cell tumors|19012396|2003
<1|4.9|6.5|5.7|220|IV Neuroblastoma and other peripheral nervous cell tumors|3882968|2003
1-4|0.9|1.3|1.1|156|III(c) Intracranial and intraspinal embryonal tumors|14396227|2002
10-14|0.3|0.5|0.4|83|III(c) Intracranial and intraspinal embryonal tumors|19533296|2002
15-19|0.2|0.4|0.3|61|III(c) Intracranial and intraspinal embryonal tumors|18815493|2002
5-9|0.6|0.9|0.8|140|III(c) Intracranial and intraspinal embryonal tumors|18503153|2002
<1|0.7|1.4|1.0|37|III(c) Intracranial and intraspinal embryonal tumors|3691140|2002
1-4|4.0|4.3|4.1|2959|III CNS and misc intracranial and intraspinal neoplasms|72032406|2002-2006
10-14|2.4|2.6|2.5|2407|III CNS and misc intracranial and intraspinal neoplasms|94924078|2002-2006
15-19|2.1|2.3|2.2|2058|III CNS and misc intracranial and intraspinal neoplasms|93992876|2002-2006
5-9|3.2|3.4|3.3|2961|III CNS and misc intracranial and intraspinal neoplasms|89136197|2002-2006
1-4|~|~|~|~|XI(d) Malignant melanomas|15607694|2006
10-14|0.4|0.6|0.5|90|XI(d) Malignant melanomas|19773006|2006
15-19|1.3|1.6|1.4|296|XI(d) Malignant melanomas|20449826|2006
5-9|0.1|0.2|0.2|29|XI(d) Malignant melanomas|18880537|2006
<1|~|~|~|~|XI(d) Malignant melanomas|4007564|2006
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15917630|2005
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20461017|2005
15-19|~|~|~|~|IX(c) Kaposi sarcoma|20618219|2005
5-9|~|~|~|~|IX(c) Kaposi sarcoma|19173994|2005
<1|~|~|~|~|IX(c) Kaposi sarcoma|4030153|2005
1-4|0.1|0.2|0.1|21|I(c) Chronic myeloproliferative diseases|14214314|2001
10-14|0.1|0.3|0.2|36|I(c) Chronic myeloproliferative diseases|19360577|2001
15-19|0.3|0.4|0.3|65|I(c) Chronic myeloproliferative diseases|18791536|2001
5-9|~|~|~|~|I(c) Chronic myeloproliferative diseases|18776213|2001
<1|0.4|0.9|0.6|22|I(c) Chronic myeloproliferative diseases|3735453|2001
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15688413|2004
10-14|~|~|~|~|VII(b) Hepatic carcinomas|20724858|2004
15-19|0.1|0.2|0.2|32|VII(b) Hepatic carcinomas|20301027|2004
5-9|~|~|~|~|VII(b) Hepatic carcinomas|19244948|2004
<1|~|~|~|~|VII(b) Hepatic carcinomas|4020211|2004
1-4|1.8|2.2|2.0|302|IV(a) Neuroblastoma and ganglioneuroblastoma|15151945|2003
10-14|0.1|0.2|0.1|30|IV(a) Neuroblastoma and ganglioneuroblastoma|20383692|2003
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|19681033|2003
5-9|0.2|0.4|0.3|53|IV(a) Neuroblastoma and ganglioneuroblastoma|19012396|2003
<1|4.9|6.5|5.7|220|IV(a) Neuroblastoma and ganglioneuroblastoma|3882968|2003
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|13822338|1999
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|18146881|1999
15-19|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|17976823|1999
<1|3.0|3.5|3.3|603|III CNS and misc intracranial and intraspinal neoplasms|18407240|2002-2006
1-4|~|~|~|~|XI(e) Skin carcinomas|15607694|2006
10-14|~|~|~|~|XI(e) Skin carcinomas|19773006|2006
15-19|~|~|~|~|XI(e) Skin carcinomas|20449826|2006
5-9|~|~|~|~|XI(e) Skin carcinomas|18880537|2006
<1|~|~|~|~|XI(e) Skin carcinomas|4007564|2006
1-4|0.8|1.1|0.9|149|IX Soft tissue and other extraosseous sarcomas|15688413|2004
10-14|1.1|1.4|1.3|261|IX Soft tissue and other extraosseous sarcomas|20724858|2004
15-19|1.5|1.8|1.6|333|IX Soft tissue and other extraosseous sarcomas|20301027|2004
5-9|0.6|0.9|0.7|143|IX Soft tissue and other extraosseous sarcomas|19244948|2004
<1|1.5|2.3|1.9|75|IX Soft tissue and other extraosseous sarcomas|4020211|2004
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15151945|2003
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20383692|2003
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19681033|2003
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19012396|2003
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3882968|2003
1-4|0.5|0.7|0.6|85|III(d) Other gliomas|14396227|2002
10-14|0.4|0.6|0.5|91|III(d) Other gliomas|19533296|2002
15-19|0.3|0.5|0.4|81|III(d) Other gliomas|18815493|2002
5-9|0.6|0.9|0.7|137|III(d) Other gliomas|18503153|2002
<1|~|~|~|~|III(d) Other gliomas|3691140|2002
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|18557028|1999
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3417510|1999
1-4|0.4|0.5|0.5|355|III(a) Ependymomas and choroid plexus tumor|72032406|2002-2006
10-14|0.2|0.2|0.2|170|III(a) Ependymomas and choroid plexus tumor|94924078|2002-2006
15-19|0.2|0.2|0.2|166|III(a) Ependymomas and choroid plexus tumor|93992876|2002-2006
5-9|0.2|0.3|0.2|202|III(a) Ependymomas and choroid plexus tumor|89136197|2002-2006
<1|0.5|0.7|0.6|103|III(a) Ependymomas and choroid plexus tumor|18407240|2002-2006
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15607694|2006
10-14|0.3|0.5|0.4|72|XI(f) Other and unspecified carcinomas|19773006|2006
15-19|1.0|1.3|1.1|226|XI(f) Other and unspecified carcinomas|20449826|2006
5-9|0.1|0.2|0.1|24|XI(f) Other and unspecified carcinomas|18880537|2006
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|4007564|2006
1-4|0.1|0.2|0.1|19|IX(d) Other specified soft tissue sarcomas|15917630|2005
10-14|0.5|0.7|0.6|114|IX(d) Other specified soft tissue sarcomas|20461017|2005
15-19|0.8|1.1|1.0|196|IX(d) Other specified soft tissue sarcomas|20618219|2005
5-9|0.1|0.3|0.2|37|IX(d) Other specified soft tissue sarcomas|19173994|2005
<1|0.4|0.9|0.6|23|IX(d) Other specified soft tissue sarcomas|4030153|2005
1-4|0.2|0.3|0.2|33|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|14214314|2001
10-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19360577|2001
15-19|0.1|0.2|0.1|23|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|18791536|2001
5-9|0.1|0.2|0.1|20|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|18776213|2001
<1|0.4|0.9|0.6|23|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3735453|2001
1-4|0.6|0.9|0.7|112|IX(a) Rhabdomyosarcomas|15688413|2004
10-14|0.3|0.5|0.4|75|IX(a) Rhabdomyosarcomas|20724858|2004
15-19|0.3|0.4|0.3|68|IX(a) Rhabdomyosarcomas|20301027|2004
5-9|0.3|0.5|0.4|75|IX(a) Rhabdomyosarcomas|19244948|2004
<1|0.3|0.7|0.5|19|IX(a) Rhabdomyosarcomas|4020211|2004
1-4|1.0|1.3|1.1|171|IX Soft tissue and other extraosseous sarcomas|15151945|2003
10-14|1.1|1.4|1.2|246|IX Soft tissue and other extraosseous sarcomas|20383692|2003
15-19|1.5|1.9|1.7|329|IX Soft tissue and other extraosseous sarcomas|19681033|2003
5-9|0.6|0.9|0.8|144|IX Soft tissue and other extraosseous sarcomas|19012396|2003
<1|1.3|2.1|1.6|64|IX Soft tissue and other extraosseous sarcomas|3882968|2003
1-4|0.1|0.2|0.1|16|XI Other malignant epithelial neoplasms and malignant melanomas|13822338|1999
10-14|1.1|1.4|1.2|222|XI Other malignant epithelial neoplasms and malignant melanomas|18146881|1999
15-19|4.0|4.6|4.3|777|XI Other malignant epithelial neoplasms and malignant melanomas|17976823|1999
5-9|0.2|0.4|0.3|57|XI Other malignant epithelial neoplasms and malignant melanomas|18557028|1999
<1|0.3|0.8|0.5|17|XI Other malignant epithelial neoplasms and malignant melanomas|3417510|1999
1-4|1.8|2.0|1.9|1371|III(b) Astrocytomas|72032406|2002-2006
10-14|1.3|1.5|1.4|1341|III(b) Astrocytomas|94924078|2002-2006
15-19|1.1|1.3|1.2|1144|III(b) Astrocytomas|93992876|2002-2006
5-9|1.5|1.6|1.6|1382|III(b) Astrocytomas|89136197|2002-2006
<1|1.0|1.3|1.2|213|III(b) Astrocytomas|18407240|2002-2006
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15607694|2006
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19773006|2006
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20449826|2006
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|18880537|2006
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|4007564|2006
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15917630|2005
10-14|0.1|0.2|0.1|21|IX(e) Unspecified soft tissue sarcomas|20461017|2005
15-19|0.1|0.3|0.2|40|IX(e) Unspecified soft tissue sarcomas|20618219|2005
5-9|0.1|0.2|0.1|19|IX(e) Unspecified soft tissue sarcomas|19173994|2005
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|4030153|2005
1-4|~|~|~|~|XI(b) Thyroid carcinomas|14042091|2000
10-14|0.3|0.5|0.4|79|XI(b) Thyroid carcinomas|18847598|2000
15-19|1.5|1.8|1.6|304|XI(b) Thyroid carcinomas|18475345|2000
5-9|0.1|0.1|0.1|17|XI(b) Thyroid carcinomas|18755372|2000
<1|~|~|~|~|XI(b) Thyroid carcinomas|3528687|2000
1-4|0.6|0.9|0.8|118|IX(a) Rhabdomyosarcomas|15151945|2003
10-14|0.3|0.5|0.4|82|IX(a) Rhabdomyosarcomas|20383692|2003
15-19|0.3|0.5|0.4|80|IX(a) Rhabdomyosarcomas|19681033|2003
5-9|0.4|0.5|0.4|84|IX(a) Rhabdomyosarcomas|19012396|2003
<1|0.3|0.8|0.5|19|IX(a) Rhabdomyosarcomas|3882968|2003
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|13822338|1999
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|18146881|1999
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|17976823|1999
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|18557028|1999
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3417510|1999
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|14396227|2002
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|19533296|2002
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|18815493|2002
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|18503153|2002
1-4|~|~|~|~|Not classified by ICCC|15917630|2005
10-14|~|~|~|~|Not classified by ICCC|20461017|2005
15-19|~|~|~|~|Not classified by ICCC|20618219|2005
5-9|~|~|~|~|Not classified by ICCC|19173994|2005
<1|~|~|~|~|Not classified by ICCC|4030153|2005
1-4|1.0|1.1|1.0|754|III(c) Intracranial and intraspinal embryonal tumors|72032406|2002-2006
10-14|0.4|0.4|0.4|375|III(c) Intracranial and intraspinal embryonal tumors|94924078|2002-2006
15-19|0.2|0.3|0.3|255|III(c) Intracranial and intraspinal embryonal tumors|93992876|2002-2006
5-9|0.7|0.8|0.7|663|III(c) Intracranial and intraspinal embryonal tumors|89136197|2002-2006
<1|1.0|1.3|1.1|206|III(c) Intracranial and intraspinal embryonal tumors|18407240|2002-2006
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|14042091|2000
10-14|0.0|0.1|0.1|16|XI(c) Nasopharyngeal carcinomas|18847598|2000
15-19|0.1|0.2|0.1|21|XI(c) Nasopharyngeal carcinomas|18475345|2000
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|18755372|2000
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15688413|2004
10-14|0.1|0.2|0.2|36|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20724858|2004
15-19|0.1|0.2|0.2|32|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20301027|2004
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19244948|2004
<1|0.4|0.9|0.6|26|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|4020211|2004
1-4|~|~|~|~|XI(b) Thyroid carcinomas|13822338|1999
10-14|0.3|0.5|0.4|69|XI(b) Thyroid carcinomas|18146881|1999
15-19|1.6|2.0|1.8|319|XI(b) Thyroid carcinomas|17976823|1999
5-9|0.1|0.2|0.2|30|XI(b) Thyroid carcinomas|18557028|1999
<1|~|~|~|~|XI(b) Thyroid carcinomas|3417510|1999
1-4|0.2|0.4|0.3|47|X Germ cell, trophoblastic tumors & neoplasms of gonads|15607694|2006
10-14|0.6|0.8|0.7|131|X Germ cell, trophoblastic tumors & neoplasms of gonads|19773006|2006
15-19|2.2|2.7|2.5|503|X Germ cell, trophoblastic tumors & neoplasms of gonads|20449826|2006
5-9|0.2|0.3|0.2|41|X Germ cell, trophoblastic tumors & neoplasms of gonads|18880537|2006
<1|1.4|2.2|1.8|71|X Germ cell, trophoblastic tumors & neoplasms of gonads|4007564|2006
1-4|0.6|0.9|0.8|121|V Retinoblastoma|15917630|2005
10-14|~|~|~|~|V Retinoblastoma|20461017|2005
15-19|~|~|~|~|V Retinoblastoma|20618219|2005
5-9|~|~|~|~|V Retinoblastoma|19173994|2005
<1|2.0|2.9|2.4|97|V Retinoblastoma|4030153|2005
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3528687|2000
1-4|0.5|0.6|0.5|386|III(d) Other gliomas|72032406|2002-2006
10-14|0.4|0.5|0.5|435|III(d) Other gliomas|94924078|2002-2006
15-19|0.4|0.5|0.4|391|III(d) Other gliomas|93992876|2002-2006
5-9|0.6|0.7|0.7|604|III(d) Other gliomas|89136197|2002-2006
<1|0.2|0.3|0.2|43|III(d) Other gliomas|18407240|2002-2006
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3691140|2002
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15688413|2004
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20724858|2004
15-19|~|~|~|~|IX(c) Kaposi sarcoma|20301027|2004
5-9|~|~|~|~|IX(c) Kaposi sarcoma|19244948|2004
<1|~|~|~|~|IX(c) Kaposi sarcoma|4020211|2004
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15151945|2003
10-14|0.1|0.2|0.1|21|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20383692|2003
15-19|0.2|0.3|0.3|51|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19681033|2003
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19012396|2003
<1|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3882968|2003
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|13822338|1999
10-14|0.1|0.2|0.1|18|XI(c) Nasopharyngeal carcinomas|18146881|1999
15-19|0.1|0.2|0.1|19|XI(c) Nasopharyngeal carcinomas|17976823|1999
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|18557028|1999
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3417510|1999
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15607694|2006
10-14|0.2|0.3|0.3|50|X(a) Intracranial & intraspinal germ cell tumors|19773006|2006
15-19|0.1|0.3|0.2|42|X(a) Intracranial & intraspinal germ cell tumors|20449826|2006
5-9|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|18880537|2006
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|4007564|2006
1-4|1.7|2.1|1.9|305|VI Renal tumors|15917630|2005
10-14|0.1|0.2|0.1|25|VI Renal tumors|20461017|2005
15-19|0.1|0.3|0.2|42|VI Renal tumors|20618219|2005
5-9|0.4|0.6|0.5|94|VI Renal tumors|19173994|2005
<1|1.1|1.9|1.5|60|VI Renal tumors|4030153|2005
1-4|~|~|~|~|XI(d) Malignant melanomas|14042091|2000
10-14|0.2|0.4|0.3|61|XI(d) Malignant melanomas|18847598|2000
15-19|1.3|1.7|1.5|277|XI(d) Malignant melanomas|18475345|2000
5-9|~|~|~|~|XI(d) Malignant melanomas|18755372|2000
<1|~|~|~|~|XI(d) Malignant melanomas|3528687|2000
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|14396227|2002
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19533296|2002
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|18815493|2002
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|18503153|2002
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3691140|2002
1-4|0.1|0.3|0.2|28|IX(d) Other specified soft tissue sarcomas|15688413|2004
10-14|0.5|0.7|0.6|117|IX(d) Other specified soft tissue sarcomas|20724858|2004
15-19|0.8|1.1|1.0|194|IX(d) Other specified soft tissue sarcomas|20301027|2004
5-9|0.2|0.3|0.2|46|IX(d) Other specified soft tissue sarcomas|19244948|2004
<1|0.3|0.8|0.5|21|IX(d) Other specified soft tissue sarcomas|4020211|2004
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15151945|2003
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20383692|2003
15-19|~|~|~|~|IX(c) Kaposi sarcoma|19681033|2003
5-9|~|~|~|~|IX(c) Kaposi sarcoma|19012396|2003
<1|~|~|~|~|IX(c) Kaposi sarcoma|3882968|2003
1-4|~|~|~|~|XI(d) Malignant melanomas|13822338|1999
10-14|0.3|0.4|0.3|63|XI(d) Malignant melanomas|18146881|1999
15-19|1.2|1.5|1.3|240|XI(d) Malignant melanomas|17976823|1999
5-9|~|~|~|~|XI(d) Malignant melanomas|18557028|1999
<1|~|~|~|~|XI(d) Malignant melanomas|3417510|1999
1-4|0.1|0.3|0.2|27|X(b) Malignant extracranial & extragonadal germ cell tumors|15607694|2006
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19773006|2006
15-19|0.1|0.2|0.1|30|X(b) Malignant extracranial & extragonadal germ cell tumors|20449826|2006
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|18880537|2006
<1|0.9|1.6|1.2|49|X(b) Malignant extracranial & extragonadal germ cell tumors|4007564|2006
1-4|1.7|2.1|1.9|304|VI(a) Nephroblastoma and other nonepithelial renal tumors|15917630|2005
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|20461017|2005
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|20618219|2005
5-9|0.4|0.6|0.4|86|VI(a) Nephroblastoma and other nonepithelial renal tumors|19173994|2005
<1|1.1|1.9|1.5|60|VI(a) Nephroblastoma and other nonepithelial renal tumors|4030153|2005
1-4|~|~|~|~|XI(e) Skin carcinomas|14042091|2000
10-14|~|~|~|~|XI(e) Skin carcinomas|18847598|2000
15-19|~|~|~|~|XI(e) Skin carcinomas|18475345|2000
5-9|~|~|~|~|XI(e) Skin carcinomas|18755372|2000
<1|~|~|~|~|XI(e) Skin carcinomas|3528687|2000
1-4|0.1|0.1|0.1|53|III(e) Other specified intracranial & intraspinal neoplasms|72032406|2002-2006
10-14|0.0|0.1|0.1|54|III(e) Other specified intracranial & intraspinal neoplasms|94924078|2002-2006
15-19|0.1|0.1|0.1|62|III(e) Other specified intracranial & intraspinal neoplasms|93992876|2002-2006
5-9|0.1|0.1|0.1|66|III(e) Other specified intracranial & intraspinal neoplasms|89136197|2002-2006
<1|0.0|0.1|0.1|16|III(e) Other specified intracranial & intraspinal neoplasms|18407240|2002-2006
1-4|0.2|0.3|0.2|155|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|72032406|2002-2006
10-14|0.1|0.1|0.1|97|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|94924078|2002-2006
15-19|0.1|0.1|0.1|111|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|93992876|2002-2006
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15688413|2004
10-14|0.1|0.2|0.2|32|IX(e) Unspecified soft tissue sarcomas|20724858|2004
15-19|0.1|0.3|0.2|37|IX(e) Unspecified soft tissue sarcomas|20301027|2004
5-9|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|19244948|2004
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|4020211|2004
1-4|0.2|0.3|0.2|36|IX(d) Other specified soft tissue sarcomas|15151945|2003
1-4|1.8|2.3|2.0|290|IV Neuroblastoma and other peripheral nervous cell tumors|14396227|2002
10-14|0.1|0.2|0.1|25|IV Neuroblastoma and other peripheral nervous cell tumors|19533296|2002
15-19|~|~|~|~|IV Neuroblastoma and other peripheral nervous cell tumors|18815493|2002
5-9|0.3|0.5|0.4|74|IV Neuroblastoma and other peripheral nervous cell tumors|18503153|2002
<1|5.3|6.9|6.0|223|IV Neuroblastoma and other peripheral nervous cell tumors|3691140|2002
1-4|~|~|~|~|XI(e) Skin carcinomas|13822338|1999
10-14|~|~|~|~|XI(e) Skin carcinomas|18146881|1999
1-4|0.1|0.2|0.1|18|X(c) Malignant gonadal germ cell tumors|15607694|2006
10-14|0.3|0.4|0.4|70|X(c) Malignant gonadal germ cell tumors|19773006|2006
15-19|1.7|2.1|1.9|383|X(c) Malignant gonadal germ cell tumors|20449826|2006
5-9|0.1|0.2|0.1|22|X(c) Malignant gonadal germ cell tumors|18880537|2006
<1|0.2|0.7|0.4|17|X(c) Malignant gonadal germ cell tumors|4007564|2006
1-4|~|~|~|~|VI(b) Renal carcinomas|15917630|2005
10-14|~|~|~|~|VI(b) Renal carcinomas|20461017|2005
15-19|0.1|0.2|0.1|28|VI(b) Renal carcinomas|20618219|2005
5-9|~|~|~|~|VI(b) Renal carcinomas|19173994|2005
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|14042091|2000
10-14|0.2|0.4|0.3|54|XI(f) Other and unspecified carcinomas|18847598|2000
15-19|1.0|1.3|1.1|210|XI(f) Other and unspecified carcinomas|18475345|2000
5-9|~|~|~|~|XI(f) Other and unspecified carcinomas|18755372|2000
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3528687|2000
5-9|0.1|0.1|0.1|80|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|89136197|2002-2006
<1|0.5|0.7|0.6|106|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|18407240|2002-2006
1-4|~|~|~|~|Not classified by ICCC|15688413|2004
10-14|~|~|~|~|Not classified by ICCC|20724858|2004
15-19|~|~|~|~|Not classified by ICCC|20301027|2004
5-9|~|~|~|~|Not classified by ICCC|19244948|2004
<1|~|~|~|~|Not classified by ICCC|4020211|2004
1-4|0.4|0.6|0.5|70|III(a) Ependymomas and choroid plexus tumor|15151945|2003
10-14|0.1|0.2|0.1|30|III(a) Ependymomas and choroid plexus tumor|20383692|2003
15-19|0.1|0.2|0.2|35|III(a) Ependymomas and choroid plexus tumor|19681033|2003
5-9|0.1|0.2|0.2|34|III(a) Ependymomas and choroid plexus tumor|19012396|2003
<1|~|~|~|~|III(a) Ependymomas and choroid plexus tumor|3882968|2003
15-19|~|~|~|~|XI(e) Skin carcinomas|17976823|1999
5-9|~|~|~|~|XI(e) Skin carcinomas|18557028|1999
<1|~|~|~|~|XI(e) Skin carcinomas|3417510|1999
1-4|1.8|2.2|2.0|288|IV(a) Neuroblastoma and ganglioneuroblastoma|14396227|2002
10-14|0.1|0.2|0.1|23|IV(a) Neuroblastoma and ganglioneuroblastoma|19533296|2002
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|18815493|2002
5-9|0.3|0.5|0.4|72|IV(a) Neuroblastoma and ganglioneuroblastoma|18503153|2002
<1|5.3|6.9|6.0|223|IV(a) Neuroblastoma and ganglioneuroblastoma|3691140|2002
<1|~|~|~|~|VI(b) Renal carcinomas|4030153|2005
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20461017|2005
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20618219|2005
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19173994|2005
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|4030153|2005
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|14042091|2000
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|18847598|2000
15-19|~|~|~|~|XII Other and unspecified malignant neoplasms|18475345|2000
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|18755372|2000
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3528687|2000
1-4|0.1|0.2|0.2|115|I(e) Unspecified and other specified leukemias|72032406|2002-2006
10-14|0.1|0.1|0.1|84|I(e) Unspecified and other specified leukemias|94924078|2002-2006
15-19|0.1|0.1|0.1|109|I(e) Unspecified and other specified leukemias|93992876|2002-2006
5-9|0.1|0.1|0.1|85|I(e) Unspecified and other specified leukemias|89136197|2002-2006
<1|0.3|0.5|0.4|70|I(e) Unspecified and other specified leukemias|18407240|2002-2006
1-4|0.8|1.1|0.9|140|V Retinoblastoma|15688413|2004
10-14|~|~|~|~|V Retinoblastoma|20724858|2004
15-19|~|~|~|~|V Retinoblastoma|20301027|2004
5-9|~|~|~|~|V Retinoblastoma|19244948|2004
<1|2.2|3.2|2.7|107|V Retinoblastoma|4020211|2004
1-4|1.7|2.2|2.0|298|III(b) Astrocytomas|15151945|2003
10-14|1.2|1.6|1.4|285|III(b) Astrocytomas|20383692|2003
15-19|1.0|1.3|1.2|230|III(b) Astrocytomas|19681033|2003
5-9|1.3|1.7|1.5|286|III(b) Astrocytomas|19012396|2003
<1|1.0|1.8|1.4|54|III(b) Astrocytomas|3882968|2003
1-4|~|~|~|~|X(d) Gonadal carcinomas|15607694|2006
10-14|~|~|~|~|X(d) Gonadal carcinomas|19773006|2006
15-19|0.1|0.2|0.2|33|X(d) Gonadal carcinomas|20449826|2006
5-9|~|~|~|~|X(d) Gonadal carcinomas|18880537|2006
<1|~|~|~|~|X(d) Gonadal carcinomas|4007564|2006
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|13822338|1999
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|18146881|1999
15-19|0.1|0.1|0.1|16|VIII(d) Other specified malignant bone tumors|17976823|1999
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|18557028|1999
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3417510|1999
1-4|~|~|~|~|XII(a) Other specified malignant tumors|14042091|2000
10-14|~|~|~|~|XII(a) Other specified malignant tumors|18847598|2000
15-19|~|~|~|~|XII(a) Other specified malignant tumors|18475345|2000
5-9|~|~|~|~|XII(a) Other specified malignant tumors|18755372|2000
<1|~|~|~|~|XII(a) Other specified malignant tumors|3528687|2000
1-4|2.0|2.5|2.2|357|IV Neuroblastoma and other peripheral nervous cell tumors|15917630|2005
10-14|0.1|0.2|0.1|28|IV Neuroblastoma and other peripheral nervous cell tumors|20461017|2005
15-19|~|~|~|~|IV Neuroblastoma and other peripheral nervous cell tumors|20618219|2005
5-9|0.3|0.4|0.3|64|IV Neuroblastoma and other peripheral nervous cell tumors|19173994|2005
<1|5.3|6.9|6.1|244|IV Neuroblastoma and other peripheral nervous cell tumors|4030153|2005
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|14396227|2002
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19533296|2002
1-4|0.9|1.0|1.0|699|II Lymphomas and reticuloendothelial neoplasms|72032406|2002-2006
10-14|2.3|2.5|2.4|2317|II Lymphomas and reticuloendothelial neoplasms|94924078|2002-2006
15-19|4.9|5.2|5.0|4715|II Lymphomas and reticuloendothelial neoplasms|93992876|2002-2006
5-9|1.3|1.5|1.4|1248|II Lymphomas and reticuloendothelial neoplasms|89136197|2002-2006
<1|0.8|1.1|1.0|175|II Lymphomas and reticuloendothelial neoplasms|18407240|2002-2006
1-4|0.4|0.6|0.5|78|III(d) Other gliomas|15688413|2004
1-4|0.8|1.1|0.9|138|III(c) Intracranial and intraspinal embryonal tumors|15151945|2003
10-14|0.3|0.5|0.4|80|III(c) Intracranial and intraspinal embryonal tumors|20383692|2003
15-19|0.2|0.4|0.3|55|III(c) Intracranial and intraspinal embryonal tumors|19681033|2003
5-9|0.7|0.9|0.8|148|III(c) Intracranial and intraspinal embryonal tumors|19012396|2003
<1|1.0|1.7|1.3|50|III(c) Intracranial and intraspinal embryonal tumors|3882968|2003
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15607694|2006
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19773006|2006
15-19|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20449826|2006
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|18880537|2006
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|4007564|2006
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|13822338|1999
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|18146881|1999
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|17976823|1999
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|18557028|1999
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3417510|1999
1-4|2.0|2.5|2.2|355|IV(a) Neuroblastoma and ganglioneuroblastoma|15917630|2005
10-14|0.1|0.2|0.1|25|IV(a) Neuroblastoma and ganglioneuroblastoma|20461017|2005
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|20618219|2005
5-9|0.2|0.4|0.3|62|IV(a) Neuroblastoma and ganglioneuroblastoma|19173994|2005
<1|5.3|6.8|6.0|243|IV(a) Neuroblastoma and ganglioneuroblastoma|4030153|2005
1-4|0.1|0.1|0.1|66|II(a) Hodgkin lymphomas|72032406|2002-2006
10-14|1.1|1.3|1.2|1138|II(a) Hodgkin lymphomas|94924078|2002-2006
15-19|3.1|3.3|3.2|3033|II(a) Hodgkin lymphomas|93992876|2002-2006
5-9|0.4|0.4|0.4|360|II(a) Hodgkin lymphomas|89136197|2002-2006
<1|~|~|~|~|II(a) Hodgkin lymphomas|18407240|2002-2006
10-14|0.3|0.5|0.4|89|III(d) Other gliomas|20724858|2004
15-19|0.3|0.5|0.4|79|III(d) Other gliomas|20301027|2004
5-9|0.6|0.8|0.7|135|III(d) Other gliomas|19244948|2004
<1|~|~|~|~|III(d) Other gliomas|4020211|2004
1-4|0.4|0.7|0.5|81|III(d) Other gliomas|15151945|2003
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|18815493|2002
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|18503153|2002
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3691140|2002
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15607694|2006
10-14|0.0|0.1|0.1|16|VII(b) Hepatic carcinomas|19773006|2006
15-19|0.1|0.2|0.1|28|VII(b) Hepatic carcinomas|20449826|2006
5-9|~|~|~|~|VII(b) Hepatic carcinomas|18880537|2006
<1|~|~|~|~|VII(b) Hepatic carcinomas|4007564|2006
1-4|0.2|0.5|0.3|47|X Germ cell, trophoblastic tumors & neoplasms of gonads|13822338|1999
10-14|0.5|0.8|0.7|119|X Germ cell, trophoblastic tumors & neoplasms of gonads|18146881|1999
15-19|2.4|2.8|2.6|464|X Germ cell, trophoblastic tumors & neoplasms of gonads|17976823|1999
5-9|0.1|0.2|0.2|33|X Germ cell, trophoblastic tumors & neoplasms of gonads|18557028|1999
<1|1.5|2.5|1.9|66|X Germ cell, trophoblastic tumors & neoplasms of gonads|3417510|1999
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|14042091|2000
10-14|0.2|0.3|0.2|43|X(a) Intracranial & intraspinal germ cell tumors|18847598|2000
15-19|0.2|0.3|0.2|42|X(a) Intracranial & intraspinal germ cell tumors|18475345|2000
5-9|0.1|0.2|0.1|25|X(a) Intracranial & intraspinal germ cell tumors|18755372|2000
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3528687|2000
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15917630|2005
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20461017|2005
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20618219|2005
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19173994|2005
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15688413|2004
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20724858|2004
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20301027|2004
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|19244948|2004
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|4020211|2004
10-14|0.5|0.7|0.6|120|III(d) Other gliomas|20383692|2003
15-19|0.3|0.5|0.4|74|III(d) Other gliomas|19681033|2003
5-9|0.5|0.7|0.6|117|III(d) Other gliomas|19012396|2003
<1|~|~|~|~|III(d) Other gliomas|3882968|2003
1-4|0.4|0.5|0.4|324|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|72032406|2002-2006
10-14|0.8|1.0|0.9|860|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|94924078|2002-2006
15-19|1.4|1.5|1.5|1374|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|93992876|2002-2006
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15607694|2006
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19773006|2006
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20449826|2006
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|18880537|2006
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|4007564|2006
1-4|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|14042091|2000
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|18847598|2000
15-19|0.2|0.3|0.2|41|X(b) Malignant extracranial & extragonadal germ cell tumors|18475345|2000
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|18755372|2000
<1|0.8|1.5|1.1|40|X(b) Malignant extracranial & extragonadal germ cell tumors|3528687|2000
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|4030153|2005
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15688413|2004
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20724858|2004
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20301027|2004
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19244948|2004
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|4020211|2004
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15151945|2003
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20383692|2003
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|19681033|2003
5-9|0.1|0.2|0.1|21|III(e) Other specified intracranial & intraspinal neoplasms|19012396|2003
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3882968|2003
5-9|0.6|0.7|0.6|539|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|89136197|2002-2006
<1|0.3|0.4|0.3|61|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|18407240|2002-2006
1-4|0.4|0.6|0.5|70|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|14396227|2002
10-14|0.7|0.9|0.8|157|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19533296|2002
15-19|1.3|1.6|1.4|270|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|18815493|2002
5-9|0.5|0.7|0.6|109|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|18503153|2002
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3691140|2002
1-4|0.1|0.2|0.1|21|VIII Malignant bone tumors|15607694|2006
10-14|1.1|1.4|1.2|244|VIII Malignant bone tumors|19773006|2006
1-4|~|~|~|~|X(c) Malignant gonadal germ cell tumors|14042091|2000
10-14|0.3|0.5|0.4|73|X(c) Malignant gonadal germ cell tumors|18847598|2000
15-19|1.9|2.3|2.1|387|X(c) Malignant gonadal germ cell tumors|18475345|2000
5-9|0.1|0.2|0.1|23|X(c) Malignant gonadal germ cell tumors|18755372|2000
<1|~|~|~|~|X(c) Malignant gonadal germ cell tumors|3528687|2000
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|13822338|1999
10-14|0.2|0.3|0.2|44|X(a) Intracranial & intraspinal germ cell tumors|18146881|1999
15-19|0.1|0.2|0.2|31|X(a) Intracranial & intraspinal germ cell tumors|17976823|1999
5-9|0.1|0.1|0.1|17|X(a) Intracranial & intraspinal germ cell tumors|18557028|1999
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3417510|1999
1-4|0.8|1.1|1.0|155|IX Soft tissue and other extraosseous sarcomas|15917630|2005
10-14|1.0|1.3|1.1|232|IX Soft tissue and other extraosseous sarcomas|20461017|2005
15-19|1.5|1.9|1.7|355|IX Soft tissue and other extraosseous sarcomas|20618219|2005
5-9|0.8|1.0|0.9|173|IX Soft tissue and other extraosseous sarcomas|19173994|2005
<1|1.0|1.8|1.4|55|IX Soft tissue and other extraosseous sarcomas|4030153|2005
1-4|1.9|2.4|2.1|335|IV Neuroblastoma and other peripheral nervous cell tumors|15688413|2004
10-14|0.1|0.2|0.1|24|IV Neuroblastoma and other peripheral nervous cell tumors|20724858|2004
15-19|0.0|0.1|0.1|16|IV Neuroblastoma and other peripheral nervous cell tumors|20301027|2004
5-9|0.3|0.4|0.3|64|IV Neuroblastoma and other peripheral nervous cell tumors|19244948|2004
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15151945|2003
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20383692|2003
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19681033|2003
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19012396|2003
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3882968|2003
1-4|0.2|0.2|0.2|147|II(c) Burkitt lymphoma|72032406|2002-2006
10-14|0.2|0.3|0.3|265|II(c) Burkitt lymphoma|94924078|2002-2006
15-19|0.2|0.3|0.2|226|II(c) Burkitt lymphoma|93992876|2002-2006
5-9|0.3|0.4|0.3|287|II(c) Burkitt lymphoma|89136197|2002-2006
<1|~|~|~|~|II(c) Burkitt lymphoma|18407240|2002-2006
1-4|0.1|0.3|0.2|28|II(c) Burkitt lymphoma|14396227|2002
10-14|0.2|0.4|0.3|59|II(c) Burkitt lymphoma|19533296|2002
15-19|0.2|0.4|0.3|50|II(c) Burkitt lymphoma|18815493|2002
5-9|0.3|0.4|0.3|63|II(c) Burkitt lymphoma|18503153|2002
<1|~|~|~|~|II(c) Burkitt lymphoma|3691140|2002
15-19|1.4|1.8|1.6|324|VIII Malignant bone tumors|20449826|2006
5-9|0.6|0.8|0.7|125|VIII Malignant bone tumors|18880537|2006
<1|~|~|~|~|VIII Malignant bone tumors|4007564|2006
1-4|~|~|~|~|X(d) Gonadal carcinomas|14042091|2000
10-14|~|~|~|~|X(d) Gonadal carcinomas|18847598|2000
15-19|0.1|0.2|0.1|27|X(d) Gonadal carcinomas|18475345|2000
1-4|0.1|0.2|0.1|20|X(b) Malignant extracranial & extragonadal germ cell tumors|13822338|1999
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|18146881|1999
15-19|0.1|0.2|0.1|26|X(b) Malignant extracranial & extragonadal germ cell tumors|17976823|1999
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|18557028|1999
<1|0.9|1.7|1.2|42|X(b) Malignant extracranial & extragonadal germ cell tumors|3417510|1999
1-4|0.6|0.9|0.7|119|IX(a) Rhabdomyosarcomas|15917630|2005
10-14|0.3|0.4|0.3|71|IX(a) Rhabdomyosarcomas|20461017|2005
15-19|0.3|0.5|0.4|74|IX(a) Rhabdomyosarcomas|20618219|2005
5-9|0.4|0.6|0.5|102|IX(a) Rhabdomyosarcomas|19173994|2005
<1|0.2|0.7|0.4|17|IX(a) Rhabdomyosarcomas|4030153|2005
<1|5.2|6.7|5.9|238|IV Neuroblastoma and other peripheral nervous cell tumors|4020211|2004
1-4|1.8|2.2|2.0|303|IV Neuroblastoma and other peripheral nervous cell tumors|15151945|2003
10-14|0.1|0.2|0.2|34|IV Neuroblastoma and other peripheral nervous cell tumors|20383692|2003
15-19|~|~|~|~|IV Neuroblastoma and other peripheral nervous cell tumors|19681033|2003
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|3882968|2003
1-4|0.2|0.2|0.2|147|II(d) Miscellaneous lymphoreticular neoplasms|72032406|2002-2006
10-14|0.0|0.0|0.0|33|II(d) Miscellaneous lymphoreticular neoplasms|94924078|2002-2006
15-19|0.0|0.0|0.0|23|II(d) Miscellaneous lymphoreticular neoplasms|93992876|2002-2006
5-9|0.0|0.1|0.0|43|II(d) Miscellaneous lymphoreticular neoplasms|89136197|2002-2006
<1|0.5|0.7|0.6|109|II(d) Miscellaneous lymphoreticular neoplasms|18407240|2002-2006
5-9|~|~|~|~|X(d) Gonadal carcinomas|18755372|2000
<1|~|~|~|~|X(d) Gonadal carcinomas|3528687|2000
1-4|~|~|~|~|VIII(a) Osteosarcomas|15607694|2006
10-14|0.7|0.9|0.8|154|VIII(a) Osteosarcomas|19773006|2006
15-19|0.8|1.1|0.9|191|VIII(a) Osteosarcomas|20449826|2006
5-9|0.3|0.4|0.3|65|VIII(a) Osteosarcomas|18880537|2006
<1|~|~|~|~|VIII(a) Osteosarcomas|4007564|2006
1-4|0.1|0.2|0.2|21|X(c) Malignant gonadal germ cell tumors|13822338|1999
10-14|0.2|0.4|0.3|57|X(c) Malignant gonadal germ cell tumors|18146881|1999
15-19|1.9|2.3|2.1|374|X(c) Malignant gonadal germ cell tumors|17976823|1999
5-9|~|~|~|~|X(c) Malignant gonadal germ cell tumors|18557028|1999
<1|0.3|0.8|0.5|18|X(c) Malignant gonadal germ cell tumors|3417510|1999
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15917630|2005
10-14|0.1|0.2|0.1|25|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20461017|2005
15-19|0.2|0.3|0.2|44|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20618219|2005
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19173994|2005
<1|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|4030153|2005
1-4|1.9|2.4|2.1|333|IV(a) Neuroblastoma and ganglioneuroblastoma|15688413|2004
10-14|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|20724858|2004
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|20301027|2004
5-9|0.3|0.4|0.3|64|IV(a) Neuroblastoma and ganglioneuroblastoma|19244948|2004
<1|5.1|6.6|5.8|235|IV(a) Neuroblastoma and ganglioneuroblastoma|4020211|2004
1-4|0.1|0.2|0.2|24|II(d) Miscellaneous lymphoreticular neoplasms|14396227|2002
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19533296|2002
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|18815493|2002
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|18503153|2002
<1|0.4|0.9|0.6|22|II(d) Miscellaneous lymphoreticular neoplasms|3691140|2002
1-4|~|~|~|~|XII(a) Other specified malignant tumors|14396227|2002
10-14|~|~|~|~|XII(a) Other specified malignant tumors|19533296|2002
15-19|~|~|~|~|XII(a) Other specified malignant tumors|18815493|2002
5-9|~|~|~|~|XII(a) Other specified malignant tumors|18503153|2002
<1|~|~|~|~|XII(a) Other specified malignant tumors|3691140|2002
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|14042091|2000
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|18847598|2000
15-19|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|18475345|2000
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|18755372|2000
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3528687|2000
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15607694|2006
10-14|~|~|~|~|VIII(b) Chondrosarcomas|19773006|2006
15-19|~|~|~|~|VIII(b) Chondrosarcomas|20449826|2006
5-9|~|~|~|~|VIII(b) Chondrosarcomas|18880537|2006
<1|~|~|~|~|VIII(b) Chondrosarcomas|4007564|2006
1-4|~|~|~|~|X(d) Gonadal carcinomas|13822338|1999
10-14|~|~|~|~|X(d) Gonadal carcinomas|18146881|1999
15-19|0.1|0.2|0.1|26|X(d) Gonadal carcinomas|17976823|1999
5-9|~|~|~|~|X(d) Gonadal carcinomas|18557028|1999
<1|~|~|~|~|X(d) Gonadal carcinomas|3417510|1999
5-9|~|~|~|~|II(e) Unspecified lymphomas|19173994|2005
<1|~|~|~|~|II(e) Unspecified lymphomas|4030153|2005
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15688413|2004
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20724858|2004
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20301027|2004
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19244948|2004
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|4020211|2004
1-4|0.9|1.2|1.1|160|II Lymphomas and reticuloendothelial neoplasms|15151945|2003
10-14|2.0|2.4|2.2|454|II Lymphomas and reticuloendothelial neoplasms|20383692|2003
15-19|4.5|5.2|4.8|953|II Lymphomas and reticuloendothelial neoplasms|19681033|2003
5-9|1.3|1.7|1.5|281|II Lymphomas and reticuloendothelial neoplasms|19012396|2003
<1|0.6|1.2|0.8|33|II Lymphomas and reticuloendothelial neoplasms|3882968|2003
1-4|0.1|0.2|0.1|21|XI Other malignant epithelial neoplasms and malignant melanomas|14042091|2000
10-14|1.0|1.3|1.1|215|XI Other malignant epithelial neoplasms and malignant melanomas|18847598|2000
15-19|4.2|4.8|4.4|822|XI Other malignant epithelial neoplasms and malignant melanomas|18475345|2000
5-9|0.2|0.4|0.3|55|XI Other malignant epithelial neoplasms and malignant melanomas|18755372|2000
<1|~|~|~|~|XI Other malignant epithelial neoplasms and malignant melanomas|3528687|2000
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|14396227|2002
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|19533296|2002
15-19|~|~|~|~|XII(b) Other unspecified malignant tumors|18815493|2002
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|18503153|2002
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3691140|2002
1-4|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|15607694|2006
10-14|0.3|0.4|0.3|68|VIII(c) Ewing tumor and related sarcomas of bone|19773006|2006
15-19|0.4|0.6|0.5|98|VIII(c) Ewing tumor and related sarcomas of bone|20449826|2006
5-9|0.2|0.3|0.3|50|VIII(c) Ewing tumor and related sarcomas of bone|18880537|2006
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|4007564|2006
1-4|~|~|~|~|II(e) Unspecified lymphomas|14396227|2002
10-14|~|~|~|~|II(e) Unspecified lymphomas|19533296|2002
15-19|~|~|~|~|II(e) Unspecified lymphomas|18815493|2002
5-9|~|~|~|~|II(e) Unspecified lymphomas|18503153|2002
<1|~|~|~|~|II(e) Unspecified lymphomas|3691140|2002
1-4|3.6|4.2|3.9|621|III CNS and misc intracranial and intraspinal neoplasms|15917630|2005
10-14|2.3|2.7|2.5|513|III CNS and misc intracranial and intraspinal neoplasms|20461017|2005
15-19|1.9|2.3|2.1|441|III CNS and misc intracranial and intraspinal neoplasms|20618219|2005
5-9|3.0|3.5|3.2|621|III CNS and misc intracranial and intraspinal neoplasms|19173994|2005
<1|2.2|3.2|2.7|108|III CNS and misc intracranial and intraspinal neoplasms|4030153|2005
1-4|0.3|0.5|0.4|54|VII(a) Hepatoblastoma|13822338|1999
10-14|~|~|~|~|VII(a) Hepatoblastoma|18146881|1999
15-19|~|~|~|~|VII(a) Hepatoblastoma|17976823|1999
5-9|~|~|~|~|VII(a) Hepatoblastoma|18557028|1999
<1|0.6|1.3|0.9|31|VII(a) Hepatoblastoma|3417510|1999
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|14042091|2000
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|18847598|2000
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|18475345|2000
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|18755372|2000
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3528687|2000
1-4|0.4|0.6|0.5|77|III(a) Ependymomas and choroid plexus tumor|15917630|2005
10-14|0.1|0.2|0.2|36|III(a) Ependymomas and choroid plexus tumor|20461017|2005
15-19|0.1|0.3|0.2|38|III(a) Ependymomas and choroid plexus tumor|20618219|2005
5-9|0.2|0.3|0.3|51|III(a) Ependymomas and choroid plexus tumor|19173994|2005
<1|0.4|0.9|0.6|25|III(a) Ependymomas and choroid plexus tumor|4030153|2005
1-4|~|~|~|~|VIII Malignant bone tumors|14042091|2000
10-14|1.2|1.5|1.3|253|VIII Malignant bone tumors|18847598|2000
15-19|1.2|1.6|1.4|256|VIII Malignant bone tumors|18475345|2000
5-9|0.4|0.6|0.5|96|VIII Malignant bone tumors|18755372|2000
<1|~|~|~|~|VIII Malignant bone tumors|3528687|2000
1-4|1.6|2.1|1.9|295|III(b) Astrocytomas|15917630|2005
10-14|1.3|1.7|1.5|307|III(b) Astrocytomas|20461017|2005
15-19|1.0|1.3|1.1|237|III(b) Astrocytomas|20618219|2005
5-9|1.4|1.7|1.5|293|III(b) Astrocytomas|19173994|2005
<1|0.5|1.1|0.8|32|III(b) Astrocytomas|4030153|2005
1-4|0.8|1.2|1.0|157|III(c) Intracranial and intraspinal embryonal tumors|15917630|2005
10-14|0.3|0.4|0.4|72|III(c) Intracranial and intraspinal embryonal tumors|20461017|2005
15-19|0.2|0.3|0.3|55|III(c) Intracranial and intraspinal embryonal tumors|20618219|2005
5-9|0.6|0.9|0.7|138|III(c) Intracranial and intraspinal embryonal tumors|19173994|2005
<1|0.6|1.2|0.9|36|III(c) Intracranial and intraspinal embryonal tumors|4030153|2005
1-4|0.4|0.6|0.5|80|III(d) Other gliomas|15917630|2005
10-14|0.3|0.5|0.4|82|III(d) Other gliomas|20461017|2005
15-19|0.3|0.5|0.4|84|III(d) Other gliomas|20618219|2005
5-9|0.5|0.7|0.6|112|III(d) Other gliomas|19173994|2005
<1|~|~|~|~|III(d) Other gliomas|4030153|2005
1-4|3.9|4.6|4.3|613|III CNS and misc intracranial and intraspinal neoplasms|14396227|2002
10-14|2.3|2.8|2.5|496|III CNS and misc intracranial and intraspinal neoplasms|19533296|2002
15-19|1.9|2.4|2.1|403|III CNS and misc intracranial and intraspinal neoplasms|18815493|2002
5-9|3.2|3.8|3.5|646|III CNS and misc intracranial and intraspinal neoplasms|18503153|2002
<1|2.8|4.1|3.4|126|III CNS and misc intracranial and intraspinal neoplasms|3691140|2002
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15917630|2005
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20461017|2005
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20618219|2005
5-9|0.0|0.1|0.1|16|III(e) Other specified intracranial & intraspinal neoplasms|19173994|2005
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|4030153|2005
1-4|~|~|~|~|VIII(a) Osteosarcomas|14042091|2000
10-14|0.6|0.9|0.8|145|VIII(a) Osteosarcomas|18847598|2000
1-4|0.5|0.8|0.6|88|III(a) Ependymomas and choroid plexus tumor|14396227|2002
10-14|0.2|0.3|0.2|45|III(a) Ependymomas and choroid plexus tumor|19533296|2002
15-19|0.1|0.2|0.1|20|III(a) Ependymomas and choroid plexus tumor|18815493|2002
5-9|0.2|0.3|0.2|43|III(a) Ependymomas and choroid plexus tumor|18503153|2002
<1|0.5|1.0|0.7|26|III(a) Ependymomas and choroid plexus tumor|3691140|2002
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15917630|2005
1-4|0.1|0.3|0.2|30|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15917630|2005
10-14|0.0|0.1|0.1|17|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20461017|2005
15-19|0.1|0.2|0.1|27|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20618219|2005
5-9|0.1|0.2|0.1|22|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19173994|2005
<1|0.3|0.8|0.5|22|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|4030153|2005
15-19|0.7|1.0|0.8|150|VIII(a) Osteosarcomas|18475345|2000
5-9|0.2|0.4|0.3|52|VIII(a) Osteosarcomas|18755372|2000
<1|~|~|~|~|VIII(a) Osteosarcomas|3528687|2000
1-4|0.1|0.2|0.1|18|II(a) Hodgkin lymphomas|15151945|2003
10-14|1.0|1.3|1.2|238|II(a) Hodgkin lymphomas|20383692|2003
15-19|3.0|3.5|3.2|630|II(a) Hodgkin lymphomas|19681033|2003
5-9|0.4|0.5|0.4|84|II(a) Hodgkin lymphomas|19012396|2003
<1|~|~|~|~|II(a) Hodgkin lymphomas|3882968|2003
1-4|~|~|~|~|VII(b) Hepatic carcinomas|13822338|1999
10-14|~|~|~|~|VII(b) Hepatic carcinomas|18146881|1999
15-19|0.1|0.2|0.2|30|VII(b) Hepatic carcinomas|17976823|1999
5-9|~|~|~|~|VII(b) Hepatic carcinomas|18557028|1999
<1|~|~|~|~|VII(b) Hepatic carcinomas|3417510|1999
1-4|0.1|0.2|0.2|24|I(e) Unspecified and other specified leukemias|15917630|2005
10-14|0.1|0.2|0.1|24|I(e) Unspecified and other specified leukemias|20461017|2005
15-19|0.1|0.2|0.1|21|I(e) Unspecified and other specified leukemias|20618219|2005
5-9|~|~|~|~|I(e) Unspecified and other specified leukemias|19173994|2005
<1|0.2|0.7|0.4|17|I(e) Unspecified and other specified leukemias|4030153|2005
1-4|0.8|1.2|1.0|159|II Lymphomas and reticuloendothelial neoplasms|15917630|2005
10-14|2.3|2.8|2.6|522|II Lymphomas and reticuloendothelial neoplasms|20461017|2005
15-19|5.0|5.6|5.3|1089|II Lymphomas and reticuloendothelial neoplasms|20618219|2005
5-9|1.2|1.5|1.3|256|II Lymphomas and reticuloendothelial neoplasms|19173994|2005
<1|0.8|1.4|1.1|43|II Lymphomas and reticuloendothelial neoplasms|4030153|2005
1-4|~|~|~|~|VIII(b) Chondrosarcomas|14042091|2000
10-14|~|~|~|~|VIII(b) Chondrosarcomas|18847598|2000
15-19|~|~|~|~|VIII(b) Chondrosarcomas|18475345|2000
5-9|~|~|~|~|VIII(b) Chondrosarcomas|18755372|2000
<1|~|~|~|~|VIII(b) Chondrosarcomas|3528687|2000
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|13822338|1999
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|18146881|1999
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|17976823|1999
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|18557028|1999
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3417510|1999
1-4|0.3|0.5|0.4|67|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15688413|2004
10-14|0.9|1.2|1.1|218|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20724858|2004
15-19|1.2|1.5|1.3|272|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20301027|2004
5-9|0.5|0.7|0.6|117|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19244948|2004
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|4020211|2004
1-4|1.6|2.1|1.8|263|III(b) Astrocytomas|14396227|2002
10-14|1.2|1.5|1.3|261|III(b) Astrocytomas|19533296|2002
15-19|1.0|1.3|1.2|222|III(b) Astrocytomas|18815493|2002
5-9|1.5|1.9|1.7|307|III(b) Astrocytomas|18503153|2002
<1|0.9|1.6|1.2|44|III(b) Astrocytomas|3691140|2002
1-4|0.4|0.6|0.5|76|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15151945|2003
10-14|0.7|0.9|0.8|166|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20383692|2003
15-19|1.2|1.5|1.3|263|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19681033|2003
5-9|0.5|0.7|0.6|118|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19012396|2003
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3882968|2003
1-4|0.1|0.2|0.1|16|II(a) Hodgkin lymphomas|15917630|2005
10-14|1.1|1.4|1.3|257|II(a) Hodgkin lymphomas|20461017|2005
15-19|3.1|3.6|3.3|679|II(a) Hodgkin lymphomas|20618219|2005
5-9|0.3|0.5|0.4|75|II(a) Hodgkin lymphomas|19173994|2005
<1|~|~|~|~|II(a) Hodgkin lymphomas|4030153|2005
1-4|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|14042091|2000
10-14|0.4|0.6|0.5|91|VIII(c) Ewing tumor and related sarcomas of bone|18847598|2000
15-19|0.3|0.5|0.4|78|VIII(c) Ewing tumor and related sarcomas of bone|18475345|2000
5-9|0.2|0.3|0.2|43|VIII(c) Ewing tumor and related sarcomas of bone|18755372|2000
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3528687|2000
1-4|0.2|0.3|0.2|34|II(c) Burkitt lymphoma|15688413|2004
10-14|0.2|0.3|0.3|52|II(c) Burkitt lymphoma|20724858|2004
15-19|0.2|0.3|0.2|43|II(c) Burkitt lymphoma|20301027|2004
5-9|0.2|0.4|0.3|57|II(c) Burkitt lymphoma|19244948|2004
<1|~|~|~|~|II(c) Burkitt lymphoma|4020211|2004
1-4|6.7|7.6|7.2|1030|I(a) Lymphoid leukemias|14396227|2002
10-14|1.7|2.1|1.9|362|I(a) Lymphoid leukemias|19533296|2002
15-19|1.4|1.8|1.6|306|I(a) Lymphoid leukemias|18815493|2002
5-9|2.9|3.4|3.2|586|I(a) Lymphoid leukemias|18503153|2002
<1|1.4|2.3|1.8|66|I(a) Lymphoid leukemias|3691140|2002
1-4|0.1|0.2|0.2|22|VIII Malignant bone tumors|13822338|1999
10-14|1.3|1.6|1.4|258|VIII Malignant bone tumors|18146881|1999
15-19|1.2|1.6|1.4|246|VIII Malignant bone tumors|17976823|1999
5-9|0.5|0.7|0.6|103|VIII Malignant bone tumors|18557028|1999
<1|~|~|~|~|VIII Malignant bone tumors|3417510|1999
1-4|0.2|0.3|0.2|37|II(d) Miscellaneous lymphoreticular neoplasms|15688413|2004
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20724858|2004
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20301027|2004
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19244948|2004
1-4|0.9|1.2|1.0|150|I(b) Acute myeloid leukemias|14396227|2002
10-14|0.6|0.9|0.7|143|I(b) Acute myeloid leukemias|19533296|2002
15-19|0.8|1.1|0.9|173|I(b) Acute myeloid leukemias|18815493|2002
5-9|0.4|0.6|0.5|87|I(b) Acute myeloid leukemias|18503153|2002
<1|1.3|2.2|1.7|63|I(b) Acute myeloid leukemias|3691140|2002
1-4|0.2|0.3|0.2|35|II(c) Burkitt lymphoma|15151945|2003
10-14|0.2|0.3|0.2|47|II(c) Burkitt lymphoma|20383692|2003
15-19|0.2|0.3|0.2|46|II(c) Burkitt lymphoma|19681033|2003
5-9|0.3|0.5|0.4|69|II(c) Burkitt lymphoma|19012396|2003
<1|~|~|~|~|II(c) Burkitt lymphoma|3882968|2003
1-4|~|~|~|~|VIII(a) Osteosarcomas|13822338|1999
10-14|0.8|1.1|0.9|165|VIII(a) Osteosarcomas|18146881|1999
15-19|0.7|0.9|0.8|139|VIII(a) Osteosarcomas|17976823|1999
5-9|0.2|0.4|0.3|57|VIII(a) Osteosarcomas|18557028|1999
<1|~|~|~|~|VIII(a) Osteosarcomas|3417510|1999
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|14396227|2002
10-14|0.1|0.3|0.2|36|I(c) Chronic myeloproliferative diseases|19533296|2002
15-19|0.3|0.4|0.3|64|I(c) Chronic myeloproliferative diseases|18815493|2002
5-9|0.1|0.2|0.1|20|I(c) Chronic myeloproliferative diseases|18503153|2002
<1|0.4|0.9|0.6|21|I(c) Chronic myeloproliferative diseases|3691140|2002
1-4|0.4|0.6|0.5|72|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15917630|2005
10-14|0.8|1.0|0.9|182|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20461017|2005
15-19|1.5|1.8|1.7|342|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20618219|2005
5-9|0.5|0.7|0.6|111|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19173994|2005
<1|0.2|0.6|0.4|16|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|4030153|2005
1-4|~|~|~|~|VIII(b) Chondrosarcomas|13822338|1999
10-14|~|~|~|~|VIII(b) Chondrosarcomas|18146881|1999
15-19|0.1|0.2|0.1|18|VIII(b) Chondrosarcomas|17976823|1999
5-9|~|~|~|~|VIII(b) Chondrosarcomas|18557028|1999
<1|~|~|~|~|VIII(b) Chondrosarcomas|3417510|1999
1-4|0.1|0.3|0.2|32|II(c) Burkitt lymphoma|15917630|2005
10-14|0.2|0.4|0.3|66|II(c) Burkitt lymphoma|20461017|2005
15-19|0.2|0.3|0.2|46|II(c) Burkitt lymphoma|20618219|2005
5-9|0.2|0.4|0.3|55|II(c) Burkitt lymphoma|19173994|2005
<1|~|~|~|~|II(c) Burkitt lymphoma|4030153|2005
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|14042091|2000
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|18847598|2000
15-19|~|~|~|~|VIII(d) Other specified malignant bone tumors|18475345|2000
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|18755372|2000
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3528687|2000
1-4|0.1|0.3|0.2|31|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|14396227|2002
10-14|0.1|0.1|0.1|18|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19533296|2002
15-19|0.1|0.2|0.1|23|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|18815493|2002
5-9|0.0|0.1|0.1|16|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|18503153|2002
<1|0.4|1.0|0.7|25|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3691140|2002
1-4|20.5|21.1|20.8|14975|All ICCC Groups Combined|72032406|2002-2006
10-14|12.8|13.2|13.0|12345|All ICCC Groups Combined|94924078|2002-2006
15-19|21.4|22.0|21.7|20351|All ICCC Groups Combined|93992876|2002-2006
5-9|11.4|11.9|11.6|10376|All ICCC Groups Combined|89136197|2002-2006
<1|24.2|25.6|24.9|4581|All ICCC Groups Combined|18407240|2002-2006
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15607694|2006
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|19773006|2006
15-19|0.1|0.2|0.1|22|VIII(d) Other specified malignant bone tumors|20449826|2006
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|18880537|2006
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|4007564|2006
<1|0.4|0.9|0.6|25|II(d) Miscellaneous lymphoreticular neoplasms|4020211|2004
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|14042091|2000
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|18847598|2000
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|18475345|2000
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|18755372|2000
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3528687|2000
1-4|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|13822338|1999
10-14|0.3|0.5|0.4|79|VIII(c) Ewing tumor and related sarcomas of bone|18146881|1999
15-19|0.3|0.5|0.4|69|VIII(c) Ewing tumor and related sarcomas of bone|17976823|1999
5-9|0.1|0.3|0.2|37|VIII(c) Ewing tumor and related sarcomas of bone|18557028|1999
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3417510|1999
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|13822338|1999
10-14|0.1|0.2|0.1|24|IX(e) Unspecified soft tissue sarcomas|18146881|1999
15-19|0.1|0.3|0.2|38|IX(e) Unspecified soft tissue sarcomas|17976823|1999
5-9|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|18557028|1999
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3417510|1999
1-4|0.1|0.2|0.2|24|I(e) Unspecified and other specified leukemias|14396227|2002
10-14|~|~|~|~|I(e) Unspecified and other specified leukemias|19533296|2002
15-19|0.1|0.2|0.1|18|I(e) Unspecified and other specified leukemias|18815493|2002
5-9|0.1|0.2|0.1|26|I(e) Unspecified and other specified leukemias|18503153|2002
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|3691140|2002
1-4|0.1|0.3|0.2|29|II(d) Miscellaneous lymphoreticular neoplasms|15151945|2003
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20383692|2003
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19681033|2003
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19012396|2003
<1|0.3|0.8|0.5|20|II(d) Miscellaneous lymphoreticular neoplasms|3882968|2003
1-4|8.4|8.8|8.6|6172|I Leukemias, myeloproliferative & myelodysplastic diseases|72032406|2002-2006
10-14|2.9|3.1|3.0|2825|I Leukemias, myeloproliferative & myelodysplastic diseases|94924078|2002-2006
1-4|0.2|0.3|0.2|33|X Germ cell, trophoblastic tumors & neoplasms of gonads|14042091|2000
1-4|~|~|~|~|II(e) Unspecified lymphomas|15688413|2004
10-14|~|~|~|~|II(e) Unspecified lymphomas|20724858|2004
15-19|~|~|~|~|II(e) Unspecified lymphomas|20301027|2004
5-9|~|~|~|~|II(e) Unspecified lymphomas|19244948|2004
<1|~|~|~|~|II(e) Unspecified lymphomas|4020211|2004
1-4|~|~|~|~|Not classified by ICCC|13822338|1999
10-14|~|~|~|~|Not classified by ICCC|18146881|1999
15-19|~|~|~|~|Not classified by ICCC|17976823|1999
5-9|~|~|~|~|Not classified by ICCC|18557028|1999
<1|~|~|~|~|Not classified by ICCC|3417510|1999
1-4|~|~|~|~|Not classified by ICCC|15607694|2006
10-14|~|~|~|~|Not classified by ICCC|19773006|2006
15-19|~|~|~|~|Not classified by ICCC|20449826|2006
5-9|~|~|~|~|Not classified by ICCC|18880537|2006
<1|~|~|~|~|Not classified by ICCC|4007564|2006
1-4|~|~|~|~|II(e) Unspecified lymphomas|15151945|2003
15-19|3.0|3.2|3.1|2913|I Leukemias, myeloproliferative & myelodysplastic diseases|93992876|2002-2006
5-9|3.8|4.0|3.9|3472|I Leukemias, myeloproliferative & myelodysplastic diseases|89136197|2002-2006
<1|4.7|5.4|5.0|927|I Leukemias, myeloproliferative & myelodysplastic diseases|18407240|2002-2006
10-14|0.6|0.8|0.7|128|X Germ cell, trophoblastic tumors & neoplasms of gonads|18847598|2000
15-19|2.5|3.0|2.7|508|X Germ cell, trophoblastic tumors & neoplasms of gonads|18475345|2000
5-9|0.2|0.4|0.3|50|X Germ cell, trophoblastic tumors & neoplasms of gonads|18755372|2000
<1|1.3|2.3|1.8|62|X Germ cell, trophoblastic tumors & neoplasms of gonads|3528687|2000
1-4|1.8|2.3|2.0|285|VI Renal tumors|14042091|2000
10-14|0.1|0.2|0.1|23|VI Renal tumors|18847598|2000
15-19|0.1|0.2|0.1|19|VI Renal tumors|18475345|2000
5-9|0.5|0.7|0.6|113|VI Renal tumors|18755372|2000
<1|1.0|1.7|1.3|46|VI Renal tumors|3528687|2000
1-4|0.8|1.1|0.9|133|II Lymphomas and reticuloendothelial neoplasms|14396227|2002
10-14|2.2|2.6|2.4|466|II Lymphomas and reticuloendothelial neoplasms|19533296|2002
15-19|4.7|5.3|5.0|938|II Lymphomas and reticuloendothelial neoplasms|18815493|2002
5-9|1.2|1.5|1.3|243|II Lymphomas and reticuloendothelial neoplasms|18503153|2002
<1|0.6|1.3|0.9|34|II Lymphomas and reticuloendothelial neoplasms|3691140|2002
10-14|~|~|~|~|II(e) Unspecified lymphomas|20383692|2003
15-19|~|~|~|~|II(e) Unspecified lymphomas|19681033|2003
5-9|~|~|~|~|II(e) Unspecified lymphomas|19012396|2003
<1|~|~|~|~|II(e) Unspecified lymphomas|3882968|2003
1-4|3.9|4.6|4.2|666|III CNS and misc intracranial and intraspinal neoplasms|15688413|2004
10-14|2.3|2.8|2.6|529|III CNS and misc intracranial and intraspinal neoplasms|20724858|2004
15-19|2.1|2.5|2.3|464|III CNS and misc intracranial and intraspinal neoplasms|20301027|2004
5-9|3.2|3.7|3.4|660|III CNS and misc intracranial and intraspinal neoplasms|19244948|2004
<1|3.0|4.2|3.6|145|III CNS and misc intracranial and intraspinal neoplasms|4020211|2004
1-4|0.8|1.1|0.9|128|V Retinoblastoma|13822338|1999
10-14|~|~|~|~|V Retinoblastoma|18146881|1999
15-19|~|~|~|~|V Retinoblastoma|17976823|1999
5-9|~|~|~|~|V Retinoblastoma|18557028|1999
<1|2.2|3.3|2.7|92|V Retinoblastoma|3417510|1999
1-4|0.5|0.8|0.6|98|V Retinoblastoma|15607694|2006
10-14|~|~|~|~|V Retinoblastoma|19773006|2006
15-19|~|~|~|~|V Retinoblastoma|20449826|2006
5-9|~|~|~|~|V Retinoblastoma|18880537|2006
<1|2.6|3.7|3.1|123|V Retinoblastoma|4007564|2006
1-4|1.8|2.3|2.0|282|VI(a) Nephroblastoma and other nonepithelial renal tumors|14042091|2000
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|18847598|2000
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|18475345|2000
5-9|0.5|0.7|0.6|108|VI(a) Nephroblastoma and other nonepithelial renal tumors|18755372|2000
<1|1.0|1.7|1.3|46|VI(a) Nephroblastoma and other nonepithelial renal tumors|3528687|2000
1-4|6.9|7.3|7.1|5134|I(a) Lymphoid leukemias|72032406|2002-2006
10-14|1.8|2.0|1.9|1807|I(a) Lymphoid leukemias|94924078|2002-2006
15-19|1.5|1.7|1.6|1508|I(a) Lymphoid leukemias|93992876|2002-2006
5-9|3.1|3.3|3.2|2823|I(a) Lymphoid leukemias|89136197|2002-2006
<1|1.7|2.2|1.9|357|I(a) Lymphoid leukemias|18407240|2002-2006
1-4|0.4|0.6|0.5|75|III(a) Ependymomas and choroid plexus tumor|15688413|2004
10-14|0.1|0.2|0.2|33|III(a) Ependymomas and choroid plexus tumor|20724858|2004
15-19|0.1|0.3|0.2|41|III(a) Ependymomas and choroid plexus tumor|20301027|2004
5-9|0.2|0.3|0.2|44|III(a) Ependymomas and choroid plexus tumor|19244948|2004
<1|0.4|0.9|0.6|26|III(a) Ependymomas and choroid plexus tumor|4020211|2004
1-4|1.6|2.1|1.9|256|VI Renal tumors|13822338|1999
10-14|0.1|0.2|0.1|22|VI Renal tumors|18146881|1999
15-19|0.1|0.2|0.1|26|VI Renal tumors|17976823|1999
5-9|0.4|0.6|0.5|93|VI Renal tumors|18557028|1999
<1|1.4|2.4|1.8|63|VI Renal tumors|3417510|1999
1-4|3.7|4.3|4.0|604|III CNS and misc intracranial and intraspinal neoplasms|15151945|2003
10-14|2.4|2.9|2.6|536|III CNS and misc intracranial and intraspinal neoplasms|20383692|2003
15-19|1.9|2.3|2.1|413|III CNS and misc intracranial and intraspinal neoplasms|19681033|2003
5-9|3.0|3.5|3.2|609|III CNS and misc intracranial and intraspinal neoplasms|19012396|2003
<1|2.9|4.1|3.5|134|III CNS and misc intracranial and intraspinal neoplasms|3882968|2003
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|18407240|2002-2006
1-4|1.7|2.2|1.9|300|VI Renal tumors|15607694|2006
10-14|0.1|0.2|0.1|21|VI Renal tumors|19773006|2006
15-19|0.2|0.3|0.2|46|VI Renal tumors|20449826|2006
5-9|0.4|0.6|0.5|98|VI Renal tumors|18880537|2006
<1|1.2|2.0|1.5|62|VI Renal tumors|4007564|2006
1-4|0.9|1.1|1.0|705|I(b) Acute myeloid leukemias|72032406|2002-2006
10-14|0.7|0.8|0.7|676|I(b) Acute myeloid leukemias|94924078|2002-2006
15-19|0.8|1.0|0.9|842|I(b) Acute myeloid leukemias|93992876|2002-2006
5-9|0.4|0.5|0.4|400|I(b) Acute myeloid leukemias|89136197|2002-2006
<1|1.5|1.9|1.7|311|I(b) Acute myeloid leukemias|18407240|2002-2006
1-4|1.8|2.2|2.0|311|III(b) Astrocytomas|15688413|2004
10-14|1.3|1.6|1.4|292|III(b) Astrocytomas|20724858|2004
15-19|1.2|1.5|1.3|266|III(b) Astrocytomas|20301027|2004
5-9|1.5|1.8|1.6|315|III(b) Astrocytomas|19244948|2004
<1|1.1|1.8|1.4|56|III(b) Astrocytomas|4020211|2004
1-4|19.7|21.1|20.4|3092|All ICCC Groups Combined|15151945|2003
10-14|12.3|13.3|12.8|2610|All ICCC Groups Combined|20383692|2003
15-19|20.5|21.8|21.1|4159|All ICCC Groups Combined|19681033|2003
5-9|10.8|11.7|11.2|2137|All ICCC Groups Combined|19012396|2003
<1|23.2|26.4|24.8|962|All ICCC Groups Combined|3882968|2003
1-4|1.6|2.1|1.8|255|VI(a) Nephroblastoma and other nonepithelial renal tumors|13822338|1999
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|18146881|1999
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|17976823|1999
5-9|0.4|0.6|0.5|87|VI(a) Nephroblastoma and other nonepithelial renal tumors|18557028|1999
<1|1.3|2.2|1.7|58|VI(a) Nephroblastoma and other nonepithelial renal tumors|3417510|1999
1-4|1.7|2.1|1.9|299|VI(a) Nephroblastoma and other nonepithelial renal tumors|15607694|2006
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|19773006|2006
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|20449826|2006
1-4|~|~|~|~|VI(b) Renal carcinomas|13822338|1999
10-14|~|~|~|~|VI(b) Renal carcinomas|18146881|1999
15-19|0.1|0.1|0.1|16|VI(b) Renal carcinomas|17976823|1999
5-9|~|~|~|~|VI(b) Renal carcinomas|18557028|1999
<1|~|~|~|~|VI(b) Renal carcinomas|3417510|1999
1-4|~|~|~|~|VI(b) Renal carcinomas|14042091|2000
10-14|~|~|~|~|VI(b) Renal carcinomas|18847598|2000
15-19|~|~|~|~|VI(b) Renal carcinomas|18475345|2000
5-9|~|~|~|~|VI(b) Renal carcinomas|18755372|2000
<1|~|~|~|~|VI(b) Renal carcinomas|3528687|2000
1-4|0.1|0.1|0.1|63|I(c) Chronic myeloproliferative diseases|72032406|2002-2006
10-14|0.1|0.2|0.2|161|I(c) Chronic myeloproliferative diseases|94924078|2002-2006
15-19|0.3|0.4|0.4|343|I(c) Chronic myeloproliferative diseases|93992876|2002-2006
5-9|0.1|0.1|0.1|84|I(c) Chronic myeloproliferative diseases|89136197|2002-2006
<1|0.4|0.6|0.5|83|I(c) Chronic myeloproliferative diseases|18407240|2002-2006
1-4|1.0|1.3|1.1|176|III(c) Intracranial and intraspinal embryonal tumors|15688413|2004
10-14|0.4|0.5|0.4|92|III(c) Intracranial and intraspinal embryonal tumors|20724858|2004
15-19|0.2|0.4|0.3|61|III(c) Intracranial and intraspinal embryonal tumors|20301027|2004
1-4|7.8|8.7|8.2|1244|I Leukemias, myeloproliferative & myelodysplastic diseases|15151945|2003
10-14|2.6|3.0|2.8|566|I Leukemias, myeloproliferative & myelodysplastic diseases|20383692|2003
15-19|2.8|3.2|3.0|589|I Leukemias, myeloproliferative & myelodysplastic diseases|19681033|2003
5-9|3.6|4.2|3.9|744|I Leukemias, myeloproliferative & myelodysplastic diseases|19012396|2003
<1|4.3|5.7|5.0|193|I Leukemias, myeloproliferative & myelodysplastic diseases|3882968|2003
5-9|0.4|0.6|0.5|93|VI(a) Nephroblastoma and other nonepithelial renal tumors|18880537|2006
<1|1.2|2.0|1.5|62|VI(a) Nephroblastoma and other nonepithelial renal tumors|4007564|2006
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|14042091|2000
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|18847598|2000
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|18475345|2000
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|18755372|2000
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3528687|2000
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|13822338|1999
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|18146881|1999
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|17976823|1999
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|18557028|1999
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3417510|1999
1-4|~|~|~|~|II(a) Hodgkin lymphomas|14396227|2002
10-14|1.1|1.4|1.2|236|II(a) Hodgkin lymphomas|19533296|2002
15-19|3.0|3.5|3.2|605|II(a) Hodgkin lymphomas|18815493|2002
5-9|0.3|0.4|0.3|61|II(a) Hodgkin lymphomas|18503153|2002
<1|~|~|~|~|II(a) Hodgkin lymphomas|3691140|2002
5-9|0.6|0.9|0.8|146|III(c) Intracranial and intraspinal embryonal tumors|19244948|2004
<1|0.7|1.4|1.0|41|III(c) Intracranial and intraspinal embryonal tumors|4020211|2004
15-19|1.5|1.9|1.7|338|I(a) Lymphoid leukemias|20301027|2004
5-9|3.0|3.5|3.3|626|I(a) Lymphoid leukemias|19244948|2004
<1|1.6|2.5|2.0|81|I(a) Lymphoid leukemias|4020211|2004
1-4|6.4|7.2|6.8|1026|I(a) Lymphoid leukemias|15151945|2003
1-4|0.3|0.6|0.4|59|VII Hepatic tumors|13822338|1999
10-14|~|~|~|~|VII Hepatic tumors|18146881|1999
15-19|0.1|0.3|0.2|32|VII Hepatic tumors|17976823|1999
5-9|~|~|~|~|VII Hepatic tumors|18557028|1999
<1|0.6|1.3|0.9|31|VII Hepatic tumors|3417510|1999
1-4|1.8|2.3|2.1|287|IV(a) Neuroblastoma and ganglioneuroblastoma|13822338|1999
10-14|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|18146881|1999
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|17976823|1999
5-9|0.2|0.4|0.3|50|IV(a) Neuroblastoma and ganglioneuroblastoma|18557028|1999
<1|5.3|7.0|6.1|208|IV(a) Neuroblastoma and ganglioneuroblastoma|3417510|1999
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|13822338|1999
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|18146881|1999
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|17976823|1999
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|18557028|1999
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3417510|1999
1-4|~|~|~|~|VI(b) Renal carcinomas|15607694|2006
10-14|~|~|~|~|VI(b) Renal carcinomas|19773006|2006
15-19|0.1|0.2|0.2|37|VI(b) Renal carcinomas|20449826|2006
5-9|~|~|~|~|VI(b) Renal carcinomas|18880537|2006
<1|~|~|~|~|VI(b) Renal carcinomas|4007564|2006
1-4|0.3|0.6|0.4|63|VII Hepatic tumors|14042091|2000
10-14|0.0|0.1|0.1|16|VII Hepatic tumors|18847598|2000
15-19|~|~|~|~|VII Hepatic tumors|18475345|2000
5-9|~|~|~|~|VII Hepatic tumors|18755372|2000
<1|0.7|1.4|1.0|36|VII Hepatic tumors|3528687|2000
1-4|0.9|1.2|1.0|163|I(b) Acute myeloid leukemias|15688413|2004
10-14|0.6|0.8|0.7|143|I(b) Acute myeloid leukemias|20724858|2004
15-19|0.8|1.1|0.9|187|I(b) Acute myeloid leukemias|20301027|2004
5-9|0.4|0.6|0.5|98|I(b) Acute myeloid leukemias|19244948|2004
<1|1.4|2.2|1.7|70|I(b) Acute myeloid leukemias|4020211|2004
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|14396227|2002
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|19533296|2002
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|18815493|2002
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|18503153|2002
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3691140|2002
10-14|1.6|2.0|1.8|359|I(a) Lymphoid leukemias|20383692|2003
15-19|1.3|1.7|1.5|291|I(a) Lymphoid leukemias|19681033|2003
5-9|3.0|3.5|3.2|616|I(a) Lymphoid leukemias|19012396|2003
<1|1.5|2.4|1.9|73|I(a) Lymphoid leukemias|3882968|2003
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15607694|2006
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|19773006|2006
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|20449826|2006
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|18880537|2006
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|4007564|2006
1-4|0.3|0.6|0.4|63|VII(a) Hepatoblastoma|14042091|2000
10-14|~|~|~|~|VII(a) Hepatoblastoma|18847598|2000
15-19|~|~|~|~|VII(a) Hepatoblastoma|18475345|2000
5-9|~|~|~|~|VII(a) Hepatoblastoma|18755372|2000
<1|0.7|1.4|1.0|35|VII(a) Hepatoblastoma|3528687|2000
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|15688413|2004
10-14|0.2|0.3|0.2|43|I(c) Chronic myeloproliferative diseases|20724858|2004
15-19|0.2|0.4|0.3|64|I(c) Chronic myeloproliferative diseases|20301027|2004
5-9|0.1|0.2|0.1|20|I(c) Chronic myeloproliferative diseases|19244948|2004
<1|~|~|~|~|I(c) Chronic myeloproliferative diseases|4020211|2004
1-4|~|~|~|~|XI(b) Thyroid carcinomas|14396227|2002
10-14|0.4|0.5|0.4|86|XI(b) Thyroid carcinomas|19533296|2002
15-19|1.5|1.9|1.7|317|XI(b) Thyroid carcinomas|18815493|2002
5-9|0.1|0.2|0.1|20|XI(b) Thyroid carcinomas|18503153|2002
<1|~|~|~|~|XI(b) Thyroid carcinomas|3691140|2002
1-4|0.8|1.1|1.0|134|IX Soft tissue and other extraosseous sarcomas|13822338|1999
10-14|0.8|1.1|0.9|164|IX Soft tissue and other extraosseous sarcomas|18146881|1999
15-19|1.3|1.7|1.5|268|IX Soft tissue and other extraosseous sarcomas|17976823|1999
5-9|0.7|1.0|0.8|152|IX Soft tissue and other extraosseous sarcomas|18557028|1999
<1|1.1|1.9|1.4|49|IX Soft tissue and other extraosseous sarcomas|3417510|1999
1-4|0.8|1.1|1.0|147|I(b) Acute myeloid leukemias|15151945|2003
10-14|0.6|0.8|0.7|139|I(b) Acute myeloid leukemias|20383692|2003
15-19|0.7|1.0|0.8|167|I(b) Acute myeloid leukemias|19681033|2003
5-9|0.3|0.5|0.4|83|I(b) Acute myeloid leukemias|19012396|2003
<1|1.3|2.2|1.7|67|I(b) Acute myeloid leukemias|3882968|2003
1-4|~|~|~|~|XI(e) Skin carcinomas|14214314|2001
10-14|~|~|~|~|XI(e) Skin carcinomas|19360577|2001
15-19|~|~|~|~|XI(e) Skin carcinomas|18791536|2001
5-9|~|~|~|~|XI(e) Skin carcinomas|18776213|2001
<1|~|~|~|~|XI(e) Skin carcinomas|3735453|2001
1-4|0.4|0.6|0.5|71|VII Hepatic tumors|15607694|2006
10-14|0.1|0.1|0.1|18|VII Hepatic tumors|19773006|2006
15-19|0.1|0.2|0.1|29|VII Hepatic tumors|20449826|2006
5-9|~|~|~|~|VII Hepatic tumors|18880537|2006
<1|1.0|1.8|1.4|55|VII Hepatic tumors|4007564|2006
1-4|~|~|~|~|VII(b) Hepatic carcinomas|14042091|2000
10-14|~|~|~|~|VII(b) Hepatic carcinomas|18847598|2000
15-19|~|~|~|~|VII(b) Hepatic carcinomas|18475345|2000
5-9|~|~|~|~|VII(b) Hepatic carcinomas|18755372|2000
<1|~|~|~|~|VII(b) Hepatic carcinomas|3528687|2000
1-4|0.2|0.3|0.3|40|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15688413|2004
10-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20724858|2004
15-19|0.1|0.1|0.1|18|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20301027|2004
5-9|0.1|0.1|0.1|17|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19244948|2004
<1|0.3|0.8|0.5|20|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|4020211|2004
1-4|0.5|0.8|0.7|90|IX(a) Rhabdomyosarcomas|13822338|1999
10-14|0.2|0.4|0.3|56|IX(a) Rhabdomyosarcomas|18146881|1999
15-19|0.3|0.5|0.4|64|IX(a) Rhabdomyosarcomas|17976823|1999
5-9|0.4|0.6|0.5|89|IX(a) Rhabdomyosarcomas|18557028|1999
<1|0.5|1.1|0.7|25|IX(a) Rhabdomyosarcomas|3417510|1999
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|14396227|2002
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|19533296|2002
15-19|0.1|0.3|0.2|36|XI(c) Nasopharyngeal carcinomas|18815493|2002
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|18503153|2002
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3691140|2002
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|15151945|2003
10-14|0.1|0.2|0.1|25|I(c) Chronic myeloproliferative diseases|20383692|2003
15-19|0.3|0.5|0.4|84|I(c) Chronic myeloproliferative diseases|19681033|2003
5-9|0.1|0.2|0.1|19|I(c) Chronic myeloproliferative diseases|19012396|2003
<1|0.3|0.8|0.5|21|I(c) Chronic myeloproliferative diseases|3882968|2003
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|14214314|2001
10-14|0.3|0.5|0.4|70|XI(f) Other and unspecified carcinomas|19360577|2001
15-19|0.9|1.2|1.1|204|XI(f) Other and unspecified carcinomas|18791536|2001
5-9|0.1|0.2|0.1|23|XI(f) Other and unspecified carcinomas|18776213|2001
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3735453|2001
1-4|0.3|0.6|0.4|69|VII(a) Hepatoblastoma|15607694|2006
10-14|~|~|~|~|VII(a) Hepatoblastoma|19773006|2006
15-19|~|~|~|~|VII(a) Hepatoblastoma|20449826|2006
5-9|~|~|~|~|VII(a) Hepatoblastoma|18880537|2006
<1|0.9|1.6|1.2|50|VII(a) Hepatoblastoma|4007564|2006
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|14042091|2000
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|18847598|2000
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|18475345|2000
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|18755372|2000
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3528687|2000
1-4|0.1|0.3|0.2|31|I(e) Unspecified and other specified leukemias|15688413|2004
10-14|0.1|0.2|0.1|23|I(e) Unspecified and other specified leukemias|20724858|2004
15-19|0.1|0.2|0.1|20|I(e) Unspecified and other specified leukemias|20301027|2004
5-9|~|~|~|~|I(e) Unspecified and other specified leukemias|19244948|2004
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|13822338|1999
10-14|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|18146881|1999
15-19|0.1|0.2|0.2|28|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|17976823|1999
5-9|0.1|0.1|0.1|17|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|18557028|1999
<1|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3417510|1999
1-4|~|~|~|~|IX(c) Kaposi sarcoma|13822338|1999
10-14|~|~|~|~|IX(c) Kaposi sarcoma|18146881|1999
15-19|~|~|~|~|IX(c) Kaposi sarcoma|17976823|1999
5-9|~|~|~|~|IX(c) Kaposi sarcoma|18557028|1999
<1|~|~|~|~|IX(c) Kaposi sarcoma|3417510|1999
1-4|0.2|0.4|0.3|41|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15151945|2003
10-14|0.1|0.2|0.2|31|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20383692|2003
15-19|0.1|0.2|0.1|23|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19681033|2003
5-9|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19012396|2003
<1|0.3|0.7|0.4|17|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3882968|2003
1-4|0.1|0.2|0.1|17|XI(d) Malignant melanomas|14396227|2002
10-14|0.3|0.5|0.4|77|XI(d) Malignant melanomas|19533296|2002
15-19|1.8|2.2|2.0|371|XI(d) Malignant melanomas|18815493|2002
5-9|0.1|0.2|0.2|32|XI(d) Malignant melanomas|18503153|2002
<1|~|~|~|~|XI(d) Malignant melanomas|3691140|2002
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15607694|2006
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19773006|2006
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20449826|2006
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|18880537|2006
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|4007564|2006
1-4|0.7|1.0|0.8|118|IX(a) Rhabdomyosarcomas|14042091|2000
10-14|0.3|0.5|0.4|69|IX(a) Rhabdomyosarcomas|18847598|2000
15-19|0.3|0.5|0.4|68|IX(a) Rhabdomyosarcomas|18475345|2000
5-9|0.3|0.5|0.4|75|IX(a) Rhabdomyosarcomas|18755372|2000
<1|0.5|1.0|0.7|25|IX(a) Rhabdomyosarcomas|3528687|2000
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|4020211|2004
1-4|0.1|0.2|0.1|18|I(e) Unspecified and other specified leukemias|15151945|2003
10-14|~|~|~|~|I(e) Unspecified and other specified leukemias|20383692|2003
15-19|0.1|0.2|0.1|24|I(e) Unspecified and other specified leukemias|19681033|2003
5-9|~|~|~|~|I(e) Unspecified and other specified leukemias|19012396|2003
1-4|0.1|0.3|0.2|27|IX(d) Other specified soft tissue sarcomas|13822338|1999
10-14|0.3|0.5|0.4|69|IX(d) Other specified soft tissue sarcomas|18146881|1999
15-19|0.6|0.9|0.8|136|IX(d) Other specified soft tissue sarcomas|17976823|1999
5-9|0.1|0.2|0.2|33|IX(d) Other specified soft tissue sarcomas|18557028|1999
1-4|~|~|~|~|XI(e) Skin carcinomas|14396227|2002
10-14|~|~|~|~|XI(e) Skin carcinomas|19533296|2002
15-19|~|~|~|~|XI(e) Skin carcinomas|18815493|2002
5-9|~|~|~|~|XI(e) Skin carcinomas|18503153|2002
<1|~|~|~|~|XI(e) Skin carcinomas|3691140|2002
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|14214314|2001
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|19360577|2001
15-19|0.1|0.2|0.1|20|XII Other and unspecified malignant neoplasms|18791536|2001
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|18776213|2001
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3735453|2001
1-4|~|~|~|~|XII(a) Other specified malignant tumors|14214314|2001
10-14|~|~|~|~|XII(a) Other specified malignant tumors|19360577|2001
15-19|~|~|~|~|XII(a) Other specified malignant tumors|18791536|2001
5-9|~|~|~|~|XII(a) Other specified malignant tumors|18776213|2001
<1|~|~|~|~|XII(a) Other specified malignant tumors|3735453|2001
<1|~|~|~|~|IX(d) Other specified soft tissue sarcomas|3417510|1999
1-4|0.3|0.6|0.4|60|III(a) Ependymomas and choroid plexus tumor|13822338|1999
1-4|0.8|1.1|1.0|151|IX Soft tissue and other extraosseous sarcomas|15607694|2006
10-14|1.0|1.3|1.1|225|IX Soft tissue and other extraosseous sarcomas|19773006|2006
15-19|1.3|1.7|1.5|304|IX Soft tissue and other extraosseous sarcomas|20449826|2006
5-9|0.7|0.9|0.8|153|IX Soft tissue and other extraosseous sarcomas|18880537|2006
<1|1.3|2.1|1.6|66|IX Soft tissue and other extraosseous sarcomas|4007564|2006
15-19|1.7|1.9|1.8|1721|XI(b) Thyroid carcinomas|93992876|2002-2006
5-9|0.1|0.1|0.1|108|XI(b) Thyroid carcinomas|89136197|2002-2006
<1|~|~|~|~|XI(b) Thyroid carcinomas|18407240|2002-2006
1-4|0.8|1.2|1.0|156|II Lymphomas and reticuloendothelial neoplasms|15688413|2004
10-14|2.3|2.7|2.5|515|II Lymphomas and reticuloendothelial neoplasms|20724858|2004
15-19|4.5|5.1|4.8|973|II Lymphomas and reticuloendothelial neoplasms|20301027|2004
5-9|1.2|1.5|1.3|258|II Lymphomas and reticuloendothelial neoplasms|19244948|2004
<1|0.6|1.2|0.9|35|II Lymphomas and reticuloendothelial neoplasms|4020211|2004
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|14042091|2000
10-14|0.1|0.2|0.1|21|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|18847598|2000
15-19|0.1|0.3|0.2|36|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|18475345|2000
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|18755372|2000
<1|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3528687|2000
10-14|0.1|0.3|0.2|37|III(a) Ependymomas and choroid plexus tumor|18146881|1999
15-19|0.1|0.2|0.2|28|III(a) Ependymomas and choroid plexus tumor|17976823|1999
5-9|0.2|0.3|0.2|41|III(a) Ependymomas and choroid plexus tumor|18557028|1999
<1|0.3|0.8|0.5|17|III(a) Ependymomas and choroid plexus tumor|3417510|1999
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|14396227|2002
10-14|0.3|0.5|0.4|77|XI(f) Other and unspecified carcinomas|19533296|2002
15-19|0.9|1.2|1.1|203|XI(f) Other and unspecified carcinomas|18815493|2002
5-9|0.1|0.1|0.1|17|XI(f) Other and unspecified carcinomas|18503153|2002
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3691140|2002
1-4|0.5|0.8|0.7|103|IX(a) Rhabdomyosarcomas|15607694|2006
10-14|0.3|0.4|0.3|68|IX(a) Rhabdomyosarcomas|19773006|2006
15-19|0.3|0.5|0.4|79|IX(a) Rhabdomyosarcomas|20449826|2006
5-9|0.3|0.5|0.4|82|IX(a) Rhabdomyosarcomas|18880537|2006
<1|0.3|0.7|0.5|19|IX(a) Rhabdomyosarcomas|4007564|2006
1-4|1.3|1.7|1.5|208|III(b) Astrocytomas|13822338|1999
10-14|1.2|1.5|1.3|240|III(b) Astrocytomas|18146881|1999
15-19|1.0|1.3|1.1|199|III(b) Astrocytomas|17976823|1999
5-9|1.3|1.6|1.4|266|III(b) Astrocytomas|18557028|1999
<1|0.9|1.6|1.2|41|III(b) Astrocytomas|3417510|1999
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|72032406|2002-2006
10-14|0.1|0.1|0.1|70|XI(c) Nasopharyngeal carcinomas|94924078|2002-2006
15-19|0.1|0.2|0.2|144|XI(c) Nasopharyngeal carcinomas|93992876|2002-2006
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|89136197|2002-2006
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|18407240|2002-2006
1-4|~|~|~|~|IX(c) Kaposi sarcoma|14042091|2000
10-14|~|~|~|~|IX(c) Kaposi sarcoma|18847598|2000
15-19|~|~|~|~|IX(c) Kaposi sarcoma|18475345|2000
1-4|0.9|1.2|1.1|146|III(c) Intracranial and intraspinal embryonal tumors|13822338|1999
10-14|0.5|0.7|0.6|110|III(c) Intracranial and intraspinal embryonal tumors|18146881|1999
15-19|0.2|0.4|0.3|57|III(c) Intracranial and intraspinal embryonal tumors|17976823|1999
5-9|0.7|1.0|0.9|159|III(c) Intracranial and intraspinal embryonal tumors|18557028|1999
<1|0.4|0.9|0.6|21|III(c) Intracranial and intraspinal embryonal tumors|3417510|1999
5-9|~|~|~|~|IX(c) Kaposi sarcoma|18755372|2000
<1|~|~|~|~|IX(c) Kaposi sarcoma|3528687|2000
1-4|0.1|0.1|0.1|70|XI(d) Malignant melanomas|72032406|2002-2006
10-14|0.4|0.4|0.4|377|XI(d) Malignant melanomas|94924078|2002-2006
15-19|1.7|1.9|1.8|1680|XI(d) Malignant melanomas|93992876|2002-2006
5-9|0.1|0.2|0.2|145|XI(d) Malignant melanomas|89136197|2002-2006
<1|0.2|0.4|0.3|54|XI(d) Malignant melanomas|18407240|2002-2006
1-4|0.5|0.8|0.6|85|III(d) Other gliomas|13822338|1999
10-14|0.2|0.4|0.3|59|III(d) Other gliomas|18146881|1999
15-19|0.2|0.4|0.3|59|III(d) Other gliomas|17976823|1999
5-9|0.5|0.8|0.7|121|III(d) Other gliomas|18557028|1999
<1|~|~|~|~|III(d) Other gliomas|3417510|1999
1-4|~|~|~|~|II(a) Hodgkin lymphomas|15688413|2004
10-14|1.0|1.3|1.1|234|II(a) Hodgkin lymphomas|20724858|2004
15-19|2.9|3.4|3.1|638|II(a) Hodgkin lymphomas|20301027|2004
5-9|0.3|0.4|0.4|68|II(a) Hodgkin lymphomas|19244948|2004
<1|~|~|~|~|II(a) Hodgkin lymphomas|4020211|2004
1-4|0.1|0.2|0.1|20|IX(d) Other specified soft tissue sarcomas|14042091|2000
10-14|0.4|0.6|0.5|90|IX(d) Other specified soft tissue sarcomas|18847598|2000
15-19|0.7|1.0|0.8|152|IX(d) Other specified soft tissue sarcomas|18475345|2000
5-9|0.2|0.3|0.3|49|IX(d) Other specified soft tissue sarcomas|18755372|2000
<1|~|~|~|~|IX(d) Other specified soft tissue sarcomas|3528687|2000
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|14042091|2000
10-14|0.1|0.3|0.2|34|IX(e) Unspecified soft tissue sarcomas|18847598|2000
15-19|0.2|0.3|0.2|40|IX(e) Unspecified soft tissue sarcomas|18475345|2000
5-9|0.1|0.2|0.1|19|IX(e) Unspecified soft tissue sarcomas|18755372|2000
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3528687|2000
1-4|~|~|~|~|XI(e) Skin carcinomas|72032406|2002-2006
10-14|~|~|~|~|XI(e) Skin carcinomas|94924078|2002-2006
15-19|~|~|~|~|XI(e) Skin carcinomas|93992876|2002-2006
5-9|~|~|~|~|XI(e) Skin carcinomas|89136197|2002-2006
<1|~|~|~|~|XI(e) Skin carcinomas|18407240|2002-2006
1-4|~|~|~|~|XI(e) Skin carcinomas|15151945|2003
10-14|~|~|~|~|XI(e) Skin carcinomas|20383692|2003
15-19|~|~|~|~|XI(e) Skin carcinomas|19681033|2003
5-9|~|~|~|~|XI(e) Skin carcinomas|19012396|2003
<1|~|~|~|~|XI(e) Skin carcinomas|3882968|2003
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15607694|2006
10-14|0.1|0.2|0.2|32|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19773006|2006
15-19|0.1|0.2|0.2|36|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20449826|2006
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|18880537|2006
<1|0.3|0.7|0.4|18|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|4007564|2006
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|13822338|1999
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|18146881|1999
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|17976823|1999
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|18557028|1999
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3417510|1999
1-4|~|~|~|~|Not classified by ICCC|14042091|2000
10-14|~|~|~|~|Not classified by ICCC|18847598|2000
15-19|~|~|~|~|Not classified by ICCC|18475345|2000
5-9|~|~|~|~|Not classified by ICCC|18755372|2000
<1|~|~|~|~|Not classified by ICCC|3528687|2000
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15151945|2003
10-14|0.3|0.5|0.4|78|XI(f) Other and unspecified carcinomas|20383692|2003
15-19|1.0|1.3|1.1|225|XI(f) Other and unspecified carcinomas|19681033|2003
5-9|0.1|0.2|0.1|20|XI(f) Other and unspecified carcinomas|19012396|2003
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3882968|2003
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|13822338|1999
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|18146881|1999
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|17976823|1999
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|18557028|1999
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3417510|1999
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15607694|2006
10-14|~|~|~|~|IX(c) Kaposi sarcoma|19773006|2006
15-19|~|~|~|~|IX(c) Kaposi sarcoma|20449826|2006
1-4|0.0|0.0|0.0|16|XI(f) Other and unspecified carcinomas|72032406|2002-2006
10-14|0.3|0.4|0.4|355|XI(f) Other and unspecified carcinomas|94924078|2002-2006
15-19|1.0|1.2|1.1|1039|XI(f) Other and unspecified carcinomas|93992876|2002-2006
5-9|0.1|0.1|0.1|97|XI(f) Other and unspecified carcinomas|89136197|2002-2006
<1|0.1|0.2|0.2|29|XI(f) Other and unspecified carcinomas|18407240|2002-2006
1-4|0.8|1.1|0.9|128|V Retinoblastoma|14042091|2000
10-14|~|~|~|~|V Retinoblastoma|18847598|2000
15-19|~|~|~|~|V Retinoblastoma|18475345|2000
5-9|~|~|~|~|V Retinoblastoma|18755372|2000
<1|2.1|3.2|2.6|93|V Retinoblastoma|3528687|2000
1-4|0.1|0.2|0.1|21|XII Other and unspecified malignant neoplasms|15151945|2003
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20383692|2003
15-19|0.1|0.2|0.2|34|XII Other and unspecified malignant neoplasms|19681033|2003
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|19012396|2003
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|14396227|2002
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|19533296|2002
15-19|0.1|0.2|0.1|26|XII Other and unspecified malignant neoplasms|18815493|2002
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|18503153|2002
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3691140|2002
1-4|1.8|2.3|2.1|287|IV Neuroblastoma and other peripheral nervous cell tumors|13822338|1999
10-14|0.1|0.2|0.1|20|IV Neuroblastoma and other peripheral nervous cell tumors|18146881|1999
15-19|0.1|0.2|0.1|18|IV Neuroblastoma and other peripheral nervous cell tumors|17976823|1999
5-9|0.2|0.4|0.3|52|IV Neuroblastoma and other peripheral nervous cell tumors|18557028|1999
<1|5.3|7.0|6.1|208|IV Neuroblastoma and other peripheral nervous cell tumors|3417510|1999
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|14214314|2001
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|19360577|2001
15-19|~|~|~|~|XII(b) Other unspecified malignant tumors|18791536|2001
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|18776213|2001
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3735453|2001
5-9|~|~|~|~|IX(c) Kaposi sarcoma|18880537|2006
<1|~|~|~|~|IX(c) Kaposi sarcoma|4007564|2006
1-4|0.1|0.1|0.1|66|XII Other and unspecified malignant neoplasms|72032406|2002-2006
10-14|0.0|0.1|0.1|56|XII Other and unspecified malignant neoplasms|94924078|2002-2006
15-19|0.1|0.2|0.1|133|XII Other and unspecified malignant neoplasms|93992876|2002-2006
5-9|0.0|0.0|0.0|29|XII Other and unspecified malignant neoplasms|89136197|2002-2006
1-4|20.3|21.8|21.1|3033|All ICCC Groups Combined|14396227|2002
10-14|12.2|13.2|12.6|2470|All ICCC Groups Combined|19533296|2002
15-19|20.8|22.1|21.5|4038|All ICCC Groups Combined|18815493|2002
5-9|11.5|12.5|12.0|2219|All ICCC Groups Combined|18503153|2002
<1|23.0|26.2|24.6|907|All ICCC Groups Combined|3691140|2002
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3882968|2003
1-4|0.8|1.1|0.9|128|II Lymphomas and reticuloendothelial neoplasms|13822338|1999
10-14|2.2|2.6|2.4|434|II Lymphomas and reticuloendothelial neoplasms|18146881|1999
15-19|4.4|5.0|4.7|839|II Lymphomas and reticuloendothelial neoplasms|17976823|1999
5-9|1.1|1.5|1.3|243|II Lymphomas and reticuloendothelial neoplasms|18557028|1999
<1|0.6|1.2|0.8|29|II Lymphomas and reticuloendothelial neoplasms|3417510|1999
1-4|0.3|0.6|0.4|60|III(d) Other gliomas|14042091|2000
10-14|0.3|0.5|0.4|73|III(d) Other gliomas|18847598|2000
15-19|0.3|0.5|0.4|75|III(d) Other gliomas|18475345|2000
5-9|0.4|0.6|0.5|99|III(d) Other gliomas|18755372|2000
<1|~|~|~|~|III(d) Other gliomas|3528687|2000
1-4|~|~|~|~|II(a) Hodgkin lymphomas|13822338|1999
10-14|1.0|1.3|1.1|207|II(a) Hodgkin lymphomas|18146881|1999
15-19|2.8|3.4|3.1|556|II(a) Hodgkin lymphomas|17976823|1999
5-9|0.3|0.5|0.4|73|II(a) Hodgkin lymphomas|18557028|1999
<1|~|~|~|~|II(a) Hodgkin lymphomas|3417510|1999
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15151945|2003
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20383692|2003
15-19|0.1|0.1|0.1|17|XII(a) Other specified malignant tumors|19681033|2003
5-9|~|~|~|~|XII(a) Other specified malignant tumors|19012396|2003
<1|~|~|~|~|XII(a) Other specified malignant tumors|3882968|2003
<1|0.1|0.3|0.2|33|XII Other and unspecified malignant neoplasms|18407240|2002-2006
1-4|0.2|0.4|0.3|47|X Germ cell, trophoblastic tumors & neoplasms of gonads|14396227|2002
10-14|0.5|0.8|0.7|128|X Germ cell, trophoblastic tumors & neoplasms of gonads|19533296|2002
15-19|2.6|3.1|2.8|530|X Germ cell, trophoblastic tumors & neoplasms of gonads|18815493|2002
5-9|0.2|0.4|0.3|50|X Germ cell, trophoblastic tumors & neoplasms of gonads|18503153|2002
<1|1.9|2.9|2.3|86|X Germ cell, trophoblastic tumors & neoplasms of gonads|3691140|2002
1-4|0.1|0.2|0.2|24|IX(d) Other specified soft tissue sarcomas|15607694|2006
10-14|0.4|0.6|0.5|102|IX(d) Other specified soft tissue sarcomas|19773006|2006
15-19|0.6|0.9|0.7|152|IX(d) Other specified soft tissue sarcomas|20449826|2006
5-9|0.2|0.3|0.2|45|IX(d) Other specified soft tissue sarcomas|18880537|2006
<1|0.4|0.9|0.6|24|IX(d) Other specified soft tissue sarcomas|4007564|2006
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|14042091|2000
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|18847598|2000
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|18475345|2000
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|18755372|2000
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3528687|2000
1-4|0.1|0.2|0.1|16|III(f) Unspecified intracranial and intraspinal neoplasms|14042091|2000
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|18847598|2000
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|18475345|2000
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|18755372|2000
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3528687|2000
1-4|0.4|0.6|0.5|69|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|13822338|1999
10-14|0.7|1.0|0.8|152|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|18146881|1999
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15151945|2003
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20383692|2003
15-19|0.1|0.1|0.1|17|XII(b) Other unspecified malignant tumors|19681033|2003
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|19012396|2003
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3882968|2003
1-4|0.0|0.1|0.1|45|XII(a) Other specified malignant tumors|72032406|2002-2006
10-14|0.0|0.0|0.0|22|XII(a) Other specified malignant tumors|94924078|2002-2006
15-19|0.0|0.1|0.1|61|XII(a) Other specified malignant tumors|93992876|2002-2006
5-9|~|~|~|~|XII(a) Other specified malignant tumors|89136197|2002-2006
<1|0.1|0.2|0.1|18|XII(a) Other specified malignant tumors|18407240|2002-2006
1-4|0.1|0.2|0.1|16|IX(e) Unspecified soft tissue sarcomas|15607694|2006
10-14|0.1|0.2|0.1|22|IX(e) Unspecified soft tissue sarcomas|19773006|2006
15-19|0.1|0.2|0.2|36|IX(e) Unspecified soft tissue sarcomas|20449826|2006
5-9|0.1|0.1|0.1|17|IX(e) Unspecified soft tissue sarcomas|18880537|2006
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|4007564|2006
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|14396227|2002
10-14|0.2|0.3|0.3|52|X(a) Intracranial & intraspinal germ cell tumors|19533296|2002
15-19|0.2|0.3|0.2|43|X(a) Intracranial & intraspinal germ cell tumors|18815493|2002
5-9|0.1|0.2|0.1|22|X(a) Intracranial & intraspinal germ cell tumors|18503153|2002
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3691140|2002
1-4|0.0|0.0|0.0|21|XII(b) Other unspecified malignant tumors|72032406|2002-2006
10-14|0.0|0.1|0.0|34|XII(b) Other unspecified malignant tumors|94924078|2002-2006
15-19|0.1|0.1|0.1|72|XII(b) Other unspecified malignant tumors|93992876|2002-2006
5-9|0.0|0.0|0.0|17|XII(b) Other unspecified malignant tumors|89136197|2002-2006
15-19|1.1|1.4|1.2|224|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|17976823|1999
5-9|0.4|0.6|0.5|98|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|18557028|1999
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3417510|1999
1-4|8.2|9.1|8.6|1245|I Leukemias, myeloproliferative & myelodysplastic diseases|14396227|2002
10-14|2.7|3.2|2.9|572|I Leukemias, myeloproliferative & myelodysplastic diseases|19533296|2002
15-19|2.9|3.4|3.1|584|I Leukemias, myeloproliferative & myelodysplastic diseases|18815493|2002
5-9|3.7|4.3|4.0|735|I Leukemias, myeloproliferative & myelodysplastic diseases|18503153|2002
<1|4.4|5.8|5.1|187|I Leukemias, myeloproliferative & myelodysplastic diseases|3691140|2002
1-4|20.9|22.4|21.7|3400|All ICCC Groups Combined|15688413|2004
10-14|12.9|13.9|13.4|2767|All ICCC Groups Combined|20724858|2004
15-19|20.9|22.2|21.6|4378|All ICCC Groups Combined|20301027|2004
5-9|11.2|12.2|11.7|2256|All ICCC Groups Combined|19244948|2004
<1|23.9|27.0|25.4|1022|All ICCC Groups Combined|4020211|2004
1-4|1.7|2.1|1.9|265|IV Neuroblastoma and other peripheral nervous cell tumors|14042091|2000
10-14|0.1|0.2|0.1|23|IV Neuroblastoma and other peripheral nervous cell tumors|18847598|2000
15-19|~|~|~|~|IV Neuroblastoma and other peripheral nervous cell tumors|18475345|2000
5-9|0.2|0.4|0.3|61|IV Neuroblastoma and other peripheral nervous cell tumors|18755372|2000
<1|4.7|6.2|5.4|191|IV Neuroblastoma and other peripheral nervous cell tumors|3528687|2000
1-4|~|~|~|~|X(d) Gonadal carcinomas|14214314|2001
10-14|~|~|~|~|X(d) Gonadal carcinomas|19360577|2001
15-19|0.1|0.2|0.1|19|X(d) Gonadal carcinomas|18791536|2001
5-9|~|~|~|~|X(d) Gonadal carcinomas|18776213|2001
<1|~|~|~|~|X(d) Gonadal carcinomas|3735453|2001
1-4|1.6|2.0|1.8|282|III(b) Astrocytomas|15607694|2006
10-14|1.2|1.6|1.4|278|III(b) Astrocytomas|19773006|2006
15-19|1.1|1.4|1.2|248|III(b) Astrocytomas|20449826|2006
5-9|1.2|1.5|1.3|254|III(b) Astrocytomas|18880537|2006
<1|0.8|1.5|1.1|45|III(b) Astrocytomas|4007564|2006
1-4|8.7|9.6|9.1|1432|I Leukemias, myeloproliferative & myelodysplastic diseases|15688413|2004
10-14|2.7|3.2|2.9|606|I Leukemias, myeloproliferative & myelodysplastic diseases|20724858|2004
15-19|2.9|3.3|3.1|627|I Leukemias, myeloproliferative & myelodysplastic diseases|20301027|2004
5-9|3.8|4.3|4.0|776|I Leukemias, myeloproliferative & myelodysplastic diseases|19244948|2004
<1|4.2|5.6|4.9|197|I Leukemias, myeloproliferative & myelodysplastic diseases|4020211|2004
1-4|1.7|2.1|1.9|265|IV(a) Neuroblastoma and ganglioneuroblastoma|14042091|2000
10-14|0.1|0.2|0.1|19|IV(a) Neuroblastoma and ganglioneuroblastoma|18847598|2000
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|18475345|2000
5-9|0.2|0.4|0.3|59|IV(a) Neuroblastoma and ganglioneuroblastoma|18755372|2000
<1|4.7|6.2|5.4|191|IV(a) Neuroblastoma and ganglioneuroblastoma|3528687|2000
1-4|0.1|0.2|0.2|115|X(b) Malignant extracranial & extragonadal germ cell tumors|72032406|2002-2006
10-14|0.0|0.0|0.0|27|X(b) Malignant extracranial & extragonadal germ cell tumors|94924078|2002-2006
15-19|0.1|0.2|0.2|145|X(b) Malignant extracranial & extragonadal germ cell tumors|93992876|2002-2006
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|89136197|2002-2006
<1|1.2|1.6|1.4|255|X(b) Malignant extracranial & extragonadal germ cell tumors|18407240|2002-2006
1-4|0.1|0.3|0.2|24|II(c) Burkitt lymphoma|13822338|1999
10-14|0.2|0.4|0.3|56|II(c) Burkitt lymphoma|18146881|1999
15-19|0.1|0.3|0.2|37|II(c) Burkitt lymphoma|17976823|1999
5-9|0.2|0.4|0.3|58|II(c) Burkitt lymphoma|18557028|1999
<1|~|~|~|~|II(c) Burkitt lymphoma|3417510|1999
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|14214314|2001
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19360577|2001
15-19|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|18791536|2001
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|18776213|2001
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3735453|2001
1-4|0.9|1.3|1.1|173|III(c) Intracranial and intraspinal embryonal tumors|15607694|2006
10-14|0.3|0.5|0.4|74|III(c) Intracranial and intraspinal embryonal tumors|19773006|2006
15-19|0.2|0.3|0.2|47|III(c) Intracranial and intraspinal embryonal tumors|20449826|2006
5-9|0.6|0.8|0.7|135|III(c) Intracranial and intraspinal embryonal tumors|18880537|2006
<1|0.9|1.6|1.2|50|III(c) Intracranial and intraspinal embryonal tumors|4007564|2006
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|14042091|2000
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|18847598|2000
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|18475345|2000
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|18755372|2000
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3528687|2000
1-4|0.1|0.2|0.1|19|X(b) Malignant extracranial & extragonadal germ cell tumors|14396227|2002
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19533296|2002
15-19|0.1|0.3|0.2|36|X(b) Malignant extracranial & extragonadal germ cell tumors|18815493|2002
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|18503153|2002
<1|1.2|2.1|1.6|60|X(b) Malignant extracranial & extragonadal germ cell tumors|3691140|2002
1-4|0.1|0.2|0.1|102|X(c) Malignant gonadal germ cell tumors|72032406|2002-2006
10-14|0.4|0.4|0.4|371|X(c) Malignant gonadal germ cell tumors|94924078|2002-2006
15-19|2.1|2.3|2.2|2028|X(c) Malignant gonadal germ cell tumors|93992876|2002-2006
5-9|0.1|0.1|0.1|92|X(c) Malignant gonadal germ cell tumors|89136197|2002-2006
<1|0.3|0.5|0.4|81|X(c) Malignant gonadal germ cell tumors|18407240|2002-2006
1-4|0.1|0.2|0.1|19|II(d) Miscellaneous lymphoreticular neoplasms|13822338|1999
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|18146881|1999
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|17976823|1999
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|18557028|1999
<1|0.3|0.9|0.6|19|II(d) Miscellaneous lymphoreticular neoplasms|3417510|1999
1-4|0.1|0.2|0.2|22|XI Other malignant epithelial neoplasms and malignant melanomas|14214314|2001
10-14|1.3|1.6|1.5|284|XI Other malignant epithelial neoplasms and malignant melanomas|19360577|2001
15-19|4.2|4.9|4.5|853|XI Other malignant epithelial neoplasms and malignant melanomas|18791536|2001
5-9|0.3|0.5|0.4|72|XI Other malignant epithelial neoplasms and malignant melanomas|18776213|2001
<1|~|~|~|~|XI Other malignant epithelial neoplasms and malignant melanomas|3735453|2001
1-4|0.9|1.3|1.1|151|IX Soft tissue and other extraosseous sarcomas|14042091|2000
10-14|1.0|1.3|1.1|214|IX Soft tissue and other extraosseous sarcomas|18847598|2000
15-19|1.4|1.8|1.6|299|IX Soft tissue and other extraosseous sarcomas|18475345|2000
5-9|0.7|0.9|0.8|149|IX Soft tissue and other extraosseous sarcomas|18755372|2000
<1|1.2|2.1|1.6|57|IX Soft tissue and other extraosseous sarcomas|3528687|2000
1-4|0.4|0.6|0.5|80|III(d) Other gliomas|15607694|2006
10-14|0.3|0.5|0.4|79|III(d) Other gliomas|19773006|2006
15-19|0.3|0.5|0.4|89|III(d) Other gliomas|20449826|2006
5-9|0.6|0.8|0.7|129|III(d) Other gliomas|18880537|2006
<1|~|~|~|~|III(d) Other gliomas|4007564|2006
1-4|~|~|~|~|X(d) Gonadal carcinomas|72032406|2002-2006
10-14|0.0|0.0|0.0|26|X(d) Gonadal carcinomas|94924078|2002-2006
15-19|0.1|0.1|0.1|113|X(d) Gonadal carcinomas|93992876|2002-2006
1-4|0.1|0.2|0.2|23|X(c) Malignant gonadal germ cell tumors|14396227|2002
10-14|0.3|0.4|0.3|64|X(c) Malignant gonadal germ cell tumors|19533296|2002
15-19|2.0|2.4|2.2|418|X(c) Malignant gonadal germ cell tumors|18815493|2002
5-9|0.1|0.2|0.1|24|X(c) Malignant gonadal germ cell tumors|18503153|2002
<1|0.3|0.8|0.5|19|X(c) Malignant gonadal germ cell tumors|3691140|2002
1-4|~|~|~|~|II(e) Unspecified lymphomas|13822338|1999
10-14|~|~|~|~|II(e) Unspecified lymphomas|18146881|1999
15-19|0.1|0.2|0.1|20|II(e) Unspecified lymphomas|17976823|1999
5-9|~|~|~|~|II(e) Unspecified lymphomas|18557028|1999
<1|~|~|~|~|II(e) Unspecified lymphomas|3417510|1999
1-4|0.1|0.3|0.2|28|II(c) Burkitt lymphoma|14042091|2000
10-14|0.2|0.4|0.3|55|II(c) Burkitt lymphoma|18847598|2000
15-19|0.2|0.3|0.2|43|II(c) Burkitt lymphoma|18475345|2000
5-9|0.3|0.5|0.4|74|II(c) Burkitt lymphoma|18755372|2000
<1|~|~|~|~|II(c) Burkitt lymphoma|3528687|2000
1-4|3.4|4.1|3.8|519|III CNS and misc intracranial and intraspinal neoplasms|13822338|1999
10-14|2.3|2.8|2.5|461|III CNS and misc intracranial and intraspinal neoplasms|18146881|1999
15-19|1.8|2.2|2.0|357|III CNS and misc intracranial and intraspinal neoplasms|17976823|1999
5-9|3.0|3.5|3.2|603|III CNS and misc intracranial and intraspinal neoplasms|18557028|1999
<1|2.4|3.6|2.9|100|III CNS and misc intracranial and intraspinal neoplasms|3417510|1999
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15607694|2006
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|19773006|2006
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20449826|2006
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|14214314|2001
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|19360577|2001
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|18791536|2001
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|18776213|2001
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3735453|2001
5-9|~|~|~|~|X(d) Gonadal carcinomas|89136197|2002-2006
<1|~|~|~|~|X(d) Gonadal carcinomas|18407240|2002-2006
1-4|~|~|~|~|X(d) Gonadal carcinomas|14396227|2002
10-14|~|~|~|~|X(d) Gonadal carcinomas|19533296|2002
15-19|0.0|0.1|0.1|16|X(d) Gonadal carcinomas|18815493|2002
5-9|~|~|~|~|X(d) Gonadal carcinomas|18503153|2002
<1|~|~|~|~|X(d) Gonadal carcinomas|3691140|2002
1-4|0.1|0.3|0.2|30|II(d) Miscellaneous lymphoreticular neoplasms|14042091|2000
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|18847598|2000
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|18475345|2000
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|18755372|2000
<1|0.4|1.0|0.7|23|II(d) Miscellaneous lymphoreticular neoplasms|3528687|2000
1-4|~|~|~|~|II(e) Unspecified lymphomas|14042091|2000
10-14|~|~|~|~|II(e) Unspecified lymphomas|18847598|2000
15-19|~|~|~|~|II(e) Unspecified lymphomas|18475345|2000
5-9|0.0|0.1|0.1|16|II(e) Unspecified lymphomas|18755372|2000
<1|~|~|~|~|II(e) Unspecified lymphomas|3528687|2000
1-4|19.1|20.6|19.9|2744|All ICCC Groups Combined|13822338|1999
10-14|11.8|12.9|12.3|2239|All ICCC Groups Combined|18146881|1999
15-19|19.1|20.4|19.7|3549|All ICCC Groups Combined|17976823|1999
5-9|10.6|11.5|11.1|2052|All ICCC Groups Combined|18557028|1999
<1|22.3|25.6|23.9|817|All ICCC Groups Combined|3417510|1999
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|18880537|2006
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|4007564|2006
1-4|3.7|4.3|4.0|558|III CNS and misc intracranial and intraspinal neoplasms|14042091|2000
10-14|2.5|2.9|2.7|508|III CNS and misc intracranial and intraspinal neoplasms|18847598|2000
15-19|1.9|2.4|2.1|397|III CNS and misc intracranial and intraspinal neoplasms|18475345|2000
5-9|3.0|3.5|3.3|613|III CNS and misc intracranial and intraspinal neoplasms|18755372|2000
1-4|0.2|0.3|0.2|37|II(d) Miscellaneous lymphoreticular neoplasms|15917630|2005
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20461017|2005
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20618219|2005
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19173994|2005
<1|0.4|0.9|0.6|26|II(d) Miscellaneous lymphoreticular neoplasms|4030153|2005
<1|2.7|3.9|3.3|115|III CNS and misc intracranial and intraspinal neoplasms|3528687|2000
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|72032406|2002-2006
10-14|0.0|0.0|0.0|26|X(e) Other and unspecified malignant gonadal tumors|94924078|2002-2006
15-19|0.1|0.1|0.1|80|X(e) Other and unspecified malignant gonadal tumors|93992876|2002-2006
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|89136197|2002-2006
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|18407240|2002-2006
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|14396227|2002
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19533296|2002
15-19|0.1|0.1|0.1|17|X(e) Other and unspecified malignant gonadal tumors|18815493|2002
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|18503153|2002
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3691140|2002
1-4|~|~|~|~|XI(b) Thyroid carcinomas|14214314|2001
10-14|0.5|0.7|0.6|114|XI(b) Thyroid carcinomas|19360577|2001
15-19|1.4|1.8|1.6|303|XI(b) Thyroid carcinomas|18791536|2001
5-9|0.1|0.2|0.1|19|XI(b) Thyroid carcinomas|18776213|2001
<1|~|~|~|~|XI(b) Thyroid carcinomas|3735453|2001
1-4|7.7|8.7|8.2|1132|I Leukemias, myeloproliferative & myelodysplastic diseases|13822338|1999
10-14|2.6|3.1|2.8|515|I Leukemias, myeloproliferative & myelodysplastic diseases|18146881|1999
15-19|2.5|3.0|2.7|488|I Leukemias, myeloproliferative & myelodysplastic diseases|17976823|1999
5-9|3.5|4.0|3.7|691|I Leukemias, myeloproliferative & myelodysplastic diseases|18557028|1999
<1|3.8|5.2|4.4|152|I Leukemias, myeloproliferative & myelodysplastic diseases|3417510|1999
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15607694|2006
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19773006|2006
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20449826|2006
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|18880537|2006
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|4007564|2006
1-4|0.2|0.2|0.2|142|XI Other malignant epithelial neoplasms and malignant melanomas|72032406|2002-2006
10-14|1.3|1.5|1.4|1325|XI Other malignant epithelial neoplasms and malignant melanomas|94924078|2002-2006
15-19|4.8|5.1|4.9|4613|XI Other malignant epithelial neoplasms and malignant melanomas|93992876|2002-2006
5-9|0.4|0.5|0.4|369|XI Other malignant epithelial neoplasms and malignant melanomas|89136197|2002-2006
<1|0.4|0.6|0.5|95|XI Other malignant epithelial neoplasms and malignant melanomas|18407240|2002-2006
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|14214314|2001
1-4|6.5|7.3|6.9|952|I(a) Lymphoid leukemias|13822338|1999
10-14|1.8|2.2|2.0|363|I(a) Lymphoid leukemias|18146881|1999
15-19|1.3|1.6|1.4|257|I(a) Lymphoid leukemias|17976823|1999
5-9|2.8|3.3|3.1|572|I(a) Lymphoid leukemias|18557028|1999
<1|1.7|2.7|2.2|74|I(a) Lymphoid leukemias|3417510|1999
1-4|1.7|2.1|1.9|299|IV Neuroblastoma and other peripheral nervous cell tumors|15607694|2006
1-4|0.0|0.1|0.0|34|XI(a) Adrenocortical carcinomas|72032406|2002-2006
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|94924078|2002-2006
15-19|0.0|0.0|0.0|17|XI(a) Adrenocortical carcinomas|93992876|2002-2006
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|89136197|2002-2006
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|18407240|2002-2006
1-4|0.2|0.3|0.2|32|XI Other malignant epithelial neoplasms and malignant melanomas|14396227|2002
10-14|1.2|1.5|1.3|259|XI Other malignant epithelial neoplasms and malignant melanomas|19533296|2002
15-19|4.6|5.3|5.0|932|XI Other malignant epithelial neoplasms and malignant melanomas|18815493|2002
5-9|0.3|0.5|0.4|76|XI Other malignant epithelial neoplasms and malignant melanomas|18503153|2002
<1|~|~|~|~|XI Other malignant epithelial neoplasms and malignant melanomas|3691140|2002
10-14|0.1|0.1|0.1|17|XI(c) Nasopharyngeal carcinomas|19360577|2001
15-19|0.1|0.2|0.1|25|XI(c) Nasopharyngeal carcinomas|18791536|2001
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|18776213|2001
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3735453|2001
1-4|0.9|1.3|1.1|151|I(b) Acute myeloid leukemias|13822338|1999
10-14|0.5|0.8|0.6|116|I(b) Acute myeloid leukemias|18146881|1999
15-19|0.8|1.1|1.0|172|I(b) Acute myeloid leukemias|17976823|1999
5-9|0.4|0.6|0.5|93|I(b) Acute myeloid leukemias|18557028|1999
<1|1.2|2.1|1.6|54|I(b) Acute myeloid leukemias|3417510|1999
1-4|0.0|0.0|0.0|22|XI(b) Thyroid carcinomas|72032406|2002-2006
10-14|0.5|0.6|0.5|499|XI(b) Thyroid carcinomas|94924078|2002-2006
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|14396227|2002
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19533296|2002
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|18815493|2002
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|18503153|2002
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3691140|2002
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|13822338|1999
10-14|0.1|0.1|0.1|16|I(c) Chronic myeloproliferative diseases|18146881|1999
15-19|0.1|0.3|0.2|38|I(c) Chronic myeloproliferative diseases|17976823|1999
5-9|~|~|~|~|I(c) Chronic myeloproliferative diseases|18557028|1999
<1|~|~|~|~|I(c) Chronic myeloproliferative diseases|3417510|1999
1-4|~|~|~|~|XI(d) Malignant melanomas|14214314|2001
10-14|0.3|0.5|0.4|77|XI(d) Malignant melanomas|19360577|2001
15-19|1.5|1.9|1.7|319|XI(d) Malignant melanomas|18791536|2001
5-9|0.1|0.2|0.1|24|XI(d) Malignant melanomas|18776213|2001
<1|~|~|~|~|XI(d) Malignant melanomas|3735453|2001
1-4|0.0|0.1|0.0|27|VIII(a) Osteosarcomas|72032406|2002-2006
10-14|0.8|0.9|0.8|778|VIII(a) Osteosarcomas|94924078|2002-2006
15-19|0.8|1.0|0.9|840|VIII(a) Osteosarcomas|93992876|2002-2006
5-9|0.3|0.3|0.3|263|VIII(a) Osteosarcomas|89136197|2002-2006
<1|~|~|~|~|VIII(a) Osteosarcomas|18407240|2002-2006
1-4|0.1|0.2|0.2|23|VIII Malignant bone tumors|14396227|2002
10-14|1.2|1.5|1.3|256|VIII Malignant bone tumors|19533296|2002
15-19|1.4|1.8|1.6|295|VIII Malignant bone tumors|18815493|2002
5-9|0.5|0.7|0.6|108|VIII Malignant bone tumors|18503153|2002
<1|~|~|~|~|VIII Malignant bone tumors|3691140|2002
1-4|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|14214314|2001
10-14|0.4|0.6|0.5|96|VIII(c) Ewing tumor and related sarcomas of bone|19360577|2001
15-19|0.4|0.6|0.5|99|VIII(c) Ewing tumor and related sarcomas of bone|18791536|2001
5-9|0.2|0.3|0.2|40|VIII(c) Ewing tumor and related sarcomas of bone|18776213|2001
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3735453|2001
1-4|~|~|~|~|VIII(a) Osteosarcomas|14396227|2002
10-14|0.6|0.9|0.8|150|VIII(a) Osteosarcomas|19533296|2002
15-19|0.7|1.0|0.9|163|VIII(a) Osteosarcomas|18815493|2002
5-9|0.2|0.4|0.3|53|VIII(a) Osteosarcomas|18503153|2002
<1|~|~|~|~|VIII(a) Osteosarcomas|3691140|2002
1-4|~|~|~|~|VIII(b) Chondrosarcomas|14396227|2002
10-14|~|~|~|~|VIII(b) Chondrosarcomas|19533296|2002
15-19|0.1|0.2|0.1|28|VIII(b) Chondrosarcomas|18815493|2002
5-9|~|~|~|~|VIII(b) Chondrosarcomas|18503153|2002
<1|~|~|~|~|VIII(b) Chondrosarcomas|3691140|2002
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|14214314|2001
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|19360577|2001
15-19|0.1|0.2|0.1|19|VIII(d) Other specified malignant bone tumors|18791536|2001
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|18776213|2001
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3735453|2001
1-4|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|14396227|2002
10-14|0.3|0.5|0.4|82|VIII(c) Ewing tumor and related sarcomas of bone|19533296|2002
15-19|0.4|0.5|0.4|83|VIII(c) Ewing tumor and related sarcomas of bone|18815493|2002
5-9|0.2|0.3|0.3|47|VIII(c) Ewing tumor and related sarcomas of bone|18503153|2002
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3691140|2002
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|14214314|2001
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19360577|2001
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|18791536|2001
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|18776213|2001
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3735453|2001
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|14396227|2002
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|19533296|2002
15-19|0.1|0.2|0.1|18|VIII(d) Other specified malignant bone tumors|18815493|2002
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|18503153|2002
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3691140|2002
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|14396227|2002
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19533296|2002
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|18815493|2002
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|18503153|2002
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3691140|2002
1-4|0.3|0.5|0.3|49|X Germ cell, trophoblastic tumors & neoplasms of gonads|14214314|2001
10-14|0.5|0.8|0.7|126|X Germ cell, trophoblastic tumors & neoplasms of gonads|19360577|2001
15-19|2.4|2.9|2.6|496|X Germ cell, trophoblastic tumors & neoplasms of gonads|18791536|2001
5-9|0.1|0.3|0.2|34|X Germ cell, trophoblastic tumors & neoplasms of gonads|18776213|2001
<1|1.7|2.6|2.1|78|X Germ cell, trophoblastic tumors & neoplasms of gonads|3735453|2001
1-4|0.7|1.0|0.8|122|V Retinoblastoma|14396227|2002
10-14|~|~|~|~|V Retinoblastoma|19533296|2002
15-19|~|~|~|~|V Retinoblastoma|18815493|2002
5-9|~|~|~|~|V Retinoblastoma|18503153|2002
<1|1.8|2.8|2.3|84|V Retinoblastoma|3691140|2002
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|14214314|2001
10-14|0.2|0.4|0.3|52|X(a) Intracranial & intraspinal germ cell tumors|19360577|2001
15-19|0.2|0.3|0.3|47|X(a) Intracranial & intraspinal germ cell tumors|18791536|2001
5-9|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|18776213|2001
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3735453|2001
1-4|1.8|2.2|2.0|288|VI Renal tumors|14396227|2002
10-14|0.1|0.2|0.1|19|VI Renal tumors|19533296|2002
15-19|0.1|0.2|0.1|23|VI Renal tumors|18815493|2002
5-9|0.4|0.6|0.5|87|VI Renal tumors|18503153|2002
<1|1.4|2.3|1.8|68|VI Renal tumors|3691140|2002
1-4|0.1|0.3|0.2|25|X(b) Malignant extracranial & extragonadal germ cell tumors|14214314|2001
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19360577|2001
15-19|0.2|0.3|0.2|41|X(b) Malignant extracranial & extragonadal germ cell tumors|18791536|2001
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|18776213|2001
<1|0.9|1.7|1.3|48|X(b) Malignant extracranial & extragonadal germ cell tumors|3735453|2001
1-4|1.8|2.2|2.0|286|VI(a) Nephroblastoma and other nonepithelial renal tumors|14396227|2002
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|19533296|2002
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|18815493|2002
5-9|0.4|0.6|0.4|83|VI(a) Nephroblastoma and other nonepithelial renal tumors|18503153|2002
<1|1.4|2.3|1.8|68|VI(a) Nephroblastoma and other nonepithelial renal tumors|3691140|2002
1-4|0.1|0.2|0.2|22|X(c) Malignant gonadal germ cell tumors|14214314|2001
10-14|0.2|0.4|0.3|57|X(c) Malignant gonadal germ cell tumors|19360577|2001
15-19|1.8|2.2|2.0|380|X(c) Malignant gonadal germ cell tumors|18791536|2001
5-9|0.1|0.1|0.1|17|X(c) Malignant gonadal germ cell tumors|18776213|2001
<1|0.3|0.8|0.5|20|X(c) Malignant gonadal germ cell tumors|3735453|2001
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|19360577|2001
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|18791536|2001
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|18776213|2001
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3735453|2001
1-4|0.3|0.5|0.4|54|VII Hepatic tumors|14214314|2001
10-14|~|~|~|~|VII Hepatic tumors|19360577|2001
15-19|0.1|0.2|0.1|19|VII Hepatic tumors|18791536|2001
5-9|~|~|~|~|VII Hepatic tumors|18776213|2001
<1|0.7|1.4|1.0|39|VII Hepatic tumors|3735453|2001
1-4|0.3|0.5|0.4|51|VII(a) Hepatoblastoma|14214314|2001
10-14|~|~|~|~|VII(a) Hepatoblastoma|19360577|2001
15-19|~|~|~|~|VII(a) Hepatoblastoma|18791536|2001
5-9|~|~|~|~|VII(a) Hepatoblastoma|18776213|2001
<1|0.7|1.4|1.0|37|VII(a) Hepatoblastoma|3735453|2001
1-4|~|~|~|~|VII(b) Hepatic carcinomas|14214314|2001
10-14|~|~|~|~|VII(b) Hepatic carcinomas|19360577|2001
15-19|0.1|0.2|0.1|18|VII(b) Hepatic carcinomas|18791536|2001
5-9|~|~|~|~|VII(b) Hepatic carcinomas|18776213|2001
<1|~|~|~|~|VII(b) Hepatic carcinomas|3735453|2001
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|14214314|2001
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19360577|2001
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|18791536|2001
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|18776213|2001
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3735453|2001
1-4|0.1|0.2|0.1|21|VIII Malignant bone tumors|14214314|2001
10-14|1.2|1.5|1.4|264|VIII Malignant bone tumors|19360577|2001
15-19|1.5|1.9|1.7|314|VIII Malignant bone tumors|18791536|2001
5-9|0.4|0.6|0.5|100|VIII Malignant bone tumors|18776213|2001
<1|~|~|~|~|VIII Malignant bone tumors|3735453|2001
1-4|~|~|~|~|VIII(a) Osteosarcomas|14214314|2001
10-14|0.7|0.9|0.8|154|VIII(a) Osteosarcomas|19360577|2001
15-19|0.8|1.1|0.9|173|VIII(a) Osteosarcomas|18791536|2001
5-9|0.2|0.4|0.3|54|VIII(a) Osteosarcomas|18776213|2001
<1|~|~|~|~|VIII(a) Osteosarcomas|3735453|2001
1-4|~|~|~|~|VIII(b) Chondrosarcomas|14214314|2001
10-14|~|~|~|~|VIII(b) Chondrosarcomas|19360577|2001
15-19|0.1|0.2|0.1|18|VIII(b) Chondrosarcomas|18791536|2001
5-9|~|~|~|~|VIII(b) Chondrosarcomas|18776213|2001
<1|~|~|~|~|VIII(b) Chondrosarcomas|3735453|2001
1-4|0.1|0.2|0.2|23|IX(d) Other specified soft tissue sarcomas|14214314|2001
10-14|0.4|0.6|0.5|98|IX(d) Other specified soft tissue sarcomas|19360577|2001
15-19|0.6|0.9|0.7|136|IX(d) Other specified soft tissue sarcomas|18791536|2001
5-9|0.1|0.2|0.2|33|IX(d) Other specified soft tissue sarcomas|18776213|2001
<1|0.2|0.7|0.4|16|IX(d) Other specified soft tissue sarcomas|3735453|2001
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|14214314|2001
10-14|0.1|0.3|0.2|35|IX(e) Unspecified soft tissue sarcomas|19360577|2001
15-19|0.1|0.3|0.2|36|IX(e) Unspecified soft tissue sarcomas|18791536|2001
5-9|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|18776213|2001
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3735453|2001
1-4|~|~|~|~|Not classified by ICCC|14214314|2001
10-14|~|~|~|~|Not classified by ICCC|19360577|2001
15-19|~|~|~|~|Not classified by ICCC|18791536|2001
5-9|~|~|~|~|Not classified by ICCC|18776213|2001
<1|~|~|~|~|Not classified by ICCC|3735453|2001
1-4|0.8|1.1|0.9|129|V Retinoblastoma|14214314|2001
10-14|~|~|~|~|V Retinoblastoma|19360577|2001
15-19|~|~|~|~|V Retinoblastoma|18791536|2001
5-9|~|~|~|~|V Retinoblastoma|18776213|2001
<1|2.3|3.4|2.8|106|V Retinoblastoma|3735453|2001
1-4|1.8|2.3|2.0|288|VI Renal tumors|14214314|2001
10-14|0.1|0.2|0.1|28|VI Renal tumors|19360577|2001
15-19|0.1|0.2|0.1|25|VI Renal tumors|18791536|2001
5-9|0.4|0.6|0.5|94|VI Renal tumors|18776213|2001
<1|1.3|2.2|1.7|65|VI Renal tumors|3735453|2001
1-4|1.8|2.3|2.0|285|VI(a) Nephroblastoma and other nonepithelial renal tumors|14214314|2001
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|19360577|2001
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|18791536|2001
5-9|0.4|0.6|0.5|90|VI(a) Nephroblastoma and other nonepithelial renal tumors|18776213|2001
<1|1.3|2.2|1.7|63|VI(a) Nephroblastoma and other nonepithelial renal tumors|3735453|2001
1-4|~|~|~|~|VI(b) Renal carcinomas|14214314|2001
10-14|~|~|~|~|VI(b) Renal carcinomas|19360577|2001
15-19|0.1|0.2|0.1|22|VI(b) Renal carcinomas|18791536|2001
5-9|~|~|~|~|VI(b) Renal carcinomas|18776213|2001
<1|~|~|~|~|VI(b) Renal carcinomas|3735453|2001
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|14214314|2001
1-4|2.1|2.6|2.4|338|IV Neuroblastoma and other peripheral nervous cell tumors|14214314|2001
10-14|0.1|0.2|0.1|26|IV Neuroblastoma and other peripheral nervous cell tumors|19360577|2001
15-19|~|~|~|~|IV Neuroblastoma and other peripheral nervous cell tumors|18791536|2001
5-9|0.3|0.4|0.3|62|IV Neuroblastoma and other peripheral nervous cell tumors|18776213|2001
<1|5.4|7.1|6.2|232|IV Neuroblastoma and other peripheral nervous cell tumors|3735453|2001
1-4|2.1|2.6|2.4|336|IV(a) Neuroblastoma and ganglioneuroblastoma|14214314|2001
10-14|0.1|0.2|0.1|24|IV(a) Neuroblastoma and ganglioneuroblastoma|19360577|2001
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|18791536|2001
5-9|0.2|0.4|0.3|61|IV(a) Neuroblastoma and ganglioneuroblastoma|18776213|2001
<1|5.4|7.0|6.2|231|IV(a) Neuroblastoma and ganglioneuroblastoma|3735453|2001
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|14214314|2001
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19360577|2001
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|18791536|2001
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|18776213|2001
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3735453|2001
